Search by Journal
- HOME
- > Search by Journal
- > Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences
Volume , Issue suppl.1 / 2009
English Article 
Japanese Article- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
|
It is science and clinical fusion the future when the clinical pharmacy makes it Hitoshi Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2009. |
|---|
|
|
It is neurodegenerative with a physiology of the prion protein Shigeru Katamine Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2009. |
|---|
|
|
For establishment of the true pharmacist professional ability Soichiro Isobe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 158-158, 2009. |
|---|
|
|
A cutting edge of the clinical pharmacy in four-dimensional world with thought: Mitsuru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2009. |
|---|
|
|
Cancer molecules target medicine and biomarker Kazuto Nishio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2009. |
|---|
|
|
Today of the chronic liver disease practice Kazuhiko Nakao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2009. |
|---|
|
|
Circulatory disease and circadian rhythm Koji Maemura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2009. |
|---|
|
|
Study on origin medicine detection of the drug allergy, clinical analysis and expression mechanism Katsuji Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2009. |
|---|
|
|
Of the drug economic assessment in the hospital pharmacy, actually Ise Yuya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2009. |
|---|
|
|
A construction and application of scientific grounds for a pharmacist to contribute to inhalation therapy Masashi Sakano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2009. |
|---|
|
|
Pharmacoepidemiologic example and research design Lower temple Minoru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2009. |
|---|
|
|
Purpose of the seminar Shinko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2009. |
|---|
|
|
Knowledge and point of the author at article contribution and revision to a learned journal The amount of Ariyoshi example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2009. |
|---|
|
|
From the viewpoint of point - review person to write completeness and a reliable article more - Nobuyuki Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2009. |
|---|
|
|
Action - in S1-1 six years system pharmacy education - Hiroshima University Koichiro Ozawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2009. |
|---|
|
|
Construction of the training system educating a guidance-like pharmacist in the S1-2 future Kenji Matsuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2009. |
|---|
|
|
S1-3 Clinical Practice Guidelines as Markers of Quality in Hospitals Michael A.Oszko1, Tomoji Yoshiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2009. |
|---|
|
|
From the duties of S1-4 days to practical education from the situation of - opening of an office pharmacist - Taizo Nagata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2009. |
|---|
|
|
From the duties of S1-5 days to practical education from the situation of - hospital pharmacist - Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2009. |
|---|
|
|
Is S2-1 why CKD a problem? Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2009. |
|---|
|
|
Pharmacotherapy to do progress of S2-2 CKD slowly Akio Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2009. |
|---|
|
|
Drug proper use for complications of S2-3 CKD Motoki Urata, Miyuki Ota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2009. |
|---|
|
|
A theory and matters that require attention of the pharmacotherapy in S2-4 CKD Old Taku Kubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2009. |
|---|
|
|
Role - of the pharmacist in the S3-1 safety management general remarks - medical care security Fumito Tsuchiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2009. |
|---|
|
|
From an administrative viewpoint about S3-2 medical care security Kazuhiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2009. |
|---|
|
|
Action for the medical care that S3-3 is safe Hiroyuki Kurihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2009. |
|---|
|
|
Action of the drug industry to S3-4 medical care security Tsutomu Sonoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2009. |
|---|
|
|
Elucidation of the cancer drug resistance mechanism by the S4-1 fur Mako proteomics analysis Sumio Otsuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2009. |
|---|
|
|
The diagnosis of S4-2 cancer and the use of the transporter activity to treatment 玉井郁巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2009. |
|---|
|
|
DDS, development of the liposomal preparation to target S4-3 transferrin receptor Kazuo Maruyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2009. |
|---|
|
|
Safety management of the cancer pharmacotherapy that a pharmacist specialized in S4-4 cancer proposes Takuya Iwamoto, Shinko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2009. |
|---|
|
|
S4-5 cancer pain treatment and opioid receptor Tsutomu Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2009. |
|---|
|
|
It is the pharmacist from this S5-PL basic tone lecture Tatsuya Horiuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2009. |
|---|
|
|
The bedside training of the attack aiming at the improvement of the S5-1 pharmacist technology mainly on skill mixture: Takamura rich person, Jin Tokunaga, Kenji Ogata, Hiroki Yoshida, Nao Setoguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2009. |
|---|
|
|
For the practice of drug duties to learn from the S5-2 patients Tomonori Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2009. |
|---|
|
|
The S5-3 pressure sore measures found likelihood of the pharmacist professional ability It is passed through old Masaru Den Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2009. |
|---|
|
|
We work on the evil that S5-4 psychiatric pharmacotherapy results in with the patients Kimiko Matsuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2009. |
|---|
|
|
To grow, and to make S6-PL participation type business training a certain The Toru Irie beauty Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2009. |
|---|
|
|
For S6-1 long-term business training (from the situation of the drugstore) Yutaka Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2009. |
|---|
|
|
Problem (from the situation of the primarily basic hospital) for the success of the S6-2 pharmacy six years system long-term business training Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2009. |
|---|
|
|
Action to S6-3 Gifu Hospital Pharmacist Association Seino block group type business training Tomoyuki Hosoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2009. |
|---|
|
|
Term of the S7 organizer Takao Orii1, 2, Katsushi Yamada2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2009. |
|---|
|
|
S7-1 The Role of Hospital Pharmacist in Early-phase Clinical Trials in China Duan Jingli, Zhai Suodi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2009. |
|---|
|
|
S7-2 Pharmacists and Pharmacy Technicians:Looking to the Future of Pharmacy Care in Japan Shiho Yoshioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2009. |
|---|
|
|
S7-3 The History of Clinical Pharmacy in Korea Wan Gyoon Shin Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2009. |
|---|
|
|
S7-4 Steady-State Pharmacokinetics of Lamivudine in Plasma following Administration of Lamivudine at 300 mg Once Daily and 150 mg Twice Daily in HIV-infected patients Ye Min1, Wang Lu2, Fu Qiang1, Zhu Zhu1, Li Taisheng2, Li Peng1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2009. |
|---|
|
|
S7-5 Training Human Resources to Support Self-Medication An Experiment in Academic-Industrial Collaboration Mitsuko Onda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2009. |
|---|
|
|
S8-PL basic tone lecture is scientific, and it keeps clinic pharmacokinetics information alive for rational medical treatment Hiroyasu Ogata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2009. |
|---|
|
|
S8-1 Prescription support based on a population theory in the neonates medical treatment 湯川榮二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2009. |
|---|
|
|
Practice - of pharmacokinetics theory - pharmacist to make use of in S8-2 clinic being able to do it Toshimi Kimura, Kenichi Sagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2009. |
|---|
|
|
Around problems -PPI.clopidogrel of the S8-3 CYP2C19 genetic polymorphism - Takahisa Furuta 1, Kazuo Umemura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2009. |
|---|
|
|
Practice of the ward duties that made full use of S8-4 pharmacokinetics 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2009. |
|---|
|
|
Patients becoming essential S9-PL basic tone lecture in future in a drugstore, a hospital-centered pharmaceutical care Takatsugu Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2009. |
|---|
|
|
Unification of the pharmaceutical care of S9-1 drugstore, the hospital Tooru Hayakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2009. |
|---|
|
|
Drugstore duties aiming at the S9-2 patients-centered pharmaceutical care 鹿村恵明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2009. |
|---|
|
|
An evaluation and medication support general for patients in the S9-3 medical treatment sickbed-centered pharmaceutical care - elderly people - 賀勢泰子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2009. |
|---|
|
|
Professional ability expansion aiming at the S9-4 patients-centered pharmaceutical care Is Kurata; see it Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2009. |
|---|
|
|
Drug information necessary for the S9-5 patients-centered pharmaceutical care Mayumi Mochizuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2009. |
|---|
|
|
How to use diabetes remedy which S10-PL basic tone lecture thinks about from pathophysiology 綿田裕孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2009. |
|---|
|
|
Message - from how to use S10-1 oral hypoglycemics - consulting room Yamasaki Hironori 1, 2, Katsumi Eguchi 2, 調漸 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2009. |
|---|
|
|
Take it, and, an oral S10-2 diabetes remedy, fare-thee-well uses insulin definitely definitely; and fare-thee-well. Tiger stone Kenichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2009. |
|---|
|
|
Approaches from S10-3 opening of an office pharmacist to diabetes Kuniko Shinohara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2009. |
|---|
|
|
Development of the S10-4 diabetes injection Kazutoshi Ninomiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2009. |
|---|
|
|
It is the next stage of NST in our country S11-PL basic tone lecture Eagle Takahiro Sawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2009. |
|---|
|
|
From point - diet of the S11-1 nutrition care to patients with organ damage - Shinichi Sugiura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2009. |
|---|
|
|
Role of the pharmacist in S11-2 transfusion, the nutritional management Toru Shoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2009. |
|---|
|
|
Through the scientific evaluation of the nutrition care by the S11-3 pharmacist and nutritional management of suggestion - short bowel syndrome (ileocecal residual ileal 20cm) - Katsuji Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2009. |
|---|
|
|
Cooperation with NST practice, the pharmacist as the S11-4 dietitian Noboru Makabe 1, Yasushi Miyazawa 1, Masayuki Chikamori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2009. |
|---|
|
|
S12-1 Identity of pharmacy : Let's take advantage of the chemical 外山聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2009. |
|---|
|
|
We understand the function of drug from the structure of the S12-2 drug receptor Masaji Ishiguro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2009. |
|---|
|
|
The example that utilized chemistry about S12-3 drug information offer activity Tazuko Niwano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2009. |
|---|
|
|
We watch S12-4 compounding of medicines and a preparation in chemistry Ichiro Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2009. |
|---|
|
|
Chemical system education to understand medicine in S12-5 pharmacy six years system education essentially Toshiaki Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2009. |
|---|
|
|
Bacteria, the resistant bacteria which is important in S13-1 clinic Tachi field Kazuhiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2009. |
|---|
|
|
Importance of PK-PD theory and the patient compliance instruction in the proper use of the S13-2 antimicrobial agent Kunihiko Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2009. |
|---|
|
|
S13-3 disinfectant summary Shigeharu Oie Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2009. |
|---|
|
|
Action for the infection control that S13-4 pharmacist is available for Terumasa Sata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2009. |
|---|
|
|
Large-scale randomized controlled trial "HOMED-BP study" based on S14-1 home blood pressure Takashi Asayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2009. |
|---|
|
|
The clinical statistics that S14-2 pharmacist should know Chikuma Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2009. |
|---|
|
|
Relation environment, system and pharmacist of clinical studies of S14-3 Japan Shunsuke Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2009. |
|---|
|
|
S14-4 food effect study and pharmacist Yoshinobu Hirayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2009. |
|---|
|
|
It is the role of lung cancer treatment and the pharmacist S15-PL basic tone lecture Yoichi Nakanishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2009. |
|---|
|
|
Role of treatment and the pharmacist for the S15-1 blood malignant tumor Takuya Fukushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2009. |
|---|
|
|
Duties development of the pharmacist specialized in a cancer of the S15-2 future Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2009. |
|---|
|
|
It is an action in - Kyoto University hospital pharmacy for the upbringing of the pharmacist specialized in a cancer having high quality of S15-3 寺田智祐, Kazue Takahashi, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2009. |
|---|
|
|
Correspondence to a side effect in the S15-4 cancer chemotherapy Pond end Hiroaki, King Suetsugu table, Hiroyuki Watanabe, Uchida まやこ, The Mishima one up, Masanori Sueyasu, Nobuaki Egashira, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2009. |
|---|
|
|
It is many types of job cooperation in the at-home (area) medical care S16-1 basic tone lecture Takashi Kodama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2009. |
|---|
|
|
Examine at-home psychological care network - illness in S16-1 Nagasaki, and examine it, and examine it; cooperation and many types of job cooperation - It is full of gray mustaches Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2009. |
|---|
|
|
Many types of job cooperation in the instruction joint at an S16-2 discharge Nakata birth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2009. |
|---|
|
|
From the cooperation with role - other types of job of a drugstore function and the pharmacist in the promotion of the S16-3 treatment at home - Kazuki Kushida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2009. |
|---|
|
|
Many types of job cooperation - "local project for the psychological care spread" and many types of job cooperation - in the S16-4 at-home (area) medical care Ritsuko Yoshihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2009. |
|---|
|
|
Just before role - at-home revolution, daybreak of the drugstore in the many types of job cooperation of the S16-5 area - Tetsuji Kawazoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2009. |
|---|
|
|
It is integrated molecules understanding of "pain" by the comprehensive study the significance of the algorithmic establishment and global pane research of the pharmacotherapy in the palliation medical care S17-PL basic tone lecture Narita year Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2009. |
|---|
|
|
Can speak the scholar of - experimental medicine for life improvement of the patients with the S17-1 palliation medical care Tamotsu Uesono kernel Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2009. |
|---|
|
|
For quality of life improvement with the S17-2 palliation medical care from the situation of the doctor at - psychological care team - Shiro Tomiyasu 1, 2, Arata Uchida 2, 3, Akemi Morita 2, 4, Quantity lower Hiroko 2, 4, Tomiko Ogawa 2, 5, Toru Tsujimura 2, 6, Mariko Nakajima 2, 3, 橋口順康 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2009. |
|---|
|
|
To the member of participation in planning from the reporting to the use of S17-3 morphine patients to pain treatment and the psychological care team Michihiro Shino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2009. |
|---|
|
|
It is managing of a side effect and the interaction from the situation of the S17-4 pharmacist Shiro Katayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2009. |
|---|
|
|
Knowledge of the EBM that we want to know to understand S17-5 palliation medicine Tatsuya Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2009. |
|---|
|
|
The need of the pharmacist intervention in S18-1 schizophrenia treatment 梅田賢太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2009. |
|---|
|
|
Importance of the pharmacist intervention to the pharmacotherapy in S18-2 mood disorders Hiroko Baba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2009. |
|---|
|
|
Relation of the pharmacist to patients with S18-3 social anxiety disorder, patients given placebo Tensho era Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2009. |
|---|
|
|
About the proper use of the S18-4 psychotropic drug from the viewpoint of drug interactions: Yukihiro Noda, Side Yukari Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2009. |
|---|
|
|
It is a clinic, a diagnosis of AIDS and the research and development of the therapeutic drug S19-PL basic tone lecture Hiroaki Mitsuya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2009. |
|---|
|
|
The present situation of practice and the treatment of S19-1 HIV infection Akira Yasuoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2009. |
|---|
|
|
Role of the pharmacist in S19-2 HIV infection treatment 吉野宗宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2009. |
|---|
|
|
Support - of the S19-3 sick person - antiHIV medicine medication to stop it without being stopped Kenichi Kojima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2009. |
|---|
|
|
The problems that the S20-1 healthcare setting has Hideki Arima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2009. |
|---|
|
|
Collection of and inflection of the S20-2 evidence Kaori Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2009. |
|---|
|
|
Problems in the ethic in the S20-3 postmarketing surveillance Jun Terada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2009. |
|---|
|
|
What does the S20-4 drug industry demand? West Toshimichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2009. |
|---|
|
|
What does the S20-5 regulator demand? Kaoru Misawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2009. |
|---|
|
|
The effect that maternal disease during S21-1 pregnancy gives to fetuses Ikuko Yokoo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2009. |
|---|
|
|
A representative drug and effect to use for treatment of the S21-2 complications pregnancy on fetuses Mariko Ishii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2009. |
|---|
|
|
Growth of a merit and infants of the S21-3 maternal feeding Naoki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2009. |
|---|
|
|
Effect on pharmacotherapy and infants of S21-4 breast-feeding women Teiko Toyoguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2009. |
|---|
|
|
S22-OV Overview:Impact of individualized medicine to pharmaceutical care Vinod P.Shah Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2009. |
|---|
|
|
S22-1 Pharmacogenomic consideration in clinical pharmacokinetics Jin-ding Huang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2009. |
|---|
|
|
S22-2 Molecular diagnosis for pharmaceutical care Majid Moridani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2009. |
|---|
|
|
S22-3 Pharmaco-proteomics and metabolomics for personalized medicine Yusuke Tanigawara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2009. |
|---|
|
|
S22-4 Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy Toshiyuki Sakaeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2009. |
|---|
|
|
S22-5 Personalised Medicine in 2020 Ross A McKinnon, Michael B Ward, Michael J Sorich Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2009. |
|---|
|
|
S23-PL Plenary Lecture:Genomic medicine Hiroyuki Aburatani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2009. |
|---|
|
|
S23-1 Pharmacogenetic and biomarkers in oncology Kenji Tamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2009. |
|---|
|
|
S23-2 Imatinib resistance in CML patients Jung Mi Oh Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2009. |
|---|
|
|
S23-3 Molecular imaging of treatment for psychiatric disorder Ryosuke Arakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2009. |
|---|
|
|
Exposure and NIOSH guidelines with the cosponsorship 1-2 anticancer drug Jin Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2009. |
|---|
|
|
The change of a preparation procedure with the cosponsorship 1-3 anticancer drug preparation manual revision and the procedure and the commentary 中山季昭, Tadashi Sannomiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2009. |
|---|
|
|
Prevention of anticancer drug exposure of the cosponsorship 1-4 healthcare worker Reina Nishigaki, Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2009. |
|---|
|
|
About an in paired performance of the cosponsorship 2-1 antihistamine (from the situation of the pharmacist) 大谷道輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2009. |
|---|
|
|
About an in paired performance of the cosponsorship 2-2 antihistamine (from the situation of the physician) Yuji Kumagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2009. |
|---|
|
|
Mainly on nephrotoxicity of cosponsorship 2-3 chemical renal failure - cyclosporine - Ken Sakai 1, Kimura Ito period 2, Kan Noriko 2, Aikawa thickness 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2009. |
|---|
|
|
About cosponsorship 2-4 drug-induced hepatic injury Hajime Takikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2009. |
|---|
|
|
Relation of the pharmacist for patients with infection in O1-001 ICU/CCU Masanari Hagiwara 1, 2, Kato Takahiro 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Hiroko Ishibashi 3, Takaaki Hasegawa 1, Hiroshi Noguchi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009. |
|---|
|
|
Mainly on use of Linezolid experience - long-term use case and thrombocytopenia in the O1-002 this hospital - Yoshiko Takahashi 1, Yoshio Takesue 1, Mika Ishihara 2, Sumiyo Tatsumi 2, Hilum Muneo Hayashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009. |
|---|
|
|
Pay attention to the use of antimicrobial agent situation for the O1-003 injection and pro-examination - carbapenem about the drug-resistant Pseudomonas aeruginosa onset antimicrobial agent and imipenem resistance Pseudomonas aeruginosa; and - 藤井宏亮 1, Long Tawa person 1, Yukiko Machida 2, Masato Takamori 1, 瀧澤好廣 1, Akizuki chapter 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009. |
|---|
|
|
Drug proper use and the problem that we saw from the use situation of the O1-004 carbapenem system antimicrobial agent and change of the pyocyanic drug susceptibility Masaki Kitamura, Long volost Chikako, Junichiro Kato, Kazuhisa Akaishi, Takashi Kawakubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009. |
|---|
|
|
Evaluation of a construction and the antimicrobial agent proper use of the use registration system of the wide area antimicrobial agent which linked O1-005 Hospital information management system Yuichi Muraki 1, Masaki Tanabe 2, Akiko Nakamura 3, Yoshiko Matsushima 3, Masayuki Senoo 1, Midori Fukuda 2, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009. |
|---|
|
|
It is ... for the effect by the report of use of O1-006 wide area antimicrobial agent presentation criteria change and promotion of the effect - de-escalation therapy Masafumi Ono 1, Mizuho Yoshioka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2009. |
|---|
|
|
An effect and problems of the educational intervention for the antimicrobial agent of carbapenem for the purpose of de-escalation by the O1-007 ICT origin Kosuke Miyoshi 1, Takahiro Muro 1, Yuichi Umeda 1, Shinsuke Takemoto 1, Nakamura right one 2, Hidetoshi Kamimura 3, Yoshiharu Karube 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009. |
|---|
|
|
The in-hospital influenza outbreak that led to discovery from increase of the number of O1-008 antiinfluenza medicine prescriptions Haruka Watanabe 1, Tetsuya Hayashida 2, Yuko Takaichi 3, Hiroaki Miyaoka 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009. |
|---|
|
|
Role of the pharmacist in O1-009 new influenza measures Middle bath Shinji, 田中詳二, Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009. |
|---|
|
|
For the upbringing of the hospital pharmacist with the O1-010 specialty trial second report - of the - Nagano Hospital Pharmacist Association Kenji Kiyohara 1, Okazawa incense Tsu child 1, Teruaki Okura 1, Osamu Atobe 1, 1, Kyoshi, Nakayama, Atsushi Miura 1, Hatsutani University child 1, Mitsue Mizutani 1, Masaru Nakajima 1, 六波羅孝 1, Akihiro Tada 2, 白澤吉哲 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009. |
|---|
|
|
1 case that was tied to diagnosis of bowel chalicosis that was a side effect of the magnesium oxide by remedy history confirmation by the O2-001 pharmacist 久保嘉靖 1, Masahiro Okuno 1, Manabu Nakata 1, Koichi Hosomi 1, Masahiro Yoshioka 2, Jun Mimura 2, Eiji Komori 2, Yoshiharu Umetani 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009. |
|---|
|
|
Examination of O2-002 angiotensin II receptor blocker and the hyperkalemic onset 守内匡, Satomi Asano, Osamu Tanaka, Hiromi Matsui, Yoshimi Matsuda, 高田加壽代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2009. |
|---|
|
|
Case control study on risk factor of the constipation onset in O2-003 inpatients Tetsuya Ueki 1, 3, Keiko Nagai 1, Sen Oe spring 2, Miho Nakajima child 3, Mikiro Nakajima 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009. |
|---|
|
|
Examination of the risk factor to be associated with the occurrence of side effect of O2-004 antituberculosis drug Motoaki Nakao, Kensho Tamura, Ken Tachibana, Hidemi Isago Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009. |
|---|
|
|
Examination about the cyclosporine-induced renal failure frequency in the O2-005 hematopoietic stem cell transplantation patients and the factor Takaaki Suzuki, Jin Miyamoto, Chiaki Imai, Koga eyes, Mariko Takeda, Shingo Yamazaki, 仲佐啓詳, Hiroshi Nakamura justice, The amount of Ariyoshi example, Koichi Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009. |
|---|
|
|
The effect that O2-006 Capsaicin gives in an indomethacin-induced stomach injury model Osamu Nakao incense 1, Hiroko Nosaka 1, Yoshie Inada 1, Mitsuru Naruse 1, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009. |
|---|
|
|
Examination of hypersensitivity in the O2-007 amide-type local anesthetic 齊藤幹央 1, Manabu Abe 2, Tomoyasu Furukawa 3, Yagi Motohiro 3, Koike reason Expo 4, Katsuji Uno 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009. |
|---|
|
|
Fact-finding ... of side effect of O2-008 pharmacist management first report - drug eruption Hashimoto positive 1, 澤部公子 1, Tetsuro Koide 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2009. |
|---|
|
|
caspase-3, -8 in the O2-009 CCl4-induced liver damage, change of -9 Yuka Hattori 1, 定松舞子 1, Hilum Takaaki Hayashi 1, Daisuke Sasaki 1, Mina Takano 1, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009. |
|---|
|
|
Examination - of the immunoreactive mechanism by the clinical applied (1)-PHA of RT-PCR in the O2-010 drug allergy Takafumi Nakagawa 1, Katsuji Uno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009. |
|---|
|
|
Compliance of antibiotics for the fever at the O3-001 outpatient department chemotherapy Shinya Suzuki, Reiko Matsui, Yoshizo Watanabe, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009. |
|---|
|
|
Simple regimen prescription management using action ... Excel to O3-002 cancer chemotherapy Machiko Hiuga, Takahashi is constipated, Masashi Sasaya, The Senbongi pivot Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009. |
|---|
|
|
Cancer history of treatment database ... which helps construction ... patients with foreign chemotherapy center support software communication using O3-003 Microsoft Access Tetsuya Katori, Miki Ishioka, Yu Ono, Takuya Shirohata, Takafumi Izumo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009. |
|---|
|
|
Through 2 drug instruction bone marrow transplantation planned cases to the patients who are strong in anxiety for O3-004 anticancer drug Nobuko Takayanagi 1, Masahiro Okuno 1, Koichi Hosomi 1, Manabu Nakata 1, Yoshiharu Umetani 1, Shizuo Takamiya 2, High cover Toshiro 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2009. |
|---|
|
|
About the difference in dose by a Cockcroft-Gault type and the simple MDRD type at O3-005 carboplatin doses calculation Reiko Yokoyama 1, 2, Yoko Ichikawa 1, Small Ido Keiichi 2, Hiroshi Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009. |
|---|
|
|
Investigation about the administration postponement in O3-006 breast cancer postoperative preoperative chemotherapy regimen FEC75, FEC100 Toshihiro Uenaka 1, Eri Kashida 1, Sound Mai Kubo 1, Kozo Tatsumi 1, Mt. Tadashi Maruyama 1, Hirase friendship 1, Shuichi Kawashima 1, Shuhei Miyachi 1, Tadashi Doi reason 1, Kayo Enomoto 2, Powder river Yozo 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009. |
|---|
|
|
Search of action progress, the change factor to have an influence on the duration of recurrent colorectal cancer chemotherapy of the O3-007 Aichi Hospital Pharmacist Association on koro Gee meeting for the study Eiji Yoneyama 1, 2, 3, Masayuki Ejiri 2, Akiko Tsukada 2, Kazuo Hotta 2, Masanari Hagiwara 2, Saza Hideya 2, 金正煥 2, Manami Ichiki 2, Hiroko Saito 2, Akio Katsumi 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009. |
|---|
|
|
Method ... of trial - fact-finding and the contribution of the information sharing of the foreign chemotherapy patients that utilized O3-008 medicine notebook Shuichi Nawata 1, Takuya Sasaki 1, Nobuko Wada 2, Megumi Miyazaki 1, Yasushi Hamada Funato child 4, Mari Saito 3, 3, Kosugi Iyoko 1, Shinya Hashimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009. |
|---|
|
|
HPLC of racemate of the O3-009 thalidomide and the optically active substance, development of the blood level assay by LCMS Shoji Fukushima 1, 田中詳二 2, Yoshie Tabata 3, Nakajima truth size 1, Tomoki Hatano 1, Shoko Matsushita 3, Takayuki Takahashi 3, Shuichi Kishimoto 1, Up Kazuko 2, Yukako Morita 2, Inotsume Nobuo 4, Toru Hashida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009. |
|---|
|
|
About rearranging, the review of the O3-010 cancer chemotherapy regimen 中村尚未, Mitsue Uno, Shoichi Hotta, Takashi Hiraga, Yaeko Hondo, Toshiharu Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2009. |
|---|
|
|
The likelihood that 6 main ingredients ratio of the O4-001 teicoplanin preparation gives to a clinical response Kayoko Iwamoto, Kuniko Terada, Makiko Doi, Satoshi Yamamoto, Hiroshi Ota, Chizuru Shirokami, 面田恵, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009. |
|---|
|
|
Control mechanism ... which assumed carbohydrate metabolism control - PKC in the O4-002 skeletal muscle a target Katsuya Narumi 1, Furugen Ayako 1, Megumi Watanabe cloth 1, Masanori Kobayashi 2, Shiro Itagaki 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009. |
|---|
|
|
Evaluation - with effect - absorption prediction system that O4-003 intragastric pH change gives to pharmacokinetics Yuko Watanabe 1, Naoki Inoue 1, Masanori Kobayashi 2, Shiro Itagaki 2, Takeshi Iseki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009. |
|---|
|
|
Pharmacokinetics and proper use of the O4-004 Orr pre-non Takashi Sasaki, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009. |
|---|
|
|
Examination of the cyclosporine proper dosage method in the O4-005 same kind hematopoietic stem cell transplantation Kano sheath or 1, Tomoko Mochizuki 1, 有木宏宗 1, Yuka Ito 1, Mieko Yokoyama 1, Yasuyuki Inoue 2, Yorihisa Miura man 2, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009. |
|---|
|
|
It is the application to the evaluation of the percutaneous absorption dynamics in patients with cancer the development of the quick assay of the residual quantity out of the matrix type patch of the O4-006 fentanyl Takashina Yoshiaki, Takafumi Naito, Yagi Tatsuya, Keisuke Yamamoto, Maruyama Shuya, Naoto Kanematsu, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2009. |
|---|
|
|
Examination ... using examination - 12-lead electrocardiogram of efficacy at the O4-007 amiodarone administration and the safe predictor Yasushi Takai 1, Yorozu Suzuki law of nature 1, Takeki Kajima 1, Fumiya Uchida 2, Hideo Nishikawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009. |
|---|
|
|
Examination of the standardization of a utility and the initial dose of the TDM enforcement within O4-008 VCM initial administration 24 hours Masaru Kawase period, Yasushi Taniguchi tree, Temple Tai incense, Yoko Kataoka, Masahiko Kitagawa, 成尾千晶, Megumi Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009. |
|---|
|
|
Blood level anticipatory examination by the pharmaceutical company analysis software unlike the vancomycin hydrochloride generic medicine for the O4-009 injection The Yasushi Yokoyama method, Upper ability Yuki, Mieko Suzuki, 出羽祐基, Yasushi Osato chapter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009. |
|---|
|
|
Use of VCM fact-finding in the O4-010 this hospital Kishi, Matsuzaki, 坂本吉志維, 大槻千遥, Kana Yamazaki, Shuko Watanabe, Yasuko Mizuno, Uchida evening joy, Chiho Murata, Hiroyuki Hayashi, Akio Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009. |
|---|
|
|
Importance of the reporting of the drug interaction by the active change of O5-001 CYP Yoshiyuki Ono 1, Gutter slope Akihiro 2, Katsuyoshi Nakajima 1, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009. |
|---|
|
|
Application to cyclopedic system (PISCS) to alert in consideration of clinical significance of the drug interaction by the inhibition of O5-002 CYP2C9 Riyo Yamaguchi 1, Yoshiyuki Ono 2, Gutter slope Akihiro 3, Katsuyoshi Nakajima 2, Hitoshi Nakamura 1, Hiroshi Suzuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2009. |
|---|
|
|
Analysis of the interaction mechanism of O5-003 carvedilol and the amiodarone Yuichi Takahashi, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009. |
|---|
|
|
Pharmacokinetics study of the O5-004 candesartan New shellfish Hiroaki, Kyoko Fukumoto, Kazuyuki Ueno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009. |
|---|
|
|
Monitoring of the interaction by the combination of O5-005 bosentan and warfarin Kadomura Shota, Tatsuro Fujii, Ayako Kato, Tomoko Suzuki, Sei Suzuki Nako, Mina Takeuchi, Yuko Fukuda, Asano still, Takahiro Shiga, Tatsuya Ito, Takemoto success Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009. |
|---|
|
|
O5-006 Examination about the interaction of tacrolimus in heart-transplant recipients and Everolimus and carbamazepine 和田恭一1, 坂井美佳1, 野島香織1, 小島久仁子1, 越智浩之1, 岡田博1, 森下秀樹1, 小原延章1, 村田欣洋2, 簗瀬正伸2, 加藤倫子2, 中谷武嗣2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009. |
|---|
|
|
Action of the resident pharmacist in the O5-007 regular hospital Makoto Tanaka, Shina Sogabe, Kenichi Manabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009. |
|---|
|
|
Trial of the pharmaceutical care that adopted the breath sounds auscultation in patients with O5-008 hospitalization asthma Mika Kusanagi, Upper ability Yuki, Friend gold A flower, Yasushi Osato chapter Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2009. |
|---|
|
|
The drug application preparations duties in anesthesiologist support task (the second report) - operating room by the O5-009 pharmacist and the evaluation Yuzuru Yamamoto, Kawamorita early period, Seven field Tomomi, Rope river Tomoyuki, Katsuhisa Tahara, Makiko Morita, Kanzaki Ikuyo, Hisashi Ono, Shinya Iida, Suno study, Yasushi Yamashita example, Twig Masayoshi, Satoshi Ogawa, Chieko Hara, Kuniko Yamamoto, Yuichi Itagaki, Toshio Awaya, Toshiyuki Miyoshi, Yoshikazu Tazaki, Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009. |
|---|
|
|
Comparison ... of the treatment at home in impact - Japan and the United States which the "per Pharmacy" prescription system which became the key to O5-010 treatment at home gave for medical care Takae Tsujimoto 1, 3, Wasa Katsushi 2, Description of Toshi Ito 2, Etsuko Uejima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009. |
|---|
|
|
Action for the efficiency of O6-001 on admission bringing medicine differentiation duties Koki Yamashita, Mayumi Kaise, Willow Kimie Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009. |
|---|
|
|
Construction of the drug control system for the purpose of the bringing medicine information communalization in the O6-002 team approach in medical care Tamotsu Terunuma virtue 1, Naoko Miyakawa 1, Masahiro Sugiyama 1, Chinese bridge Katsuhiko 1, Katsumasa Suzuki 1, Oil locus Mami 1, Tomoko Mitsui 1, 荻野訓秀 1, Mihoko Kamihira 1, Yoshihisa Shiraishi 1, Kongoji Satomi 1, Toru Ozeki 1, Kazunari Nakamura 2, 若松伸洋 1, Toshihiro Sasaki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009. |
|---|
|
|
Risk aversion and economic effect by the O6-003 bringing medicine control center setting Country original Junichi 1, 2, Tomishima Kosuke 1, Miyake hemp sentence 1, 宮本直冶 1, Yozo Shimizu 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009. |
|---|
|
|
Application to assay development and a quality study of the food dye out of the food for specified health use by the O6-004 HPLC method Tadashi Okubo 1, 2, Mariko Tanaka 2, 7, Okubo branch 1, Setsuko Okubo 3, Miho Okubo 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 265-265, 2009. |
|---|
|
|
One-year evaluation of the nutrient support team in the O6-005 this hospital Setsuko Tomioka 1, Nao Sato 2, Yasuko Sudo 2, Masaaki Oshita 3, Kodo Shoji 3, Satoshi Nagata 3, Toshiaki Shimizu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009. |
|---|
|
|
Construction of the rating system of the antiplatelet action with O6-006 aspirin Haruko Yokoyama 1, Naoko Ito 1, Shinji Soeda 2, Kanbayashi bullet 3, Akira Ozaki University 3, Masayuki Watanabe 3, Emiko Kashiwakura 4, Tsutomu Kawada 4, Noriyuki Ikeda 4, Kentaro Tokuoka 5, Yasuhisa Kitagawa 5, Yasuhiko Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009. |
|---|
|
|
For use of O6-007 new medicine as an action of the pharmacists case report ... of ... pirfenidone Manabe tendon one, Makoto Tanaka, Shina Sogabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009. |
|---|
|
|
Meta analysis about the comparison between nicorandil and in efficacy, the safety antianginal drugs for O6-008 stable angina pectoris Yuki Hanai 1, Mitsuo Mita 2, Shigeru Hishinuma 2, Kenji Nishizawa 1, Kan Noriko 1, Shoji A 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009. |
|---|
|
|
Manual preparation about the use of fitness of radiopharmaceuticals by the O6-009 pharmacist leadership Satomi Niwa 1, 2, Junko Kuroda 1, History of Nasu ear 1, Toshiaki Takeuchi 1, Tetsuo Ezaki 1, Kayo Koike 1, 木村和哲 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009. |
|---|
|
|
O6-010 Skin hydration after the high water containing sheet application 二谷宜靖1, 中島法子2, 新開規弘2, 山内仁史2, 大井一弥3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2009. |
|---|
|
|
A real purpose of use of the O7-001 antiMRSA medicine and chemosensitive investigation Yukako Yasui 1, Tomoko Nishiguchi 1, Kimiko Kawano 1, Yoshihiro Niimi 2, Megumi Fujita 3, Noboru Okamura 3, Setsuko Anan 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009. |
|---|
|
|
Action for the in-hospital standardization of the use of metronidazole for the O7-002 C.difficile-related enterocolitis, diarrhea Hidechika Ueda 1, Takayuki Inagaki 1, West sinus Masaki 1, Naoki Sakaguchi 1, Tatsuro Wakata 1, Masaru Nishio 2, Shiro Yoshioka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009. |
|---|
|
|
Discussion about the O7-003 antiMRSA medicine proper use and report of use presentation rate decrease Hiroshi Hara person, Kurita sentence, Hidetaka Hirano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009. |
|---|
|
|
An effect of the O7-004 antiinfluenza medicine and examination about the compliance Tiger shallows Kazuko 1, South Kenichi 1, Katsuichiro Kamei 1, West Koichi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009. |
|---|
|
|
O7-005 Evaluation of validity, efficacy, safety of drug selection in linezolid use 島本裕子1, 富成伸次郎2, 谷口智宏2, 坂東裕基2, 本田芳久1, 山内一恭1, 小森勝也1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009. |
|---|
|
|
Use trend of the antimicrobial agent which gives it to resistance of O7-006 Pseudomonas aeruginosa Hiroshi Soeda 1, 3, Akiko Kaneko 1, 3, Inubushi thickness husband 1, Katsumi Chiba 2, 3, Kumi Sato 3, Yumiko Kusama 3, 中村造 3, Naohisa Matsunaga 3, Waist Kimito Hara 3, Tetsuya Matsumoto 3, Takao Akashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2009. |
|---|
|
|
The effect that enlightenment of the oral antimicrobial agent proper use by O7-007 inside the hospital guidelines gives to chemical sensitivity Tanaka University 1, Suzuko Fukazawa 2, Tomomi Chimura 2, Satoshi Onoda 1, Madoka Kato 1, Yosuke Kawahara 1, Satoshi Mikoshiba Saint 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009. |
|---|
|
|
Examination using the mixer revolution-type for O7-008 ointment preparation preparation the rotation Takashi Ito kernel 1, Takahiko Kagaya 1, Yuka Hikima 1, Takashi Inoue 2, Kensuke Usui 2, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009. |
|---|
|
|
Difference that O7-009 insurance pharmacist operation investigation - employment form is different and stops by according to sex, the marriage situation Keiichi Nakagome 1, Tortoise shop Toshihiko 2, Katsuhiko Fukai 3, Naoko Yamada 4, Atsushi Sugano 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009. |
|---|
|
|
Benefit of taking before CABG technique enforcement O7-010 statin Kazuo Nakamura 4, Harunobu Iwase 1, Your Nakamura existence 1, Kaya Hiroko Sono 2, Kazuo Takahama 3, Riyuzo Sakata 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009. |
|---|
|
|
Association with O7-011 pain and the K channel Takashi Kato children 1, 2, Asuka, Iwamoto, Eiji Kayano 2, Hilum Takaaki Hayashi 2, Bun Takagi virtue 2, Hiroko Nosaka 2, Wakako Miyachi 2, Yoshio Ijiri 1, Kazuhiko Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009. |
|---|
|
|
Action to bringing medicine in the O7-012 Yokohama City University center Hospital Mieko Miyazaki, Osamu Sakamoto, 3, Kosugi Iyoko, Shinya Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2009. |
|---|
|
|
An on admission bringing medicine information sharing and offer in the O7-013 Kamitsuga General Hospital Akira Nozawa, Seiki Kobayashi, Hisao Saotome Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009. |
|---|
|
|
It is ... about the association to problems - aging in the O7-014 elderly people pharmacotherapy and a drug and a fall fall Tatsuya Otsubo, Kazumasa Ueda, 野田能成, 小西偉雄, Tadashi Mikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009. |
|---|
|
|
Association with the side effect expression of O8-001 high risk UGT1A1 genetic polymorphism and CPT-11 Masahide Onoe 1, 寺田智祐 1, Ikemi Yasuaki 1, 松本繁巳 2, Kazuhiro Yanagihara 2, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009. |
|---|
|
|
Protective efficacy of rebamipide for stomatitis with the anticancer drug component chemotherapy (breast region) of O8-002 Anthracycline origin Nabeta Izumi 1, Kazuyo Nakamura 1, Midori Kimura 1, 河原崎貴伯 1, Tsuneizumi Michiko 2, Kazuhiko Nakagami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009. |
|---|
|
|
Pharmacokinetic examination ... by nephrotoxic - TDM with oxaliplatin in patients with O8-003 medium degree renal failure colorectal cancer Kozoe kernel 1, Hiroki Sugishita 2, Shinichi Watanabe 1, 田中亮裕 1, Junko Morioka 1, Yuji Watanabe 2, Kanji Kochi 2, 末丸克矢 1, Hiroshi Araki positive 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009. |
|---|
|
|
Trial of the side effect of bortezomib administration schedule change reduction for the O8-004 multiple myeloma Anna Kubo 1, 2, 3, 福島俊洋 2, Yoshimasa Saito 1, Small Masaru Hori 1, Yu Iwao 2, Akio Nakajima 2, Miyuki Miki 2, Tomoyuki Sakai 2, Shun Sawaki interest 2, Yasushi Masaki 2, Hisashi Umehara example 2, Takeo Shimazaki 3, Hideo Nakajima 3, Motoo Ryoji 3, Koji Nishio 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2009. |
|---|
|
|
Three cases of the multiple myeloma that showed peripheral neuropathy of grade3 by O8-005 bortezomib administration Horiuchi wish 1, 土手賢史 1, Toshiko Aramiya 1, Hirokazu Nakanishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009. |
|---|
|
|
Examination of the side effect of change predictor of the serum bilirubin level before containing O8-006 hydrochloric acid irinotecan chemotherapy enforcement and two days later Kazumi Watanabe 1, Junko Kitsu 2, Junichi Koike 3, Kimihiko Funabashi 3, Masashi Watanabe 3, 菊池由宣 4, Kenji Nishizawa 1, Kan Noriko 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009. |
|---|
|
|
Investigation of the G-CSF preparation administration in the O8-007 non-small cell lung cancer docetaxel chemotherapy 村永愛, Shinya Suzuki, Kenji Kawazumi, Reiko Matsui, Yoshizo Watanabe, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009. |
|---|
|
|
Onset of leukopenia factor analysis during O8-008 gemcitabine administration Toshie Matsumoto 1, Hidenori Yokoyama 1, Daisuke Arakawa 1, Seigo Nakayama 1, Megumi Iwasaki Rina 1, Yuki Matsuya 1, Okada sum intellect 2, 吉村知哲 2, Takao Noda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009. |
|---|
|
|
The onset of prolonged diarrhea situation of CPT-11 by the presence or absence of O8-009 intestinal tract oral alkalinization Kazuaki Kojima 1, Akira Maruyama 1, Miwa Takayuki 1, Relation Tadashi 1, Akihisa Fujimoto 2, 3, Shigeki Uchida 2, 篠置哲 2, Shinobu Araya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009. |
|---|
|
|
Three cases of the malignant tumor using the O8-010 low concentration Mohs ointment Yasuko Takemori 1, Takashi Toyota 1, Miho Abe 2, Yoshiko Okiyama 2, 佐藤勘治 2, 餐場伸作 2, Satoshi Kaneko 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2009. |
|---|
|
|
Side effect measures - stomatitis and mouth care - of the O8-011 cancer chemotherapy Iga Kumi, The Takashi Kawamura up Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009. |
|---|
|
|
Renal function in the O8-012 Nedaplatin administration and evaluation of weight loss criteria Kazuko Kobayashi, Tomohiko Harada, 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009. |
|---|
|
|
Safe examination when we started Erlotinib after having presented with serious liver dysfunction at O8-013 Gefitinib treatment 大橋養賢 1, Kenichi Suzuki 1, Sakurai beauty 1, Yutaka Ishikawa 1, Tomohisa Onishi 1, Michihiro Shino 1, Inner Toriyu dawn 2, Toshiaki Takahashi 2, Nobuyuki Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009. |
|---|
|
|
O8-014 Proper use of nausea and vomiting incidence and antiemetic of hepatic artery in the intra-arterial chemotherapy with intra-arterial injection for IA-call 林豊, 小野田千晴, 村松えつ乃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009. |
|---|
|
|
About an opioid rotation conversion program using O9-001 HTML Hiroyuki Horiguchi 1, Satoshi Shimizu 1, Kazuhiko Nakayama 1, Sho Shimizu original 1, Takashi Masuno 1, 岩崎英久 1, Takao Kume 1, 桜澤千世 1, Teruo Obata 1, Masayuki Tamura 1, Okoshi Nagashima Hisao 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009. |
|---|
|
|
Examination about the risk factor of hypocalcemia in O9-002 zoledronic acid hydrate treated patients Miho Hanamura 1, Takuya Iwamoto 2, 澤部公子 1, Shinko Okuda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2009. |
|---|
|
|
Effective symptom management - with the support tool using construction - electronic chart of the cooperation system between the pharmacists in the O9-003 psychological care region Furukawa order chapter, Furrow Yoshiko, Masahiro Takada, Toshio Tanaka, Kenji Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009. |
|---|
|
|
Conduct - questionary survey about the improvement of the regime of the O9-004 cancer chemotherapy; and - Motoi Kurahashi still, Ai Hagiwara, High Ayumu Tachibana, Mariko Inoue, Yukiko Tsukamoto, 小川賀偉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009. |
|---|
|
|
Inspection of the anticancer drug administration renal function evaluation by O9-005 eGFR Hiroaki Utsuki, 嘉屋道裕, Tashiro Kei life, Nabeta Izumi, Kimura relationship, Tatsu Sakamoto Ichiro, 河原崎貴伯 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009. |
|---|
|
|
Examination of the tumor singular immunotherapy using O9-006 MAGE-3 peptide pulse dendritic cells Shinji Abe 1, Yasuhiko Nishioka 2, Tree hotel Masatoshi 1, Saori Nakano 1, Your forest Tai 1, Kazuhiko Teraoka 1, Hisatsugi U.S. Toshihide 1, Kazuyoshi Kawazoe 1, 楊河宏章 3, Irahara Minoru 3, Saburo Sone 2, Kazuo Mizuguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009. |
|---|
|
|
Effect of P-gp contributing to O9-007 cancer chemotherapy effect diminishment Kei Kuronuma 1, Masanori Kobayashi 2, Natsuko Takahashi 3, Shiro Itagaki 2, Takeshi Iseki 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009. |
|---|
|
|
It is ... in reference to future way - nanny state Denmark, Sweden of a drugstore, the pharmacist in the O9-008 treatment at home Hisayuki Kato 1, Yasunori Iijima 2, 岩月進 3, Terawaki University 4, Magabuchi Naoki 5, Yasufumi Terawaki 4, Hiroyuki Sakamaki 6, Toshiro Oda 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2009. |
|---|
|
|
O9-009 Drug cooperation efforts in our hospital : Toward the uniformity of cancer and palliative medicine 近藤あい, 小林香奈, 野田菜穂子, 足垣亮介, 津田佳子, 平口晴子, 山口貴美子, 山本真世, 宮谷正哉, 勝井靖, 立道直美, 萌抜一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009. |
|---|
|
|
For the group medication support in the O9-010 medicine, medicine, psychiatry cooperation - area - Ryuichiro Fujiwara 1, Emiko Kageyama 2, Haruyo Ninomiya 3, Chiaki Ueda 4, Mayumi Kamata 5, Koji Ono 5, Ayako Ouchi 5, Ark book jasmin 5, Kenichiro Watanabe 6, Takao Orii 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009. |
|---|
|
|
The situation of the evaluation of the disaster manual for patients with O9-011 circulatory disease and the anti-disaster measures in medical facilities under Ehime Takeichi Yoshiji, Junko Morioka, Well hilum Keiko, 末丸克矢, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009. |
|---|
|
|
Action as the training institution for O9-012 to raise the clinician who became independent Satoko Kimura, Takanobu Sasamoto, Keiji Suda, Chieko Tsukada, Hideo Hamaguchi, Masanori Yarita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009. |
|---|
|
|
Suggestion of the O9-013 business training core curriculum participation type training program corresponding to "contribution to toxicologic medical treatment" Hemp lower Tomoka, Yoshikazu Tazaki, Takehiro Yamada, Koichi Otaki, Hitomi Tsuzuki, Yuzuru Yamamoto, Anna Kobayashi, Inoue Seicho, 安達知輝, Kaori Koshiro, 徳安剛, Masaru Takahashi still, Toshio Awaya, Toshiyuki Miyoshi, Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009. |
|---|
|
|
National Examination for Pharmacist (93 times, 94 times) that we saw from O9-014 settings pharmacist Megumi Kojima Yoshiko 1, 2, Aya Kawakami beauty 1, Taku Murata 2, Masako Moriya 3, Masada Keiko 4, Harumi Nakano 5, Storehouse former cool air 1, 安冨治長 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2009. |
|---|
|
|
Making of the reporting tool to the physician in the drug administration to O10-001 pregnant woman, nursing mother Suguru Kasahara Castle, Koyasu saliva lawn, Jun Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009. |
|---|
|
|
A trend and effect of the postpartum medication by the change of the clinical path in the O10-002 obstetrics and gynecology department ward Kumiko Okitsu 1, 岩瀬利康 1, Keiko Shinozaki 1, 双樹恵 1, Yoshio Ito 1, Chiaki Koshikawa 1, Kimie Sato 2, Yukiko Horikoshi 2, Kayoko Masubuchi 2, Shizue Sayama 2, Hiroshi Watanabe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009. |
|---|
|
|
Examination about the use of hypnosis sedative during O10-003 pregnancy Bamboo blind Takashi 1, Kudo sheath or 1, Kazushi Masuda 2, Eriko Kobayashi 1, Daiya Sakurada 1, Noboru Sato example 2, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009. |
|---|
|
|
Attitude survey of the pharmacist for the checking prescription of O10-004 elderly people Takeshi Miyake sentence, 須山奈見子, Saori Okamoto, Yoko Nakano, Kana Akahori, Otake A tree, Shizuka Takaoka, Ikuko Fukumoto, Takushi Morimoto, Maki Ushijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009. |
|---|
|
|
Examination using the rat for the constipation induced by O10-005 hydrochloric acid Seve Lamar Daisuke Kadowaki 1, 2, Misato Nagashima 1, 2, Ayaka Sota 1, 2, Finished river Satomi 1, 2, Mika Kano 1, 2, Sumio Hirata 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009. |
|---|
|
|
Dialysis induction prolonged effect of the erythropoietin in patients with O10-006 conservation period chronic renal failure Ayano Kato 1, Noriko Takeuchi 1, Takenoshita Minoru Eda 1, Hiroaki Tanaka 2, Takayuki Fujii 2, Osamu Suzuki will 2, Eriko Kobayashi 1, Daiya Sakurada 1, Noboru Sato example 1, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2009. |
|---|
|
|
About the effect that O10-007 angiotensin receptor blocker gives to the uric acid level Masayuki Hirose, Shigeru Yamada tree, Hiroshi Hozumi, Yuichiro Wada, Yuichi Takemoto, Ayumu Ichimura, Takako Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009. |
|---|
|
|
O10-008 Inhibitory effect of factor Xa inhibitor coagulation on cell invasion and proliferation and angiogenesis in the peritoneal fibrosis model at the time of peritoneal dialysis 加藤こずえ1, 北本将幸1, 北村久代1, 上村和秀1, 野垣文昭2, 森典子3, 武田敏也4, 森本達也1, 小野孝彦1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009. |
|---|
|
|
Role of the ICU/CCU permanent residence pharmacist prospective from O10-009 physician, a nurse Kato Takahiro 1, Masanari Hagiwara 1, Yukio Toyama 1, Tatsuya Muto 1, Hiroko Saito 1, Takaaki Hasegawa 1, Hiroko Ishibashi 2, Hiroshi Noguchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009. |
|---|
|
|
You caught DPC data in the viewpoint of the hospital pharmacist targeted for O10-010 DPC, and how did you work on medical quality, cost? Kumi Nakamura 1, Tetsuya Takei 2, Kazunobu Miyata 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009. |
|---|
|
|
Safety management using the computing system for patients with O10-011 HIV-positive Burkitt's lymphoma Yu Ito Yoshiko 1, Tomishima Kosuke 1, Country original Junichi 1, Yasushi Arima Kei 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009. |
|---|
|
|
About the regimen order use situation of the electronic chart in the hospital attached to the O10-012 Oita University School of Medicine 西村文宏, Hiroki Ito, Sato male oneself, Tomohide Abe, Yosuke Suzuki, Shoji Takeyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2009. |
|---|
|
|
Stable examination under the humidification condition of O10-013 meloxicam tablets Takayuki Nagata, Shinichi Yoshikawa, Susumu Yoshida, The Takeshi Nemoto sum, Kazuko Murata, Ryo Murata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009. |
|---|
|
|
Effective and safe comparison before and after an innovator drug of the O10-014 paclitaxel preparation and the generic article change Kazuo Hotta, Iku Kawamura person, Masafumi Onishi, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009. |
|---|
|
|
From expectation - patients questionnaire results for the pharmacist of the O11-001 psychiatric patient - Shigeru Narui, Takashi Shimano person, Tomoko Nishina, Apology name Junko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009. |
|---|
|
|
From the use of antipsychotics situation in effect - this hospital of smoking and sex differences to give it to use of O11-002 antipsychotics - Yuko Inoue, Yuki Oda, Noriko Kudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009. |
|---|
|
|
Action for the proper use of "the Yokukansan" for the peripheral symptom of O11-003 dementia Michiko Uchiyama, Hideshi Kobayashi, Sayuri Yoshioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009. |
|---|
|
|
Action to side effect measures using a check sheet in the O11-004 psychiatry outpatient department 谷藤弘淳 1, Tadashi Matoba 1, Shigeru Inamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2009. |
|---|
|
|
Relation (contribution to the second report early detection) of the pharmacist to patients with O11-005 dementia Hiroshi Tani child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009. |
|---|
|
|
Correlation ... with effect on recognition and compliance - psychological test to the side effect of the O11-006 mood disorders zone patients Yasuo Kubota 1, Toshiya Kimura 1, Noriko Watanabe 2, Akemi Osaki 3, Katsuharu Suzuki 2, Kumiko Kasashi 1, Mitsuru Sugawara 4, Tsukasa Koyama 2, Takeshi Iseki 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009. |
|---|
|
|
Formulation study ... by communalization of the patients with O11-007 mental disorder understanding and the cooperation work with role (the 40th report) ... patients of the pharmacist Satoru Ishida 1, Saso Akio 2, Ayano Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009. |
|---|
|
|
The prescription situation of the mood stabilizer in the inpatient with O11-008 schizophrenia Junji Uno, Shinichi Tojo, Miho Nakata, Saeko Yamahata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009. |
|---|
|
|
Activity report (2) of the pharmacist in the many types of job team approach in medical care in the O11-009 law concerning medical observation It is looked at Atsushi Kawashima, Ito Liao, Takuya Ishida, Shigehiro Taira, Kayoko Kikuchi, Emiko Murata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009. |
|---|
|
|
About the medication support to the methylphenidate hydrochloride remedy patients in O11-010 AD/HD Makiko Yamazaki 1, Nobuyuki Funato 1, Kuni Tsunemi order 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2009. |
|---|
|
|
One case that the tremor of medicine Hara-related extrapyramidal symptoms relieved by the switching suggestion by the O11-011 pharmacist Yasuyuki Sakamoto 1, Measure taste Noriko 1, Taichi Hara 1, Yoshihiro Sagara 1, Arrow pan Fumio 1, Chiyo Shibazaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009. |
|---|
|
|
O11-012 area life support discharge program and the pharmaceutical discussion 杉沢諭 1, Chika Sano 1, Tomohiro Ikeda 2, Kazuhiro Yamamoto 2, Sei Sakamoto 3, Toshiaki Tsuneoka 4, Junko Inamoto 4, 礒嵜育朗 1, Junichiro Murayama 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009. |
|---|
|
|
Continue the medication self-care instruction with action ... individual treatment characteristics after a discharge to the medication continuation of the O11-013 schizophrenia patient; and ... Hiroko Kito, Kunimi Miki, Cheap high Yuki, Masako Nagayama, 梅崎琴江, Yasumi Ishida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009. |
|---|
|
|
A pharmacist can be concerned in the collective guidance for trial - discharge of the patient compliance instruction in the comeback to normal life classroom in O11-014 psychiatric hospitals how; or ... Tomoko Nakagawa, Ai Miki, Naomi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009. |
|---|
|
|
Relation of the pharmacist to the insulin instruction for the outpatient including the O12-001 pregnant woman Hana Kobayashi south child, Yudachi Kyoko, Yukiko Murakami, Kenji Sada, Shozo Senba, Kiyoshi Hamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009. |
|---|
|
|
Investigation about the index of the insulin self-administration induction in our O12-002 institution Koichi Matsumoto 1, Kaoru Nagata 1, Toshiyuki Takahashi 1, Zennya Katsura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2009. |
|---|
|
|
O12-003 Comparison of insulin lispro 50/50 (M50) 1 three times a day injection method and ultra-fast-acting three times ± NPH insulin injection method at the time of foreign insulin introduction 福井宗憲1, 東さつき1, 佐野典之1, 弘世貴久2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009. |
|---|
|
|
32 analysis that required an inpatient care for hypoglycemia in O12-004 this hospital Yasushi Otani Jiro, Akira Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009. |
|---|
|
|
It is ... led by the use of patient compliance instruction - bevacizumab patients for patients with O12-005 diabetic retinopathy Motobayashi Yuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009. |
|---|
|
|
Role of the pharmacist in the O12-006 rehabilitation medical care Toshie Yamaguchi 1, Tomoyuki Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009. |
|---|
|
|
Investigation about needs and the communications gap of the fomentation in the O12-007 orthopedics outpatient Hidenori Sagara 1, Hideki Mori 2, Mami Ishibashi 2, Izushi Fumio 3, Manager former man 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009. |
|---|
|
|
Prescription fact-finding (2000-2008) of the O12-008 benzodiazepine system sleeping drug Kenji Fujita, Takashi Kasahara, Akira Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2009. |
|---|
|
|
Present conditions and problems - generic medicine of being accelerated are received use of O12-009 generic drug by a pharmacist; is ... Ide Wakana 1, 2, 高橋眞生 1, Oil field Masaki 2, Naoko Ideguchi 2, Takafumi Ota 2, 大熊哲汪 2, Mitsuhiro Okazaki 2, Kuniko Shinohara 2, Kiyoshi Sugiyama 2, Masayuki Seya 2, 栂安雅満 2, Nishimura friend man 2, Yoshio Nozaki 2, Toshi Onodera 2, Shinichi Tashiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009. |
|---|
|
|
Drugstore satisfaction investigation by the mask patients in the O12-010 (Corp.) Ueda Pharmacist Association Yasunori Iijima 1, Kiyokazu Sone 2, 合葉雅彦 2, Yoshiyuki Toshima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009. |
|---|
|
|
The change and the present conditions (2008) of the pharmacist duties in the O12-011 capital municipal hospital Mikio Hayashi 1, Tatsuo Tanaka 2, 梶谷文裕 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009. |
|---|
|
|
It is ... using a figure of schema that we added proper use - muscle, bones, tendon, ligament of the medicine for external application in the O12-012 orthopedics disease to Masaji Furusawa 1, 2, It is still 3 Sawamura, Nishikawa arch 3, Yoko Kato 1, Yuko Takahashi 2, Shigeko Yokota 1, 2, 3, Masayoshi Kimura 1, 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009. |
|---|
|
|
Comparison of action fondaparinux Na to the deep vein thrombosis prevention in the O12-013 this hospital orthopedics ward and the enoxaparin Na Aya Ido Keiko 1, 2, Fumio Yoshimoto 1, 2, Hidehiko Suzuki 1, 3, 笹哲彰 1, 3, Kitasato spirit Ichiro 1, 3, Hashimoto court official 1, 3, Hiromi Kajiwara 1, 4, 望月規央 1, 5, 瀬戸茂誉 1, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009. |
|---|
|
|
Fact-finding of the medication assistance in O12-014 elderly people Tsuyoshi Saeki, Ayako Ohara, Mizoguchi A, Mizuho Takahashi, Kiyomi Sadamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2009. |
|---|
|
|
Factor analysis and preventive measures based on the compounding of medicines error example using O13-001 factor analysis tool 4M5E model Toshiaki Miyazaki, Nawa Hideki, Toshimitsu Onuma, Rieko Kawashima, Yoko Hayashi, Takashi Makita, Kazuhiko Yamaji, Nagamachi Tomoko, Atsushi Ogawa, Satoshi Kuroda, Matsunaga still, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009. |
|---|
|
|
Dispensing error analysis based on the prescription frequency ratio of the drug different in O13-002 standard Junichi Yamada, Yusuke Futaki, 佐藤友啓, Tsuyoshi Takahashi, 結城祥充, Hiroshi Kuronuma, Shinji Iwai, Katsumi Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009. |
|---|
|
|
A tendency and analysis of the oral medicine doubt inquiry rate in the O13-003 Hokkaido University Hospital 齋藤佳敬 1, Hiroyasu Shiga 1, Masanori Kobayashi 2, Suda example line 1, Mitsuru Sugawara 2, Takeshi Iseki 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009. |
|---|
|
|
About a jet injection example of the intravenous remifentanil hydrochloride in an examination (1) transfusion tube of the O13-004 medical supplies-related medical accident Minoru Mori Tomoko 1, 岩瀬利康 1, Yoshio Ito 1, Tadashi Nagase 1, Tomoaki Toyama 1, Keiko Shinozaki 1, Kumiko Okitsu 1, Junko Miyakawa 1, 長岡匠 1, Miyuki Suehiro 1, 双樹惠 1, Chiaki Koshikawa 1, Shigeki Yamaguchi 2, Toshimitsu Kitajima 2, Misa Sakaguchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009. |
|---|
|
|
O13-005 Support of risk aversion and the use by the change to Fentanyl MT patch of opioid aptitude 木村賢治, 山形亜紀子, 阿部奈保子, 田中達夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009. |
|---|
|
|
Environmental exposure at the O13-006 anticancer drug preparation Reina Nishigaki 1, 2, Totsuka ゆ K 2, Keiji Wakabayashi 2, Hiroshi Yamamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2009. |
|---|
|
|
The regimen check of the prescription including the oral O13-007 anticancer drug and future problem Yoshimi Taniguchi, Shinya Suzuki, Yoshiko Nishimura, Yasuhiko Ichida, Yoshizo Watanabe, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009. |
|---|
|
|
About adsorption to pledget of the examination (2) chlorhexidine gluconate of the O13-008 medical supplies-related medical accident associated with - intravenous feeding cooking ahead example - 長岡匠, 岩瀬利康, Junko Miyakawa, Tomoaki Toyama, Yoshio Ito, Tadashi Nagase, Keiko Shinozaki, Kumiko Okitsu, Miyuki Suehiro, 双樹恵, Minoru Mori Tomoko, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009. |
|---|
|
|
About adsorption to pledget of examination (3) benzalkonium chloride of the O13-009 medical supplies-related medical accident associated with - intravenous feeding cooking ahead example - Tomoaki Toyama, 岩瀬利康, 長岡匠, Junko Miyakawa, Yoshio Ito, Tadashi Nagase, Keiko Shinozaki, Kumiko Okitsu, Miyuki Suehiro, 双樹恵, Minoru Mori Tomoko, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009. |
|---|
|
|
About adsorption to pledget of examination (4) benzethonium chloride of the O13-010 medical supplies-related medical accident associated with - intravenous feeding cooking ahead example - Junko Miyakawa, 岩瀬利康, 長岡匠, Tomoaki Toyama, Yoshio Ito, Tadashi Nagase, Keiko Shinozaki, Kumiko Okitsu, Miyuki Suehiro, 双樹恵, Minoru Mori Tomoko, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009. |
|---|
|
|
Associated with examination - intravenous feeding cooking ahead example of problems and measures of the proper use information of the examination (5) disinfectant of the O13-011 medical supplies-related medical accident - 岩瀬利康, 長岡匠, Junko Miyakawa, Tomoaki Toyama, Yoshio Ito, Tadashi Nagase, Keiko Shinozaki, Kumiko Okitsu, Miyuki Suehiro, 双樹恵, Minoru Mori Tomoko, Chiaki Koshikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009. |
|---|
|
|
Effect of the commercial deglutition adjuvant jelly which gives it to adhesiveness and the remedy characteristics of the O13-012 Kremezin (R) infinitesimal grain Takahiro Uchida, Tamami Haraguchi, Haji River dance, Miyako Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2009. |
|---|
|
|
Evaluation according to the grain size of O13-013 clarithromycin DS Haji River dance, 盛崎友美, Kaori Fujii, Mio Tange, Tamami Haraguchi, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009. |
|---|
|
|
It is effect of the temperature the taste bitter evaluation of the O13-014 ambroxol tablets 10 preparation Yuka Sugino, Haji River dance, Tamami Haraguchi, Miyako Yoshida, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009. |
|---|
|
|
Advice ... of analysis - magnesium densitometry of renal function and the serum magnesium density of patients receiving O13-015 magnesium Yumiko Asai, Kenichi Saito, Takaki Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009. |
|---|
|
|
Effect of the pharmaceutical intervention using the quality of life questionnaire in the O14-001 outpatient department cancer chemotherapy Tomoki Nozoe, Wataru Yasunaga, Atsushi Fukuzaki, Nesaki spring, Noriko Takeda, Higashitarumi Akiko, 牧角寛郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009. |
|---|
|
|
Depression effect of Ca/Mg for peripheral neuropathy with O14-002 oxaliplatin Miki Takeshita 1, 3, Yoshiko Sakano 2, Teramachi eyes 1, Teruo Tsuchiya 1, Masashi Ishihara 3, Yoshinori Ito 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009. |
|---|
|
|
Examination of the hematologic optimal test day of the weekly Paclitaxel/Carboplatin clinical path for the O14-003 non-small cell lung cancer Small thicket Makiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2009. |
|---|
|
|
A change and actions to be taken of the serum magnesium level with O14-004 cetuximab Yasuko Watanabe, Gain book Shuji, Michiko Nishie, Shiho Kodera, Existence Reiko Sawa, Shinsuke Akagi, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009. |
|---|
|
|
Effect on diet of the digestive system adverse event in O14-005 outpatient department chemotherapy patients 篠原義剛 1, Hidehiro Kamachi 1, Tei Hara Expo 1, Hisae Nagahama 1, Hiroshi Hidaka 1, Toshihiko Ushio 1, Kojiro Takahashi 1, Mirror Seiji 2, Hiroaki Morimoto 2, Junji Iwashige 2, Junichi Tsukada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009. |
|---|
|
|
Study of the nanoacrylate structure body inhibiting the growth of the O14-006 culture cancer cell Yasushi Ueda 1, 2, Akiko Kaneko 1, Atsushi Yoshida 2, Akira Nakagawara flat 1, Yuki Fujiwara 1, Castle Shoichi Take 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009. |
|---|
|
|
An investigation about the body-surface area calculation in the treatment with O14-007 anticancer drug and calculation-style unification Masayuki Okada 1, 成末 Masami 1, Manami Matsuura 1, Yuka Sugimoto 1, Hideko Iwamoto 1, Pond end Hiroaki 2, Uchida まやこ 2, Hiroyuki Watanabe 2, Masanori Sueyasu 2, Ryozo Oishi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009. |
|---|
|
|
Effect of the liver function to give to neutropenia of the weekly paclitaxel administration on patients with O14-008 gastric cancer Furrow Yoshiko 1, 2, 寺田智祐 1, Kazue Takahashi 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009. |
|---|
|
|
Role of the pharmacist at O14-009 newcomer regimen application Yasuhiko Sakata 1, Open Koichi 1, Yonezawa sing; 1, Hama well Chie 2, Yasuo Iwamoto 3, Yasuki Tomota 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2009. |
|---|
|
|
Action to cancer chemotherapy security use in the O14-010 this hospital Hiromi Yamaguchi, Masatoshi Ota, Tomohisa Okamoto, Yoshiyuki Ishii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009. |
|---|
|
|
Development of a very small amount of analytical procedure of the vial surface contamination of the O14-011 platinum anticancer drug and evaluation of the preparation quality Naoya Suzuki 1, 2, Takafumi Naito 1, Keiji Matsumoto 1, Takashina Yoshiaki 1, Shuji Maruyama 1, Nobuhiko Takai 1, Tomohiro Yamamoto 1, Kimie Imai 2, Kunio Nakanishi 2, Junichi Kawakami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009. |
|---|
|
|
Evaluation of of the pharmaceutics of the O15-001 high dose acetaminophen suppository and the clinical pharmacology Hiroko Noda 1, Takeura Hiroyuki 1, 3, Koji Tazoe 1, Yoichi Ishizuka 1, Mitsuru Irikura 1, Toru Irie beauty 1, Minoru Yoshida 2, Akiko Sadanaga 3, 永田浩泰 3, It is Sachiko 3 in a camp, Eiko Fukunaga 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009. |
|---|
|
|
Prediction by the in vitro liver homogenate experiment system of the pharmacokinetic change at the O15-002 hypothermia therapy The Takashi Miyamoto sky, Satoshi Matsueda, Foot Shintaro, Mikiro Nakajima, Hitoshi Sasaki, Takahiro Nishida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009. |
|---|
|
|
Examination about the P-glycoprotein antagonism of the O15-003 Thai domestic plant ingredient, paclitaxel-resistant conquest effects and the anticancer activity Senmi Masashi 1, Hot-bath resort Yoshiko 1, History of Otani Kei 1, Junya Nagai 1, D Patanasethanont2, B Sripanidkulchai2, V Junyaprasert3, N Soonthornchareonnon3, Mikihisa Takano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009. |
|---|
|
|
Effect to give to renal function of acetaminophen using the O15-004 renal failure rat Finished river Satomi, Takeki Narita, Misato Nagashima, Ayaka Sota, Daisuke Kadowaki, Sumio Hirata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2009. |
|---|
|
|
O15-005 About pharmacokinetics of Mycophenolate mofetil in liver transplant patients 千崎康司1, 葛谷孝文1, 中村太郎2, 阪井裕介1, 木内哲也2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009. |
|---|
|
|
The need of a very small amount of compounding of medicines in the treatment with O15-006 warfarin Mai Kondo 1, Tetsu Sugiyama University 1, Yuko Okada 1, Yu Haruki person 1, Seki Yuka village 1, Yu Yokoyama law of nature 1, Yoko Sunada 1, Silk field Emi 1, Akiko Sakuma 1, Sachiyo Kondo 1, Kazumasa Komatsubara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009. |
|---|
|
|
Study on pharmacokinetics of antibiotics at the O15-007 sustained hemofiltration dialysis enforcement Taketo Yamamoto 1, Shinko Yasuno 5, Gutter slope Akihiro 2, Norio Hanabusa 3, Shoichi Katada 6, Noiri Hideyo 3, Toshiro Fujita 3, 4, Hiroshi Suzuki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009. |
|---|
|
|
TDM ... which the medical treatment intervention (1) - ward person in charge through the TDM by the O15-008 pharmacist receives Tomoko Mochizuki, Good luck Kagi connection, Sho Kamokawa, 有木宏宗, Mieko Yokoyama, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009. |
|---|
|
|
Examination ... about the initial administration plan of medical treatment intervention (2) - vancomycin through the TDM by the O15-009 pharmacist Sho Kamokawa, Tomoko Mochizuki, Good luck Kagi connection, 有木宏宗, Mieko Yokoyama, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009. |
|---|
|
|
TDM of the immunosuppressive drug in the case that small intestine was performed wide excision of after O15-010 renal transplant 8, Nango Keiko 1, Kokufu Takatoshi 2, Masahiko Okamoto 3, 吉村了勇 3, Yukako Ito 1, Nobuyuki Sugioka 1, Kanji Takada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2009. |
|---|
|
|
Examination about the effect that O15-011 Bilirubin gives in pharmacokinetics of irinotecan Wakako Miyachi 1, Hilum Takaaki Hayashi 1, 1, Asuka, Iwamoto, Eiji Kayano 1, Bun Takagi virtue 1, Hiroko Nosaka 1, Takashi Kato children 2, Yoshio Ijiri 2, Kazuhiko Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009. |
|---|
|
|
Trial of the hypothesis thinking process in the O16-001 six years system pharmacist education Masahiko Shimada 1, Market Misuzu 1, Yoshikazu Tanaka 1, Shunsuke Shiromizu 1, Haru Sato or 1, Kazunori Asai 1, Masaaki Machida 1, Shotaro Sakurai 1, Kiyoshi Sugiyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009. |
|---|
|
|
For an effect and problems -6 age system business training of the O16-002 Hospital business training - Michiru Watanabe 1, 小清水治太 1, Kazu Kojima child 1, Mari Fujimoto 1, Tomoko Yoshii 1, Kenichi Negishi 1, Kiyoshi Mihara 1, Tomi Kawata branch 2, Oil field Masaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009. |
|---|
|
|
Business training preparations situation investigation by the O16-003 Fukuoka Hospital Pharmacist Association Takahiro Muro 1, 2, 篠原義剛 2, 3, Takayuki Ishimaru 2, 4, Kazue Tanaka 2, 5, Shoichi Shiotsuka 2, 6, Kojiro Nikami 2, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009. |
|---|
|
|
It is a report as a result of questionary survey in the ethical pharmacy under Oita the questionnaire about the action of an expectation image and the business training of the O16-004 six years system pharmacist Yasuhiro Matsumoto 1, Isshiyo Mori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009. |
|---|
|
|
It is ... about a training method to learn a general idea of business training measures - POS of the O16-005 hospital pharmacist Yoshiko Nishimura, Yui Yoichi Sono, 槇林智子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2009. |
|---|
|
|
Making of the nutrient menu making support tool for O16-006 pharmacist and a pharmacy student Ryuichi Fukuoka, Hisadome element, Yoshihisa Ishihara, Persimmon former Ikuyo, Taku Ando, Tadahisa Wada, Karasaki Yumi, Toru Tanabe, Sayaka Tanaka, Aya Horikiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009. |
|---|
|
|
Relation as the medical supplies safety management person in charge to the O16-007 special elderly nursing home Masako Tahara 1, Masumi Hara 2, Takashi Narazaki male 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009. |
|---|
|
|
Drug control instruction duties for the home care person judging from O16-008 reporting book Mai Yamazaki 1, Kazuki Kushida 1, Yoshio Nakamura 2, Riku Watanabe child 2, Chie Tawara 2, Yoshiko Ueno 2, Yuji Takemoto 2, Hiroki Adegawa 2, Akiko Hirao 2, Hidekazu Fujikawa 2, Iwade Nobuyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009. |
|---|
|
|
Examination about the need of the pharmaceutical management in the O16-009 treatment at home and the new directionality of pharmacist duties 中尾侑加 1, God Tomoko 2, Ichiro Inaba 2, Great Satoshi Kubo 3, Yoichi Ishizuka 1, Mitsuru Irikura 1, Toru Irie beauty 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009. |
|---|
|
|
Nursing-care cost reduction example - by the review of case report - drug by the many types of job cooperation in the O16-010 treatment at home Mikiko Nakamura 1, 牧圭子 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009. |
|---|
|
|
Construction of "the medicine medicine cooperation" for the O16-011 patients Junko Onishi 1, 2, 3, Tadashi Hiromoto 3, 4, Toshiko Terakawa 3, 5, Suguru Ohashi elegant 3, 6, Hitomi Tsuboi 7, Naoki Murao 3, 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2009. |
|---|
|
|
Effect on hypoglycaemia effect of the diabetes therapeutic drug which O17-001 celiprolol brings Yamase University male, Makoto Miyazaki, Kazunori Iwanaga, Masao Kakemi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009. |
|---|
|
|
Questionary survey about use characteristics of the O17-002 pre-filled type insulin device Main room three picture 1, Yuko Kanezaki 1, Osamu Egawa 1, Akihiko Hirano 2, Kumiko Murakami 2, Satoko Egashira 2, Great Kusu Noriko 2, 渡辺利穂 2, Kumiko Imamura 2, Hideaki Kondo 3, Kiyoshi Ashizawa person 3, Motomori Izumi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009. |
|---|
|
|
Visual disturbances simulated experience insulin injection inside the hospital training for the purpose of the standardization of the procedure instruction for the O17-003 visually impaired Hiroyuki Nishimura 1, Yoshida positive 1, Asako Eguchi 1, Takako Uozumi 1, Yoichi Ishizuka 2, Mitsuru Irikura 2, Toru Irie beauty 2, Keizo Kajiwara 3, Tomio Jinnai 3, Hideaki Jinnai 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009. |
|---|
|
|
Problem of the hospital pharmacist in the O17-004 diabetes patient education Akiko Emoto 1, 7, Fumi Okada 2, 7, Kyo Kimura 3, 7, Bell mountain Naoto 4, 7, Reiko Yasunaga 5, 7, Tadashi Sakamoto 6, 7, Fujito Expo 1, 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009. |
|---|
|
|
Intervention of the pharmacist at insulin induction to patients with foreign diabetes taking O17-005 oral hypoglycemic drug Hideko Iwamoto 1, 成末 Masami 1, Manami Matsuura 1, Masayuki Okada 1, Yuka Sugimoto 1, Ryoichi Baba 1, Shinichiro Mizumachi 1, Saki Jinnai picture 1, Mihoko Kawahara 1, Seibei Miyake 2, Fumi Murata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009. |
|---|
|
|
Action to the generic medicine in the basic hospital in O17-006 Saiki-shi Keiko Kitajima 1, Shrine Akihiro Ichiro 1, Maruyama Akina 1, Mimata Sayaka 1, Tatsuya Sasaki 1, Kaifu Masayo 1, 末安由拓 1, Akihiro Kai 1, Ishikawa immensity 1, Prince Taniguchi chapter 1, Ken Takakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2009. |
|---|
|
|
Mitsuyasu qualitative analysis of the warfarin potassium generic drug crush thing using the O17-007 air conditioning 96 well Makoto Otsuka 1, Riding ground base (Horiguchi) picture non-1, Junichiro Murayama 2, Yoichi Ishikawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2009. |
|---|
|
|
Bioequivalence in healthy adults of 30 mg of O17-008 lansoprazole OD lock "Towa" Yoshiaki Itano, Koji Ogawa, Takashi Matsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2009. |
|---|
|
|
Bioequivalence in the healthy adults of 10% of O17-009 ceph Neil infinitesimal grain children's use Kuniko Hayashi, Koji Ogawa, Takashi Matsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2009. |
|---|
|
|
About examination - injectable cefotiam of the generic medicine clinical evaluations using O17-010 DPC data and imipenem - 濱邊秋芳 1, 森宗芳 2, Koichi Hirao 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2009. |
|---|
|
|
Generic medicine lectotype based on the O17-011 bioequivalence test data Masanobu Hayakawa 1, Takashi Yanagawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2009. |
|---|
|
|
Does the P1-001 stress increase a dispensing error? Akira Koyama period, Shinji Takayama, Kenichiro Kawana, Haruna Watanabe, Rumiko Hattori, Makiko Matsui, Kazumi Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009. |
|---|
|
|
The fact-finding of the P1-002 dispensing error and evaluation of preventive measures against dispensing errors Koichiro Iwata 1, Kazue Soda 1, Sakai Naoko 1, Mayumi Iriya 1, Jun Kainuma 1, Takahiko Kagaya 1, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009. |
|---|
|
|
Wetting-related participation for the syrup attachment invulnerability for children in meter of a lot of P1-003 material Yoshihisa Yamamoto 1, 4, Suzuki Toyoshi 2, Hashizaki 3 required, Megumi Kawakita one 1, Masamichi Fukuoka 4, 深水啓朗 2, Kazuo Tomono 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009. |
|---|
|
|
The present conditions and problem of the injection preparation in the P1-004 Saitama Medical School Hospital satellite pharmacy Shigeru Koizumi 1, Yuichi Hirano 2, Norio Kameoka 1, Riyoichi Yonezu 1, Morihiro Yamashita 1, Masami Kondo 1, Egusa Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009. |
|---|
|
|
Search of the factor predicting quantity of outpatient dispensing duties that assumed P1-005 compounding of medicines waiting time end-point Takehiko Tezuka, Forest pre-Shibi, Shunsuke Kurono, Hiroaki Yamanouchi, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009. |
|---|
|
|
One patient who is addicted to carbamazepine with suspected disturbance of consciousness with the P1-006 drug hepatopathy Kenichi Ooe, Mai Higashimura, This Western philosopher, Shinji Honma, The long waterfall truth, Watanabe Kyoko, Masayo Takagi, Michiyo Terasawa, Hidekazu Kizaki, Kayo Saito, 川瀬泰裕, 澤谷佳美, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2009. |
|---|
|
|
About the examination of doubt inquiry criteria for P1-007 Axtos lock proper use Italy Sachi Haraki charges 1, Mitsugu Saegusa 1, Tomoya Asada 1, 眞鍋伸次 1, Ichiro Matsumoto 2, Yuichiro Takagi 2, 森由弘 3, Thickness well Bunichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009. |
|---|
|
|
P1-008 Current Status and Problems of distribution drugs cart all ward simultaneous introduction: medical safety initiatives by ward pharmacists and nurses cooperation 二ノ倉浩之1, 2, 木南志朗1, 五十嵐一裕1, 小川洋司1, 村岡勝2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009. |
|---|
|
|
Examination about the stability after the P1-009 gabapentin tablets crush Yuki Utsunomiya 1, Kenji Okada 1, Yusuke Miyamoto 1, Kazuya Harada 2, Kuwana Shiori 1, Toshimi Kimura 1, Mori Kiminori 2, Kenichi Sagawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009. |
|---|
|
|
Development factor of "a standard error, the medicine difference" in the P1-010 health insurance pharmacy Tokiko Okuda 1, Downhill path static Kei 1, Nobuaki Takahashi 1, Motoyashiki Kayoko 1, 高坂直宏 1, Mitsuko Onda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009. |
|---|
|
|
Effect of the conservation condition to give it to stability after the crush at P1-011 aspirin end Kazuhiko Yamaji, Yoichi Kawasaki, Nawa Hideki, Satoshi Uejima, Tomoaki Sato, Matsunaga still, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009. |
|---|
|
|
Quantity of injection room duties investigation in the P1-012 Cancer Res. Inst. Ariake Hospital Former Taro Isami, Tsuyoshi Aoyama, Takashi Sugizaki person, Kondo many children, Daigo Shoji, Ryota Furuya, Akane Hagino, Anna Inoue, Kazunori Kawakami, Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2009. |
|---|
|
|
About bringing medicine management in the P1-013 Toku Chiba bank meeting Hospital - second report - Ko Ichihara, 福井宗憲, Noriyuki Sano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009. |
|---|
|
|
A utility of the P1-014 image observation equipment and future problem (the second report) 小林万也孝, 新井成俊, Kenichi Saito, Takaki Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009. |
|---|
|
|
About an injection compounding of medicines support system using a bar code check for prevention of P1-015 medical accident Minako Yoshida, Shoji Takagi, Tetsu Wakabayashi, Hideki Okamoto, Toshiko Okura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009. |
|---|
|
|
Opioid management instruction duties in the P1-016 this hospital Yoshinori Kobayashi, Osamu Kitamura, Kazuo Katsumata, Hiroshi Kawaguchi fruit Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009. |
|---|
|
|
P1-017 Construction and operation evaluation of injection drug dispensing inspection system using a new bar code display 新家恵子, 北川克美, 小野祐志, 倉光明美, 栗谷良孝, 西井諭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009. |
|---|
|
|
A construction and use of the drug conveyance system of administration in the P1-018 this hospital Atsushi Adachi, Junko Usami, Mikiko Akabane, Katsumi Kitagawa, Akemi Kuramitsu, Kuridani Yoshitaka, 西井諭司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2009. |
|---|
|
|
Development of the injection checking prescription system which we paid our attention to for dosage interval in the foreign injection administration using P1-019 new bar code (GS1-Databar) Kazunori Shimomura 1, Tadashi Suyama 1, Senaha Hiromasa 1, 名徳倫明 2, Shinichi Kawaguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009. |
|---|
|
|
Use fact-finding of the P1-020 "drug which should perform liver function tests" Twig Nobuyuki, 永田智依世, Brook Mitsue, Koji Kishimoto, Tajima Shigetoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009. |
|---|
|
|
P1-021 Enhancement, efficiency of the prescription checking by the review of the prescription indication 杉理江, 益本周治, 亀井健人, 徳田衝紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009. |
|---|
|
|
Inflection on the electronic chart of the check item which we extracted from the P1-022 "injection compounding of medicines inspection manual revision third edition" Hagiyama Hiroshi, Fukuo Kimura, Yu Nakahara, 西村篤弘, Fujiko Yamazaki, Kazunori Yamamoto, 緒万昭, Asako Nakagawa, Yutaka Uchida, Keizo Ishimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009. |
|---|
|
|
The development of the injection set inspection system which utilized P1-023 RSS cord and the operational actual situation Hiroki Nakazato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009. |
|---|
|
|
An evaluation of the drug information for P1-024 neonates and construction of the dose check system Natsumi Tashiro, Ayako Suehiro, Takuya Suenaga, 岩尾恭寛, Yutaka Ueyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2009. |
|---|
|
|
Action to the risk management in the P1-025 anticancer drug preparation 岩尾恭寛, Yutaka Ueyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009. |
|---|
|
|
Investigation of problems about the compounding of medicines preservation of drug stability for P1-026 drugstore pharmacists Straight Katsumi Shiroyama 1, 2, 3, Yuki Kobayashi 3, Katsutoshi Takada 4, Takao Aoyama 5, Hiroshi Uno exhibition 6, 大澄朋香 1, Hisashi Iijima 1, Yoshikazu Ishino 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009. |
|---|
|
|
The incident analysis that the nurse in the nursing system is involved in at 7:1 in the P1-027 this hospital Soichiro Nakata 1, Tomoaki Toyama 1, 早乙女聡良 1, Koichi Hoshino 1, Keiko Osodo 1, Miyoko Horie 1, Mitsuharu Omori 1, 3, Yukinori Usui 1, Keiko Suzuki 2, 3, Emi Ueno 2, 3, Emiko Abe 2, 3, Yuko Suda 2, 3, Mayu Kaminaga light 2, 3, Kumiko Ode 2, 3, Shizue Sayama 2, Yu Nakatani oneself 3, Hiroshi Hirata country 3, Yuzo Suda 3, Chiaki Koshikawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009. |
|---|
|
|
Examination of the P1-028 compounding of medicines double inspection utility Gentaro Nagae, Hiroyuki Naito, Kazuo Kaneko, Masashi Suzuki, Yasushi Kawatsu kernel Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009. |
|---|
|
|
Utility evaluation of the medical supplies proper use support card making program in P1-029 risk management measures Yutaka Ito root 1, Tsuboi Mizuki 1, Shunsuke Kasai 1, Yuko Sasaki 1, Yasushi Matsuura 1, Takemoto Chihiro 2, Keiko Konishi 2, Koto Fujiwara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009. |
|---|
|
|
Present conditions and evaluation ... of set duties of the medicine to the administration cart by action ... pharmacist to the nursing service support by the pharmacist in the P1-030 this hospital Yosuke Kato, Masamitsu Matsuda, Toshihiro Osuka, Akira Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2009. |
|---|
|
|
Characteristic of the factor according to the type of the compounding of medicines error in the P1-031 health insurance pharmacy Akiko Nakagawa 1, Mitsuko Onda 1, Hidehiko Sakurai 2, Arakawa line straight 1, 早瀬幸俊 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009. |
|---|
|
|
It is whole country virtue bank society hospital "questionary survey count result about the facility suspension method" P1-032 second report Koto Fujiwara 1, 敦見真由美 1, Satoshi Takahashi 2, Nishizono Kenro 3, Tetsu Ando sincerity 3, 賀勢泰子 3, Is Kurata; see it; 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009. |
|---|
|
|
Attitude survey for the discrimination of the tablet divided into half in the P1-033 medical care security Kazuhiro Hirano, Akiko Emoto, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009. |
|---|
|
|
Factor analysis of the compounding of medicines error using the P1-034 viewpoint measurement machine Hiroki Nakamura 1, Inooka Kyoko 1, Yuriko Murai 1, 2, 眞野成康 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009. |
|---|
|
|
Than basic examination (2) - long-term storage about the storage condition of the P1-035 folding compounding of medicines medicine ... Toshi Tanaka, Masuo Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009. |
|---|
|
|
Action - pre-Abo id report promotion to promoting it campaigns pre-Abo id report in the P1-036 Kanagawa Hospital Pharmacist Association; and - Junichi Iida 1, Tetsuro Yumoto 1, Large pattern root Izumi 1, Tatsuya Kato 1, Akitoku Kojima 1, Tamura harmony, reverence, purity and tranquility 1, Hisashi Fujiwara up 1, Takuya Maeda 1, Takeshi Yamaya 1, Yukino Ayabe 1, Hajime Matsubara 1, Yoshiko Miyazaki 1, Body marsh Masami 2, Hajime Kagaya 1, Masayuki Morita 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2009. |
|---|
|
|
P1-037 Compounding changes that occur in Nicarpine (R) during constant speed intravenous injection from the side tube to the main root 岩渕安史1, 上井幸司2, 西和哉1, 阿部浩幸1, 我妻仁1, 鈴木常義2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009. |
|---|
|
|
An investigation and examination of the factor to cause P1-038 high magnesium (Mg) blood disease Toishima study 1, Daisuke Takagi 1, Yukie Harigai 1, Koji Fujimoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009. |
|---|
|
|
Analysis of fall, the fall accident that seemed to be due to P1-039 antihypertensive medications Yu Maeda ankle 1, 丹村貴之 1, Hiroyuki Mizuno 1, Kayo Koike 1, Reiko Yamada 3, 木村和哲 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009. |
|---|
|
|
Patients renal function information mention (the second report) to a prescription that we use P1-040 GFR estimation type (eGFR) Tetsuya Ito, Yuka Okada, Toshie Hirano, Yoshiteru Tanaka, Hirotaka Hashizume Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009. |
|---|
|
|
Database compilation and analysis of P1-041 doubt inquiry contents Hiroyuki Miyashita 1, Reiko Fujino 1, Yuko Sudo 1, Teruko Takano 1, Mai Tanaka 1, Jun Kainuma 1, Takahiko Kagaya 1, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009. |
|---|
|
|
Utility and problem - by the induction to trial - outpatient of the simple suspension method induction in the P1-042 Shizuoka cancer center Kaori Masuda, Tomohisa Onishi, Hiromi Iizuka, Hitoshi Hashimoto child, Satoshi Motokawa, Michihiro Shino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2009. |
|---|
|
|
Content analysis and examination (the second report) of the doubt inquiry in the scale medical institution out of P1-043 Maho Kikuta, Makoto Shuto, Yumiko Hanawa, Nakamura three kinds of filial duties, Yoshiko Yamamoto, 新熊傳治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009. |
|---|
|
|
Action to the drug control of P1-044 orthopedics inpatients Mihoko Tesaki, 瀧本美古, Nozomi Sato, 堀渕倫未, The Nakayama future, 向誠一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009. |
|---|
|
|
Problems obtained from the fact-finding of a medicine notebook and the practice reporting book in 9 institutions in P1-045 Yamaguchi Hiroyuki Watanabe, Mayuko Ito, Shiro Mitsubori, Tomoyuki Oka, Yasuaki Otsubo, Takaba University group, Hiroko Hiraoka, Light end Takayo, Gain Narihiro, Takeshi Yamamoto, Akira Kamiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009. |
|---|
|
|
Examination about the conservation method of P1-046 wettability medical supplies Yukihiko Numajiri 1, Yoshiyuki Kimura 2, Ai Kuwahara 2, Kuzuma Nobuaki 2, Yasunori Morimoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009. |
|---|
|
|
Action to risk aversion of the injection in the P1-047 drugstore Michi Iriyama, Italy Mariko Saji, Kanako Naoe, 桐越慶, Four wisteria Rika, Hiroyuki Ozaki, Tadashi Maeda University, Masahiro Yamagata, Tetsuro Hashimoto, Koji Matsubara, Lower Mizue Sawa, Takashi Oda child, Norio Sakuta, The new Tadashi Oka method Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009. |
|---|
|
|
Present conditions - of the role - Toho University medical center Sakura Hospital of the ward pharmacist in the proper use of P1-048 medical supplies and the medical safety management Kaoru Suzuki, Tsukuda Akiko, 穗苅郷美, Shinki Nakamura, Keiichi Hara, Ikuno Watanabe, Atsushi Urano, 佐野君芳, Ishii Toshihiro, Masaka Wataru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2009. |
|---|
|
|
Mainly on a drug having high - risk to propel medical security from the P1-049 pharmacy - Now Yoshiko Takada, Shinichi Tamiya, Tomohiro Umemura, Tree Masaji, Saza Yaeko, Noriaki Araki, Tomohiko Aoyama, Kenji Tokui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009. |
|---|
|
|
Injection risk management using the list of P1-050 administration attention medicine Yoko Minagawa, Satoshi Araki Eiko, Yuasa lap, Masaru Kawai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009. |
|---|
|
|
P1-051 Risk mitigation and efficiency of oral medicine one encapsulated using the Medicament audit prescription and drug aggregate list 濱田武, 畑武生, 北川俊史, 鈴木典子, 鈴木薫, 西原雅美, 玉井浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009. |
|---|
|
|
Additional mixed injection from bag mixed injection mouth in a utility, the safe report 3. risk management of the bag for the P1-0525 new hyperalimentation [TPN] preparation 深井康臣 1, 4, Nakazawa one net 1, History of Megumi Yamauchi 3, Shin Ota 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009. |
|---|
|
|
Examination of the preparation error in the P1-053 anticancer drug preparation Makoto Nakajima 1, 2, Takuya Goto 1, Yoshie Nomura 1, Yumi Suzuki 1, Yukiko Shibata 1, Takahiro Kumagai 1, Shuichi Matsumoto 1, Shisui Masumi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009. |
|---|
|
|
Examination of the dumb person who is mouth for the purpose of 1% of P1-054 itraconazole internal use liquid compliance improvement Mitsue Ishitani, Gain book Shuji, Taketo Kamei, Lake Aso Kazuyo, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2009. |
|---|
|
|
Analysis of the doubt inquiry example in the P1-055 anticancer drug injection prescription Mitsuhiro Hashimoto, Hiroshi Yamaguchi, Akihisa Koyanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009. |
|---|
|
|
Action of the drug change in the P1-056 drug risk management Nao Katayama incense, Yuko Ishikura, Foot Hideki Oka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009. |
|---|
|
|
2 case ... which gave intubation of the antiHIV medicine by the examination (the second report) - facility suspension method about the administration of antiHIV medicine method for the patients who had difficulty with P1-057 internal use Aya Yoshida 1, Naoko Miyazaki 1, 2, Tadashi Kikuchi 3, Carp Tomohiko Fuchi 3, Tsuyoshi Fujii 3, Aikichi Iwamoto 3, Masaaki Takahashi 4, Yosuke Kurokawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009. |
|---|
|
|
About the induction of the simple suspension method in the P1-058 Metropolitan Fuchu hospital 右川浩, Junko Hiroi, Masako Koike, Small Masayuki Aga, Setsuko Teraguchi, Kaori Ito, Junichi Suwa, Kanichi Kawasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009. |
|---|
|
|
Prime cause analysis of the insulin accident example that occurred in P1-059 this hospital Ground field Mikiko 1, Nami Matsui 1, Sakuma Miyuki 1, 猿谷淳 1, Yuka Nakano 1, 向一美 1, Hiroko Takahata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009. |
|---|
|
|
An action and problems to ward injection mixed preparation duties in the P1-060 this hospital satellite pharmacy Tree temple Yasuhiro 1, 2, Yasuyuki Tsukioka 1, Yuzuru Yamazoe 1, Kenzo Moriyama 1, Camellia Masahiro 2, Nishida measure three 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2009. |
|---|
|
|
Action to risk management in the P1-061 investigational new drug management Takashi Mizui term 1, 2, Osamu Umeda 1, 2, Katsutoshi Goto 1, Masamitsu Sakaida 1, 2, Kazushi Yoneta 1, 3, Oak mound Tomi man 2, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009. |
|---|
|
|
Analysis of the doubt inquiry example in the P1-062 injection compounding of medicines 澤藤園子, Hiroyuki Hayashi, History of laboratory of origin of soil, Kishi, Matsuzaki, Masahiro Kawai, Akio Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009. |
|---|
|
|
For the purpose of sensory evaluation - dispensing error prevention about the P1-063-colored discrimination - Manami Kanda 1, 1, Asuka, Matsuda, Tokushuku Keiko 2, Body marsh Masami 1, Hitoshi Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009. |
|---|
|
|
Examination of the medicinal solution plombage in the P1-064 portable constant infusion pump Senaha Hiromasa 1, 名徳倫明 2, Kazunori Shimomura 1, Shinichi Kawaguchi 1, Kenji Ikeda 2, 廣谷芳彦 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009. |
|---|
|
|
Intervention - to role - safety measures working team of the pharmacist in the P1-065 medical care security Harumi Nakano 1, Atsuko Nakajima 2, Mami Nomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009. |
|---|
|
|
About preventive measures against false administration of critical medicine in the P1-066 Kyoto Municipal Hospital Kyoko Kumagai, Yasushi Meguro, Keiichi Ono, 村田龍宣, Hiromi Fujita, Shinji Honda, Masaru Ono, Yasushi Sunda, 平田敦弘, Imagawa grammar Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2009. |
|---|
|
|
Risk management for P1-067 iodine contrast media and the drug with the interaction Keiko Shimizu 1, Katsube law of nature early 2, Hiromi Okazaki 2, Sendo Toshiaki 1, 2, 合葉哲也 1, Yuji Kurosaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009. |
|---|
|
|
P1-068 Investigation about the ratio to receive injection drug formulations, prescription checking in pharmacy 古谷祥子, 徳田衡紀, 西村健二, 森谷康志, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009. |
|---|
|
|
P1-069 The features and trends of the drug should be noted at the time of injection prescription inspecting seen from case analysis 森谷康志, 赤木晋介, 西村健二, 徳田衡紀, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009. |
|---|
|
|
Association of the communication skill in the pharmacy management judging from P1-070 doubt inquiry example Yoko Watanabe, Ryota Tsukioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009. |
|---|
|
|
It is the incompatibility between the preparation in the parcel product for becoming it P1-071 one Tomikawa Naoko, Takeshi Kotake, Masatoshi Sugiyama, Isao Sugimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009. |
|---|
|
|
Effect - of pH to give the content decrease mechanism-2-content decrease of the diazepam injection at use of P1-072 PVC/TOTM tube Norihiro Watanabe, Mutsuko Sasaki, Kenji Kawano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2009. |
|---|
|
|
Study on TOTM elution mechanism from P1-073 PVC membrane Yuka Tsukada, Mutsuko Sasaki, Kenji Kawano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009. |
|---|
|
|
Development of the pimobendan tablet that P1-074 is stable Hideshi Beppu 1, 竹縄恭恵 1, Tatsuya Ishikawa 1, Akihiko Nagai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009. |
|---|
|
|
One pack of P1-075 pimobendan tablets "TE" evaluates stability at becoming it Megumi Takada 1, 上戸啓巳 1, Ayano Komine 1, Matsumoto age world 1, 竹縄恭恵 2, Hideshi Beppu 2, Tatsuya Ishikawa 2, Masaaki Nakano 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009. |
|---|
|
|
Examination about stability and the properties of matter evaluation of the P1-076 acetaminophen (AA) component OTC preparation Misuzu Ota 1, 2, 深水啓朗 3, Yuri Takahashi 4, Description of Motoi Arakawa 1, Masanori Iwata 4, Kazuo Tomono 3, Shinji Hidaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009. |
|---|
|
|
Utility of the electrophysiological experimental method as the corneal problem-related rating system at use of P1-077 eye drop Mikiro Nakajima 1, Shin Kitamura Hideko 1, Maiko Tsuji 1, Shigeru Umeno intellect 1, Takahiro Nishida 1, Junzo Nakamura 1, Teshima infinity 2, Hitoshi Sasaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009. |
|---|
|
|
The P1-078 ISO9001:2000 certification and action of the pharmacy Rie Aisaka, Takafumi Takeuchi, Ikuko Yoshida, Hizuru Kamata, Tomoko Suzue, Yamakawa Kazunori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2009. |
|---|
|
|
Reinforcement of the dose check function in the P1-079 electronic chart 清水俊洋 1, Hiroshi Fujita 2, Mitsumasa Shimizu 2, Takafumi Ide 2, Akemi Matsubayashi 2, Shun Nagai 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009. |
|---|
|
|
Enforcement - of the measurement compounding of medicines from rebuilding - hospitalization second of the injection compounding of medicines system with the P1-080 electronic chart induction 六波羅孝 1, Junichi Hara 1, 唐澤頼勝 1, Naoto Hotta 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009. |
|---|
|
|
We ride P1-081 electronic chart system EG-MAIN GX and are changed the section compounding of medicines system with the substitute Jun Wada, Tatsuya Nakagami, 荒井久暢, 東碧, Chieko Ozuku, Yuki Imaizumi, Tomoko Takeda, Michiko Fujioka, 山下彰良, Yoshiko Murayama, Koji Hasegawa, Taeko Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009. |
|---|
|
|
The simple suspension prescription order that linked P1-082 electronic chart Land-maru Mikio 1, Akemi Shigematsu 1, Shunsuke Kuroki 2, Shigeji Torigoe 3, Isshiyo Mori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009. |
|---|
|
|
Action to P1-083 anticancer drug regimen order and prescription publication system induction Kosaku Sasaki 1, Jun Taniguchi 1, 尾之江剛樹 1, Takanori Kobayakawa 1, Shunichi Hirayama 2, Shuichi Hanada 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009. |
|---|
|
|
Of the drug control instruction incorporated in P1-084 all-in-one pass, actually Kazumi Morishita 1, Yuki Kato 1, Noge Ichiro 1, Descent from a mountain Katsuhito 2, 福長徹 3, Norikazu Urabe 4, Michiyo Hattori 5, Junko Watanabe 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2009. |
|---|
|
|
Construction of the drug control instruction support system which assumes P1-085 pharmacotherapy monitor the principal objective 打谷和記, Yumiko Tsurumi, Masayuki Tanaka, Nishiyama rich person, Ikejima Takahiro, Tatsuya Muranaka, Kenichi Ooe, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009. |
|---|
|
|
Medication history investigation about the patients with food allergy correspondence in the healthcare setting around the P1-086 drugstore Kaori Kurata 1, Mari Nishizawa 1, Mitsuhiro Okazaki 2, Tei Nomoto 3, Akira Dobashi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009. |
|---|
|
|
Action to uniform management of the drug allergy information in the P1-087 electronic chart transition Haruhiko Nakamura, 澤柳直樹, Tomokazu Fujii, Kenichi Nomura, 岩瀬定利, Hisashi Kamiya line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009. |
|---|
|
|
Drug control ... before the construction (I) - hospitalization of the P1-088 bringing medicine system of administration for electronic chart Shie Nakagawa, Mutsumi Yoshioka exhibition, Yoshimi Ogawa, Noriko Morimoto, New Yasunori, The Hashimoto 100th, Sachimi Nishiyama, Sachiko Kaji, Takashi Tsuji, 渡雅克 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009. |
|---|
|
|
Construction of drug use, the regime by the P1-089 electronic chart induction Masami Tanoe 1, Hidekatsu Fukuda 1, Yoshiro Suzuki 1, Kaori Kato 2, Sayoko Hirabayashi 2, Naomi 3 who resigns from the post Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009. |
|---|
|
|
For P1-090 medical care security an action (duties improvement 3) of the duties expansion Kazuko Tanaka, Shrine gate Takanori, Kanako Maeda, Length well Nobutaka, Kimotsuki Miho, 中拂絵里香, The pond increase sweetfish beauty, Terumasa Sata, Tokiko Hanaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2009. |
|---|
|
|
Examination of the utility of the medical treatment management based on the fact-finding of the P1-091 asthma control Kozue Tanaka 1, Kayoko Nagahashi 1, Hiroya Masuda 1, Kaoru Kondo 1, Takashi Suzuka daylight 1, Takeshi Kimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009. |
|---|
|
|
Evaluation one year after the foreign patient compliance instruction induction to the P1-092 warfarin potassium long-term use patients Yasuko Kondo, Tomomi Yamade, Fujimoto A, Koto Fujiwara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009. |
|---|
|
|
Comparison ... of effect - doubt inquiry of the pharmacist increase of the staff in the P1-093 outpatient department chemotherapy Akira Takagi Kei 1, Mitsuru Susa 1, 阿部充伸 1, 山之内恒昭 1, Yasuhiko Mimura 1, Atsushi Kato 1, Cake well Tatsuhiko 2, Isao Adachi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009. |
|---|
|
|
Role ... of the pharmacist who P1-094 comes out, and is associated with meat phosphorus and smoking cessation situation - smoking cessation outpatient of the nicotine patch prescription patients Yutaka Takahashi, Toshio Maruyama, 昆貴志, Yukari Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009. |
|---|
|
|
Device - of the medical treatment model of study - circulatory disease of the patient compliance instruction method using the P1-095 disease treatment model Shingo Mikami 1, Nakano gain charges 1, Takeshi Midorikawa 1, Toshi Umemura 2, Castle Shoichi Take 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009. |
|---|
|
|
Practice of the fur Matthew tical care of the pharmacist in the P1-096 outpatient clinic and one discussion Tomoya Asada 1, Mika Kozai 1, Mayumi Okazaki 1, Mitsugu Saegusa 2, 眞鍋伸次 1, 森由弘 3, Thickness well Bunichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2009. |
|---|
|
|
About the action of the interview list in the outpatient specialized in P1-097 diabetes and a future problem Takako Nakajima 1, 1 which is related to Nomura, House village Mai 1, Kana Kato 1, Shigeru Yamada tree 1, Toshiaki Ishiguro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009. |
|---|
|
|
It is ... through a foot gangrene case in action ... ASO of the pharmacist in the P1-098 ASO outpatient department Yuriko Nimura 1, Takako Nakajima 2, Kana Kato 2, Shigeru Yamada tree 2, Yoshitaka Kumada 3, 豊田行康 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009. |
|---|
|
|
Examination ... of effect on serum phosphorus calcium concentrations management - parathyroid gland function of the contribution of the pharmacist in the P1-099 hemodialysis patient Yuka Onoe 1, Junko Onishi 2, 3, 4, Hoe mound Keiko 1, Plum Miyoshi 3, 石田茂 4, Kazuaki Shinomiya 1, Hiromi Kawasaki 4, Yoshihisa Kitamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009. |
|---|
|
|
Examination ... from effect on serum phosphorus calcium concentrations management - laboratory values of the contribution of the pharmacist in the P1-100 hemodialysis patient Hoe mound Keiko 1, Junko Onishi 2, 3, 4, Yuka Onoe 1, Plum Miyoshi 3, 石田茂 4, Kazuaki Shinomiya 1, Hiromi Kawasaki 4, Yoshihisa Kitamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009. |
|---|
|
|
About questionary survey of the itching for the P1-101 patient on dialysis Shigeru Yamada tree 1, Kana Kato 1, Shinji Takahashi 1, 1 which is related to Nomura, Mika Shinoda 1, Ikue Terao 1, Koki Kasuga 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009. |
|---|
|
|
Intervention effect of the actual situation and the pharmacist of the Helicobacter pylori sanitization treatment in the P1-102 this hospital 舟越亮寛 1, Tsuyoshi Washiyama 1, Kenji Kobayashi 2, Fumiaki Ueno 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2009. |
|---|
|
|
Relation of the pharmacist at the outpatient department in the P1-103 colonoscopic examination Shinichiro Fukushima 1, Prince Mamiya religion 1, Shigeru Yamada 1, Koichi Hirano 2, North Shuichi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009. |
|---|
|
|
Construction of the foreign chemotherapy use method on the basis of the P1-104 Atsushi Tamura, Mika Saito, 江刺晶央, Hideo Chiba, Junichi Tamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009. |
|---|
|
|
Investigation about the PT-INR measurement in the warfarin remedy patients who started P1-105 outpatient department cancer chemotherapy Miwa Ohara 1, 矢野亨治 1, Yasuhiro Miyakawa 1, Saori Ota 1, Takashi Nagata 2, Keiko Yamamura 2, Kiyobumi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009. |
|---|
|
|
About the relation of the pharmacist to patients who received P1-106 outpatient department chemotherapy Kenta Takahashi 1, Rumi Takano 1, Junji Asano 1, Hiroshi Sasaki enthusiast 1, Yuichi Sekizawa 1, Toshiji Oe 1, Katsuyuki Nakamura 2, Atsushi Miyamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009. |
|---|
|
|
Action of the pharmacist in the P1-107 outpatient department chemotherapy room Slightly dried fish Yuka, Yusuke Terakado, Seiko Takeshita, Ayako Sakamoto, Mai Suzuki, Wataru Sato, Toshima incense, Eriko Otani, Saori Isa, Yuki Hagiwara, Risa Sakamoto, Mizuho Iida, Aya Chikamoto, 澤畠孝幸, Masayo Okawa, Masashi Onozaki, Sachiko Saito, Haruhisa Watanabe, Sanae Ehata, Yoshifumi Aoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009. |
|---|
|
|
Present conditions analysis about the communication of a pharmacist and patients in the P1-108 ethical pharmacy with cancer Motoko Kawase 1, 半谷眞七子 1, Hiroyuki Kamei 1, Kazuhisa Matsuba 1, Hitoshi Ohashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2009. |
|---|
|
|
Action about the foreign initial induction instruction of oral anticancer drug TS-1 in the P1-109 digestive organ center Satsuki Abe 1, Yuri Nagai 1, Tomoko Tomishima 1, Country original Junichi 1, Nobuhiro Ozaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009. |
|---|
|
|
About UGT1A1 genetic polymorphism result of a measurement and the side effect evasion in the P1-110 irinotecan regimen Hiroyuki Kuwahara 1, Yuki Ogata 2, Miho Nitta 3, Miki Michigami 3, Hirotaka Kato 4, Masahiro Washimi 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009. |
|---|
|
|
Examination - of onset of side effect of weekly Taxol+CPT-11 therapy - case in the patients with the P1-111 UGT1A1 *6 homozygote Koda Yuko 1, Yoshihiro Kikuchi 1, Hisashi Kita sum 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009. |
|---|
|
|
Through pharmacist second training specialized in reporting - 2008 cancer to patients who received P1-112 outpatient department chemotherapy - Ishii Tsu two to congratulate, Keisuke Ito, Yumiko Senoo, Nobuyuki Yokota, Yumiko Oshikiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009. |
|---|
|
|
Examination about the risk factor of the febrile neutropenia in the foreign R-CHOP therapy for the P1-113 malignant lymphoma Tetsushi Kanematsu 1, 宇佐美英績 2, 吉村知哲 2, Tadashi Yasuda 2, Mitsuru Takai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009. |
|---|
|
|
Medication support using Braille for patients with total blindness that P1-114 postoperative chemotherapy is introduced into Tomoko Takahashi 1, Manabu Sakurai 2, Hisashi Fujiwara up 2, Sachiko Tomioka 2, Junichiro Murayama 3, Akihiro Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2009. |
|---|
|
|
Nausea, vomiting measures ... of the utility - FEC100 therapy of the medicine notebook in the P1-115 medication explanation Eri Asago, Sachiko Iwai, Tomohiro Maruyama, Saito incense, Noboru Yoshizaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009. |
|---|
|
|
Examination of the cancellation criteria about a white-cell count and the neutrophil count in the P1-116 outpatient department cancer chemotherapy Motoaki Ishikawa, 町支優和, Takahiro Ishida, Masumi Nakagami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009. |
|---|
|
|
Trial of the injectable anticancer drug explanation documentation in the P1-117 Nagoya City University Hospital History of Nasu ear 1, Junko Kuroda 1, Katsuhiro Kondo 1, Rie Kimura 1, Saki Kimura 1, Tetsuo Ezaki 1, Takahiro Hattori 1, Neck charges green 2, Kayo Koike 1, 木村和哲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009. |
|---|
|
|
Making of the manual for patients based on an adverse event investigation of the P1-118 outpatient department cancer chemotherapy Keiko Shoji 1, Kazuhiro Ishikawa 1, Satomi Yamada 2, Yuichi Ando 2, Masayuki Umemura 3, Tomoko Tezuka 3, Kiyobumi Yamada 3, Yukihiro Noda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009. |
|---|
|
|
The duties of the pharmacist in the P1-119 outpatient department cancer chemotherapy room and the evaluation Yoshifumi Komori 1, Iibaru University Minoru 1, Masashi Ishihara 1, Hironori Fujii 1, Koji Yasuda 1, Katsuhiko Matsuura 1, Senju Goto 1, Yoshinori Ito 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009. |
|---|
|
|
Evaluation of the utility that P1-120 pharmacist outpatient gives to foreign cancer chemotherapy Imamura pasture employee, Harada seven ear, Kentaro Katayama, Hironori Matsui, Yukiko Ozaki, Natsuko Ikeda, 井上稚枝子, Chie Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2009. |
|---|
|
|
It is the trial of the side effect prediction every patients background using the cluster analysis, factor side effect monitoring in the P1-121 outpatient department cancer chemotherapy Tsuyoshi Mori 1, 2, 西迫寛隆 1, Toshi Nakamura oneself 1, 2, Yukiyo Miki 2, Horinouchi Hironari 1, 2, Takumi Sakurada 1, 2, Shinji Abe 1, Kazuhiko Teraoka 1, 2, Hisatsugi U.S. Toshihide 1, Kazuyoshi Kawazoe 1, Kazuo Mizuguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009. |
|---|
|
|
Effect of the reporting of making and the repetition of the explanation sheet about the mFOLFOX6/FOLFIRI therapy for the P1-122 outpatient department chemotherapy room patients Toshikazu Tsuji 1, 2, Hiroyuki Watanabe 1, Minoru Yoshida 1, Kazue Nakajima 1, 平川良宏 1, Nobuaki Egashira 1, Yoichi Nakanishi 2, Ryozo Oishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009. |
|---|
|
|
Examination about the hematotoxicity of hydrochloric acid gemcitabine which considered the P1-123 drug administration time Kazufumi Iwata, 合澤啓二, Boundary Saori, Takako Baba, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009. |
|---|
|
|
Making and monitoring effect of "the at-home symptom diary" which can continue by P1-124 outpatient department chemotherapy 岩下佳敬 1, 中尾承司 1, Naomi Hasegawa 1, Masako Fukumoto 1, Kimiyoshi Iwasaki 1, Yukiko Narumi 1, Chieko Kawahata 1, Yoshida Nanase 1, Shuttlecock field Shingo 1, Kazuhisa Ishida 1, Akihiko Sakamoto 2, Hiroshi Imamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009. |
|---|
|
|
Utility of the epirubicin late departure large-capacity preparation in P1-125 outpatient department chemotherapy FEC100 Ayaka Narita, Masako Suzuki, 野村眞美, Keiji Tsunoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009. |
|---|
|
|
Investigation of the enforcement situation and interruption criteria of the P1-126 outpatient department cancer chemotherapy Minako Sato, Masako Okazaki, Katsuyuki Nakamura, Hiroyuki Mashiko, 片倉道啓, Hiroshi Nakata is elegant, Rev. Noda plus, Atsushi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2009. |
|---|
|
|
P1-127 The randomized controlled trials for cancer chemotherapy patients targeted drug management guidance and self-efficacy 高山慎司1, 石丸博雅1, 塩川満1, 松井真樹子1, 後藤一美1, シャピロ美奈2, 小野寺久3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009. |
|---|
|
|
P1-128 About mixing time shortening effect associated with the high standard Levofolinate formulation introduced 齋藤雅俊1, 月野木祥子1, 樋口敬子1, 小林彦登1, 斎藤太寿1, 松本忍1, 宮下博幸1, 伊東崇仁1, 引間有香1, 柴田壮一1, 貝沼潤1, 厚田幸一郎1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009. |
|---|
|
|
Acceleration > of the effective patient compliance instruction < intelligence to P1-129 outpatient department chemotherapy patients Yukiko Okamoto, Yuka Mori, Needle ヶ valley Yoshihisa, Mieko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009. |
|---|
|
|
Construction of the P1-130 chemotherapy enforcement schedule system Tomiko Sunaga 1, Susumu Tominaga 2, Naramoto under-secretary 1, Yagi Akihiro 1, Yoshinori Suematsu 1, Chiba or 3 to fold, Harada sincerity ratio old 4, Mamoru Suzuki 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009. |
|---|
|
|
About the action of the pharmacist in the P1-131 chemotherapy center Masahiro Ogami 1, Katsuki Kurosawa 1, Yutaka Kojima 2, Masahiko Shimada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009. |
|---|
|
|
P1-132 Changes in the prescription inspection business content of pharmacists in outpatient chemotherapy associated with the anti-cancer drug regimen order introduced 加藤博史1, 手塚智子1, 梅村雅之1, 玉置紀子1, 宮崎雅之1, 熊倉康郎1, 阪井祐介1, 加藤善章1, 中尾泰子1, 山田千賀子1, 水野智博1, 山田里美2, 安藤雄一2, 山田清文1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2009. |
|---|
|
|
Examination of the efficacy of the measurement of body weight in the P1-133 outpatient department chemotherapy Yusuke Sakai 1, Tomoko Tezuka 1, Masayuki Umemura 1, Noriko Tamaoki 1, Masayuki Miyazaki 1, Yasuro Kumakura 1, Kato good chapter 1, Yasuko Nakao 1, Hiroshi Kato 1, Chikako Yamada 1, Tomohiro Mizuno 1, Satomi Yamada 2, Yuichi Ando 2, Kiyobumi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009. |
|---|
|
|
P1-134 The study on the efficacy and safety in the starting lineup goods and generic products of Levoforinate 藤井宏典1, 飯原大稔1, 渡邊千尋1, 石原正志1, 小森善文1, 松浦克彦1, 後藤千寿1, 高橋孝夫2, 吉田和弘2, 伊藤善規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009. |
|---|
|
|
Action ... to reporting by role - outpatient department chemotherapy of the pharmacist in the P1-135 breast cancer team approach in medical care 見上千昭, 平郡薫, Takashi Nishio, Hideya Sakurai, Kimiko Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009. |
|---|
|
|
Start the anticancer drug preparation of both outpatient department, hospitalization in an action - outpatient department chemotherapy room of anticancer drug preparation duties in the P1-136 this hospital; and - Koji Akiyama 1, Kumiko Kawano 2, Tomoko Matsumoto 1, Mountain Rieko Sawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009. |
|---|
|
|
Role ... of foreign cancer chemotherapy - pharmacist carried out by P1-137 team Minako Higuchi, Koichi Matsuo, Yoshimi Sasaki, Sanae Iwatsubo, Yoriko Wada, Sachi Imaizumi, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009. |
|---|
|
|
Action to P1-138 colorectal cancer chemotherapy Lower morning law of nature 1, Miki Takara 1, Tokuko Sasahara 1, Chrysanthemum Hisano Hara 1, Shuichi Iwami 1, 1 that is Zao, Yuko Kubo 1, Miwako Araki 2, Yutaka Ogata 3, Masatoshi Tanaka 4, Mieko Tsuruta 5, Michio Sada 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2009. |
|---|
|
|
Treatment continuity of the mFOLFOX6 therapy for P1-139 elderly patients and safe examination Koga 1 to bear, Child 2 too rare Mochinaga, 岡橋朋世 1, 中野行孝 2, Yoshihiko Kitajima 3, Fujito Expo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009. |
|---|
|
|
About regimen management and database compilation using the P1-140 FileMaker Upper deep water future 1, Kenji Kakehi 2, Masashi Hamada 1, Yasushi Fujii 1, Kenichiro Fujii 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009. |
|---|
|
|
Infusion reaction in the P1-141 this hospital outpatient department chemotherapy and fact-finding of the anaphylactic expression Mieko Kishi, Toshiyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009. |
|---|
|
|
Use of the foreign chemotherapy with the sickbed reservation system which incorporated a P1-142 regimen registration function Setsuko Hisada 1, Nobuko Okubo 1, 2, Eishin Takahata 2, Keiko Kawahara 3, Shinojima Noriko 1, 3, Seven Masami Sawa 3, Masao Niiyama 2, 又野禎也 4, Hisayuki Nakajima 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009. |
|---|
|
|
About relations of P1-143 colorectal cancer chemotherapy and malnutrition Hiroyuki Hayashi 1, Small Hiroyuki Moriyama 2, 澤藤園子 1, 1, Kishi, Matsuzaki, Masahiro Kawai 1, Tsuyoshi Okudaira 1, 大槻千遥 1, Akio Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009. |
|---|
|
|
Examination of the enforcement regimen based on the nutritional evaluation of P1-144 outpatient department chemotherapy patients Hiroyuki Ueno 1, Kazuyo Matsuyama 1, Hiroshi Shono 1, 1, Shibi, Shimada, Kenji Imanishi 2, Kinuyo Kajiwara 3, 山内一恭 1, Yoshihisa Honda 1, Hideyuki Mishima 4, Crossroads relation Toshimasa 4, Katsuya Komori 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2009. |
|---|
|
|
For promotion of fact-finding - medicine medicine cooperation of the action for the cancer chemotherapy of P1-145 hospital pharmacist and the health insurance pharmacy pharmacist - Okazawa incense Tsu child 1, 2, Masato Wakabayashi 1, 3, Kei Matsuoka tree 1, 4, Shinichi Sasaki 1, 5, Hiroki Mizukoshi 1, 6, Emiko Takehara 1, 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009. |
|---|
|
|
Inspection of the P1-146 carboplatin initial dose setting and examination about the GFR estimation type Yokoyama Minoru thickness, Sachiko Koyama, Norihiko Naruse, Kazuhiro Mori, Kiyoshi Fujiyoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009. |
|---|
|
|
A hiccup and association of the drug that patients with P1-147 blood disorder produced after high-dose adrenal cortical hormone administration Mayuko Mori, Takahiro Hirata, 野村浩英, Katsuyoshi Hatanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009. |
|---|
|
|
About the renal failure in the adjuvant therapy CDDP+GEM every other week administration method after the P1-148 non-small cell lung cancer resection Takashi Goto, Makoto Ishibashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009. |
|---|
|
|
Renal dysfunction and hearing loss of the P1-149 S-1+ cisplatin combination therapy Naoya Uto 1, Katsuhiko Inoue 2, Masaaki Yamato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009. |
|---|
|
|
Fact-finding of the hematotoxicity in the esophageal cancer postoperative adjuvant chemotherapy using the P1-150 High dose division FP therapy Hayasaka state straight 1, Hiroko Yamamoto 1, Yu Ito rare 1, Hidenori Kitayama 1, Kazuya Takatsu 1, Fumie Kaido 1, Kimiyoshi Takeuchi 1, Osamu Ogino 1, 西田靖仙 2, Masao Hosokawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2009. |
|---|
|
|
Difference of the myelosuppression in the regimen of the P1-151 lung cancer chemotherapy 徳泉仁介 1, Rie Kaneko 2, Goro Ikushima 2, Keiji Mizuno 2, Yasui Yamahiro 3, Ryo Kimura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009. |
|---|
|
|
Examination ... of the vincristine stopping dosage case at the drug control instruction (the eighth report) - CHOP therapy in the P1-152 blood internal medicine 宇佐美英績, Michio Kimura, Okada sum intellect, Toshiya Nakao, Keiji Nakajima, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009. |
|---|
|
|
Examination about administration continuity and the safety of S-1 in the P1-153 gastric cancer postoperative adjuvant chemotherapy Michio Kimura 1, Morihata Kazuyo 2, Daisuke Ito 1, Mina Iwai 1, Okada sum intellect 1, 宇佐美英績 1, 吉村知哲 1, Tadashi Yasuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009. |
|---|
|
|
About an effect and a side effect of the bortezomib in the P1-154 this hospital Kazuhiro Nakamura 1, Hideaki Anzai 1, 井出眞 2, Kawachi Yasunori 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009. |
|---|
|
|
Examination about the moisture load at the cisplatin administration in the P1-155 this hospital Hashimoto non-thunder, 三角紳博, Takashi Nishino, 舛重正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009. |
|---|
|
|
Use ... of construction - mixed injection support seat of the P1-156 anticancer drug mixture preparation duties support system Satoshi Yamazaki 1, Sanae Ida 1, Kazutoshi Terayama 1, 藍澤牧美 1, Kaori Saito 1, Tomoko Yamazaki 1, Yu Inoue 1, 本加典子 1, Kenichi Yumura 1, Mitsuru Kaneta Expo 1, Junko Kitsu 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2009. |
|---|
|
|
Study on dose adjustment of the P1-157 FOLFOX, FOLFIRI therapy Mikiko Okazawa, Even Chieko, Mayu Suzuki incense, Mika Sato, Hirohiko Takano, Shuichi Sakata, Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009. |
|---|
|
|
Participate in making and evaluation - graduate school ward training of the manual for patients of the P1-158 DC and TC therapy; and - Chie Yamamoto 1, Sayuri Matsumoto 2, Noriko Kamiyama 1, Junichiro Murayama 2, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009. |
|---|
|
|
Trial - of the patient compliance instruction pharmacist surgical for more P1-159 cancer chemotherapy - patients for a hospital Miyanaga Minoru Miyuki, Tomoko Hiraiwa, Hiroshi Nakase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009. |
|---|
|
|
Efficacy of the FOLFOX4 therapy for progress, recurrent colorectal cancer in the P1-160 general hospital and safe evaluation Kenichi Shimizu 1, Rie Tamaoki 1, Kazufumi Makino 1, Yuka Ando 1, Mari Kamiya 1, Kenichi Osanami 2, Kensuke Ishii 3, Nana Kawanishi 3, Nakajima ability Expo 3, Kyoko Kanazawa 3, Mariko Nakamura 4, Akiko Usami 4, 五日市宏 5, Tadashi Tamura 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009. |
|---|
|
|
The childhood malignant glioma which tried administration of P1-161 temozolomide Oak shallows 1 to bear, Tomoko Kawai 1, Shun Ito elegant 1, Toshimi Kimura 1, Kenichi Sagawa 1, Yasuo Aihara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009. |
|---|
|
|
Examination about the regimen using the bortezomib for the P1-162 multiple myeloma Mitsutoshi Sato 1, Oguro Rieko 1, Chigusa Yamanaka 2, Katsutoshi Takada 2, Yasuhiro Matsuura 3, Noboru Akiba world beauty 2, 青墳信之 3, Yutaka Taniyoshi 2, Side 3, Taku Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2009. |
|---|
|
|
The time when the drug instruction in the cancer chemotherapy that the P1-163 patients expect is appropriate Chisato Matsumoto, Satomi Harima, Kondo is constipated, 河野吏恵, Tomoko Taniguchi, Kazue Toda, Taku Kitamura Maro, Susumu Wada, Miho Kojima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009. |
|---|
|
|
Side effect investigation of the GC therapy for the P1-164 urothelial carcinoma Village shrine Kotobuki in total, Motohiko Sano, Yuka Uchida, Shinichi Kumakura, Naoko Watanabe, Toru Kishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009. |
|---|
|
|
Analysis of nephropathic onset precipitants with the P1-165 cisplatin administration Katsuya Tanizawa 1, Yagi Kotobuki true 1, Keiko Taguchi 1, Kyoko Murayama 1, Takehiko Kashiwa 1, Hideji Endo 1, Tadashi Sugiyama 3, Teruo Tsuchiya 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009. |
|---|
|
|
One case of the unresectable intrahepatic bile duct carcinoma which became available for a hepatectomy by P1-166 Gemcitabine+Fluorouracil+Cisplatin(GFP) therapy Hitoko Miyazaki 1, Yuichi Muraki 1, Takuya Iwamoto 1, Seko mouth Noriko 1, Okamoto Meiji University 1, Hideaki Tanaka 2, Norihiko Yamamoto 2, Motoo Iwasa 2, Shinko Okuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009. |
|---|
|
|
Action at cancer chemotherapy explanation in the P1-167 this hospital digestive surgery Jun Naito 1, Takayuki Sakuma 1, History of Naganuma 2, Akinori Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009. |
|---|
|
|
P1-168 An example of dasatinib use for chronic myeloid leukemia patients 島田浩1, 安田成男1, 玉置利香1, 藤重夫2, 金義浩2, 山下みゆき3, 丹原敏男1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2009. |
|---|
|
|
Example that became patient compliance instruction and the NST intervention of the unresectable progressive stomach cancer S-1+CDDP therapy in the P1-169 this hospital digestive organ internal medicine Satoshi Yamano Eiko 1, Zhuangzi summer cord village 1, Hitoshi Fukunishi 1, Tomoko Hatanaka 1, Sugimoto reason flat 1, Sanae Takada 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009. |
|---|
|
|
P1-170 Attempt corrective to the standard dose in FOLFOX therapy aimed at cancer chemotherapy uniformity 藤井加容子1, 森本茂文1, 香川邦彦2, 北村良雄1, 田伏克惇3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009. |
|---|
|
|
Side effect investigation of Bortezomib in the P1-171 this hospital Fujitani Masanori, Yuichi Koizumi, Satsuka Yuki, Mami Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009. |
|---|
|
|
Case report of the use of Zevalin (R) patients in the P1-172 Kurashiki center Hospital Sayo Kano child, The history of Torigoe sky, Tomomi Ando, Koji Moriya, Lake Aso Kazuyo, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009. |
|---|
|
|
Investigation of the adverse event of patients who received P1-173 cancer chemotherapy and the quality of life Katsura Harada product 1, 2, Keiko Nagai 1, Harumi Yamada 2, Kotaki one 2, Mariko Asahi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009. |
|---|
|
|
Development of drug control instruction duties in consideration of the characteristics of patients with P1-174 childhood cancer Mishima one up 1, Pond end Hiroaki 1, Takahiro Matsushita 2, Masanori Sueyasu 1, Nobuaki Egashira 1, Ryozo Oishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2009. |
|---|
|
|
Action of a side effect investigation of the P1-175 R-CHOP(R-THP-COP) therapy and the manual making for patients on the basis of findings 政賢悟 1, Kano Tomoko 1, Ibara country charges 2, Nosaka straight volost 3, Hiroaki Mitsuya 3, Yoshiteru Honda 1, Hideyuki Saito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009. |
|---|
|
|
Action in the small and medium size hospital to be a pharmacist found for P1-176 cancer team approach in medical care Kenichi Ito 1, Kaori Miyazono 1, 先成玲美 1, Eri Muta summer 1, Shigeru Nagatomo 1, Furukawa incense 2, Naoko Mihara 2, Shirao uniformity 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009. |
|---|
|
|
It is ... about difference between P1-177 pyrimidine system anticancer drug and interaction in (S-1, UFT, 5-FU) between drug interactions - drug of the warfarin fluoride Hiroyuki Igarashi, Yasuhiro Maeda, Yoriko Kasamatsu, Kimiko Fukuyama, 寺下朋江, Hisako Ito, The Mizuno husband who congratulates it, Masaki Sano, Kojiro Takashima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009. |
|---|
|
|
Fact-finding of the use of antiemetics for nausea of patients receiving P1-178 cisplatin and vomiting and the evaluation Kazumasa Koshikawa 1, Isobe mildness 2, Shinobu Hirayama 1, Kenji Nishizawa 1, Sakae Honma 2, Kan Noriko 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009. |
|---|
|
|
Examination of the adverse event expression situation and the administration continuation in the P1-179 sunitinib administration Masatoshi Hayasaka 1, Kayo Sekikawa 1, Horikawa tomorrow or 1, Toshimitsu Nakayama 1, Noriko Miwa 1, Zenichi Yoshida 1, Satoru Takahashi 2, 丹正勝久 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009. |
|---|
|
|
Report about the side effect of the molecular target drug for P1-180 renal cell carcinoma Kazumasa Yasui, Daisuke Suzuki, 市江敏和, 佐藤百合恵, Shogo Uchida, Akira Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2009. |
|---|
|
|
Proper use of the drug for skin reaction and the skin reaction by P1-181 EGFR-TKI Satoko Nagai 1, Tamotsu Horiuchi direct 1, Mariko Araki 1, Kawaguchi ともね 1, Masatsugu Ouchi 2, Takuya Fujita 2, Ryochi Ozaki 2, Shuhei Inoue 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009. |
|---|
|
|
The making of the side effect monitoring sheet of the P1-182 Sioux tent capsule and the evaluation Misato, Kawasaki, Temple side Toshimitsu, Utsubo Yuko, Nobuko Omoto, Mikio Kakumoto, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009. |
|---|
|
|
Problems for the use situation and the proper use of the G-CSF preparation in the P1-183 cancer chemotherapy Grass sincerity Harumi, Satomi Shiga, Hiromi Fujii, Auditor Hideo, Akemasa Imamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009. |
|---|
|
|
Inspection of the prophylaxis of the vascular pain with the epirubicin hydrochloride for the P1-184 injection Yoshiaki Ochi 1, Fujitaka Rie 1, 五郎丸剛 1, Tei Hara Expo 2, Toshihiko Ushio 2, 篠原義剛 2, Kojiro Takahashi 2, Seiji Eto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009. |
|---|
|
|
Research about hypomagnesemia with P1-185 cetuximab Shinki Yoshino 1, Prince Yasushi Takii 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009. |
|---|
|
|
Comparison of the effect on acute and delayed-action nausea, vomiting of a dexamethasone innovator drug and the generic drug in the P1-186 altitude emetic risk cancer chemotherapy Hideki Sato 1, Kengo Umehara 1, Yoshiko Wada 1, Keisuke Otsu 1, Pasture Azusa 1, First mountain Tae 1, Tooru Hayakawa 2, Inotsume Nobuo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2009. |
|---|
|
|
The case that a xerostomia symptom after the P1-187 same kind hematopoietic stem cell transplantation improved by a gargle of the pilocarpine hydrochloride Masato Matsuura 1, Hitoshi Yoshida 1, Akie Kobayashi 1, Isono Junichi 1, Toru Sakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009. |
|---|
|
|
P1-188 The effectiveness of Bromazepam suppositories as antiemetic in outpatient cancer chemotherapy 柴田佳子1, 戸谷渡1, 瀧口友美1, 中野知代1, 中島生恵2, 高橋洋子2, 川地香奈子2, 横井麻珠美2, 伊藤良則3, 濱敏弘1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009. |
|---|
|
|
Examination of weight loss criteria at onset of neutropenia in the P1-189 CBDCA+WeeklyPTX therapy Jin Arikawa period, Kimura Ito period, Kenji Nishizawa, Kan Noriko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009. |
|---|
|
|
Examination of the injection method for vascular pain with the P1-190 vinorelbine and phlebitis evasion Yasuko Aizawa 1, Kumi Wada 2, Hisato Hiranuma 3, Yoshihiro Sato 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009. |
|---|
|
|
Eruption measures of cetuximab using the side effect monitoring system in the P1-191 this hospital Saori Yamamoto, Noriko Moriwaki, 當真房子, Satoshi Taira, Terumi Nagahama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009. |
|---|
|
|
Comparison of the injection of the 5-HT3 receptor blocker in the P1-192 lung cancer chemotherapy and the oral antinausea effect Yoshiko Wada 1, Kengo Umehara 1, Keisuke Otsu 1, Pasture Azusa 1, 初山多惠 1, Hideki Sato 1, Tooru Hayakawa 2, Inotsume Nobuo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2009. |
|---|
|
|
One patient who was treated effectively with acetic acid octreotide for refractory diarrhea induced by P1-193 hydrochloric acid irinotecan Kushihara Hideyuki 1, Tomoe Miyasaka 1, Hiroko Kobayashi 2, 三輪眞純 1, Takeo Yamaguchi 2, Junichi Haruta 2, Kiyoshi Fujiyoshi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009. |
|---|
|
|
Side effect investigation of the FEC therapy in patients with P1-194 breast cancer and the EC therapy Tomoe Miyasaka 1, Kushihara Hideyuki 1, Maiko Mukoyama 1, 三輪眞純 1, Noriko Kuwahara 2, Hama snipe Nagisa 2, Kiyoshi Fujiyoshi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009. |
|---|
|
|
Correspondence to stomatitis to occur in head and neck cancer-treated patients in the P1-195 this hospital Hayato, Shibata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009. |
|---|
|
|
Action ... to side effect early detection in drug control instruction duties - cancer chemotherapy in the P1-196 this hospital urology department ward Harumi Teramoto, Yoko Ogawa, Shinichiro Matsuda, Riyo Kanbara, Reina Matsuda, Masumi Mitsui, Yuko Shimizu, Sakie Senoo, Mai Ito, Yoshihiro Inaoka, 田邨保之, Yuko Nakagawa, Takahiko Uno, Atsuko Inoue, Yu Okabayashi, Yasuhiro Haruna, 前岡翠, Chika Yamamoto, Kaoruko Onishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009. |
|---|
|
|
Application of VAS to an anorexia evaluation with the P1-197 cancer chemotherapy Masako Aida 3, Noriko Yamashita 1, Mikami eyes 1, Maemura finding 1, Mina Yanai 1, Mitsue Shindo 1, Tsuneo Hamaguchi 1, Hilum Muneo Hayashi 1, Shingo Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009. |
|---|
|
|
Evaluation of nausea with the polypharmacy cancer chemotherapy using P1-198 VAS Mina Yanai 1, Noriko Yamashita 1, Masako Aida 3, Mikami eyes 1, Mitsue Shindo 1, Tsuneo Hamaguchi 1, Hilum Muneo Hayashi 1, Shingo Yamamoto 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2009. |
|---|
|
|
P1-199 Use experience of the polaprezinc gargle water for stomatitis in the cancer chemotherapy 井上憲幸1, 中道晶子1, 渡邉亜貴1, 岩田有佳利1, 大野玲2, 山口友明1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009. |
|---|
|
|
Examination of the level classification of neutropenia according to the P1-200 regimen Open Koichi 1, Satoru Izumitani 2, 櫻下弘志 2, Yasuyuki Saeki 2, 吉田昭昌 3, Yasuhiko Sakata 1, Yonezawa sing; 1, Tree flat Kenji 2, Yasuki Tomota 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009. |
|---|
|
|
Pain control of the patients who received P1-201 neck radiotherapy Noriko Tsuchiya 1, Seiji Abe 2, Yuji Odo 2, Junichiro Murayama 2, Yasuko Nakano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009. |
|---|
|
|
Examination and measures ... to numbness with the effect on P1-202 peripheral neuropathy - FOLFOX therapy of limaprost 枝廣茂樹 1, Toshio Matsunami 1, Kumagaya 1 required, Michiko Yamada 1, Mutsuko Okada 1, Genichi Nishimura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009. |
|---|
|
|
Effect such as the decomposition liquid on vascular pain to be caused during P1-203 hydrochloric acid gemcitabine administration Mika Hiraoka 1, Azusa Shimatani 1, 乗久雅子 1, 河原申弥 1, Hongo education 1, Akiko Higashiya 2, Ando spirit chapter 2, Tsutomu Bando 3, Shimamori beauty light 3, Seiji Sato 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009. |
|---|
|
|
One case that mental neurologic symptoms developed during P1-204 mFOLFOX6 therapy enforcement, and came to have difficulty with chemotherapy continuation Takashi Yamahata 1, 藤澤守 1, Tetsuo Takebayashi 2, Masatoshi Sumiya 2, Naoya Fukuda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2009. |
|---|
|
|
Frequency of hypomagnesemia by P1-205 Cetuximab and investigation of the expression time Eri Nakamoto, Yoji Imada, Maid of honor さあ village, Takashi Yokokawa, Kazunori Kawakami, Toshihiro Hama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009. |
|---|
|
|
It is ... through participation in formulation study - graduate school ward training for nausea, vomiting with the P1-206 BEP therapy Haruka Ishizawa 1, Manabu Sakurai 2, Hisashi Fujiwara up 2, Sachiko Tomioka 2, 小林靖奈 1, Noriko Kamiyama 1, Junichiro Murayama 3, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009. |
|---|
|
|
Examination of the factor to have an influence on the expression of the hematotoxicity with the carboplatin combination chemotherapy in patients with P1-207 lung cancer Yuji Konishi 1, Toshiyuki Matsuda 1, Yoshie Kanazawa 1, Kenji Matsuyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009. |
|---|
|
|
Examination of psychroesthesia stimulation irritation induced by a single dose of P1-208 oxaliplatin Noriko Chiba 1, Takeshi Yamamoto 2, Upper part of a river Kazunori 3, Nobuyuki Katagiri 2, Iku Utsunomiya 2, Keiko Hoshi 2, Toshihiro Hama 3, Kyoji Taguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009. |
|---|
|
|
Examination of P1-209 paclitaxel-induced peripheral neuropathy Satsuka 1, Mano, Nobuyuki Katagiri 2, Takeshi Yamamoto 2, Yoshiko Shibata 2, Kazunori Kawakami 3, Hideaki Ikeshima 2, Iku Utsunomiya 2, Keiko Hoshi 2, Kyoji Taguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009. |
|---|
|
|
One case that Olanzapine which we used for antinausea, a promotion of appetite purpose in patients with pancreas cancer during P1-210 chemotherapy responded to Natsuko Sugiyama 1, 3, Mitsue Masuda 1, Kaoru Hashimoto 1, Sugiura しず 恵 1, Reiko Oguma 1, Aiko Kanazawa 1, Isamu Hashimoto period 1, Kazuhiko Fujita 2, Komoda Masayo 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2009. |
|---|
|
|
Examination about frequency and the risk factor of peripheral neuropathy in the P1-211 paclitaxel enforcement patient with breast cancer Yasumasa Tsuda 1, Kuniyoshi Sato 2, Yoshiko Harada 2, Yoshiyuki Tajima 2, Tetsushi Murayama 2, Kinuyo Matsuda 2, 閔貴善 3, Mitsue Saito 4, Hisahiro Yoshida 1, Kazuhiro Sase 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009. |
|---|
|
|
The effect that withdrawal of oxaliplatin in the P1-212 mFOLFOX6 therapy gives to the onset of side effect Yuka Isaka 1, Masato Honma 1, 2, Toshikazu Moriwaki 2, Takeshi Shibahara 2, Akira Nakahara 2, 兵頭一之介 2, Koda good luck direct 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009. |
|---|
|
|
Three cases of the anaphylactic symptom with P1-213 oxaliplatin Kabayama Tomoichi 1, 眞原達男 1, Hiroshi Morikawa 1, Michiko Matsumoto 1, Mikio Shiozawa 2, Katsumi Kurihara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009. |
|---|
|
|
Effect of sex differences to give it to hematotoxicity of the P1-214 gemcitabine hydrochloride monotherapy Atsushi Miura 1, 2, Masahide Onoe 1, 寺田智祐 1, Kazue Takahashi 1, Kenichi Inui 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009. |
|---|
|
|
A comparison between P1-215 breast cancer and febrile neutropenia (FN) frequency for the hematologic cancer and analysis of the background factor Hiroyuki Sato 1, Mariko Aota 2, Masashi Sakano 2, 中村卓巨 3, Nobuko Umemura 1, 寺井文廣 2, 豊田行康 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009. |
|---|
|
|
Examination - of the efficacy of the transfusion warming law for phlebitis by action -Vinorelbine of the P1-216 Aichi Hospital Pharmacist Association on koro Gee meeting for the study Hideo Sasaki 1, Mariko Kobayashi 1, Tatsuya Hisada 2, 牛膓沙織 2, Hiroki Arakawa 2, Masahide Matsuzaki 2, Shinobu Nakayama 2, Atsushi Yoshida 1, Hiroko Saito 2, Akio Katsumi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2009. |
|---|
|
|
Action of the side effect investigation Aichi Hospital Pharmacist Association on koro Gee meeting for the study in the P1-217 paclitaxel carboplatin combination therapy Mai Ishikawa Yoriko 1, Saori Kato 2, Kushihara Hideyuki 3, Takashi Sakakibara 4, Yumiko Sone 5, 早見知浩 6, Pine reason Koji 7, Etsuko Mishima 1, Tomoe Miyasaka 2, Watanabe method man 8, Manabu Yokota 9, Itakura affinity 10, Hiroko Saito 11, Akio Katsumi 11 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009. |
|---|
|
|
Examination about the side effect of administration method expression of P1-218 paclitaxel and the carboplatin combination chemotherapy Akira Hori charges 1, Eriko Takeo 1, Yoshihiko Sugino 1, 杢原香奈子 1, Kimura Kei and 1, Yuji Ito 2, 関剛 2, 大圓修身 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009. |
|---|
|
|
Manual revision and measures - by measures - questionary survey in the P1-219 anticancer drug extravasation Hiroaki Sakurada 1, Miki Aoi 2, Masumi Yamamura 1, Aoyama Kei daylight 1, Interval Teruyuki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009. |
|---|
|
|
Examination of an investigation and the measures of the side effect in the use of P1-220 cetuximab patients Junichi Isogai, Shinji Ito, Reiko Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009. |
|---|
|
|
1 case that experienced an allergic symptom during P1-221 docetaxel administration 早見知浩 1, Akihiro Saito 2, Masayoshi Tamaki 2, Takeshi Moriya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009. |
|---|
|
|
Examination about the beginning of dosage time of the magnesium oxide for the purpose of the prevention of constipation with the P1-222 (R-)CHOP therapy 森章哉 1, Takuya Iwamoto 2, Eiji Mitani 3, Tatsu Ito I 3, Megumi Kawakami group 3, Shinko Okuda 2, Yuko Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2009. |
|---|
|
|
One case that stomatitis with erlotinib improved with P1-223 betamethasone syrup 鹿浦香織 1, 野田能成 1, Yutaka Kubota 2, Hiroshi Hara 2, 小西偉雄 1, Tadashi Mikami 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009. |
|---|
|
|
Present conditions ... in side effect expression of Bortezomib for the P1-224 multiple myeloma and measures - this hospital Kae Hanaoka 1, Takeshi Shimada 1, Valley water Kumiko 1, Masato Ishii 1, Yoshiaki Kita 1, Yasushi Hiramatsu 2, Atsuko Inoue 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009. |
|---|
|
|
Action to a side effect investigation and proper use of the sunitinib in patients with P1-225 progress-related renal cell carcinoma Hiroki Tamaki 1, Noriko Komura 1, Tsuchie Kei incense 2, Satoshi Honda 3, Nobuhiro Nishimura 1, 直良浩司 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009. |
|---|
|
|
Reduction of the injection site reaction (phlebitis) by the change of the P1-126 vincristine sulfate administration method Shinichi Kitamoto, Yuko Yanagida, 八島加八, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009. |
|---|
|
|
P1-227 A study on the electrolyte fluctuations in antibody formulation cetuximab (Erbitux (R)) administration 吉田昭昌1, 櫻下弘志2, 開浩一3, 村瀬哲也2, 木村優美2, 立花広志1, 木平健治2, 寺谷一信1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009. |
|---|
|
|
About steroid administration for Infusion reaction reduction at the P1-228 Trastuzumab administration Naoko Tosa 1, Ryuma Sato 1, Kyoko Ohara 1, Ikuyo Toyota 1, Joji Mori 1, Satoko Fujiwara 2, Yukihiro Kawakami 2, It is still 2 Matsunaga, Ikegami English sentence 1, Sendo Toshiaki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2009. |
|---|
|
|
Seat making for P1-229 cetuximab side effect management and the utilization Tomoko Hara 1, Urashi Akiko 1, Virtue Yasumi Kazuko 2, Grass competitive game Kayo 2, Maki Yamamoto 2, 2 which is related to Nagano, 田中吏佐 3, Mitsugi Kenji 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009. |
|---|
|
|
How do you cope with skin reaction of P1-230 cetuximab? 與田香奈子, Koichi Matsuo, Minako Higuchi, Saza book Yoshimi, Sanae Iwatsubo, Yoriko Wada, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009. |
|---|
|
|
Action to peripheral neuropathy measures using neuropathy questionnaire (FACT/GOG-NtxV4.0) in the P1-231 bortezomib Koichi Matsumoto 1, Kazutaka Tsutsumi 1, Makoto Takahashi 1, Yuko Yoshimaru 1, Mieko Tsuruta 1, Hiroko Tsurusaki 2, Emiko Kawano 2, Keiko Suehiro 2, Tajima existence tree 2, Hiroko Miura 2, Rie Imamura 3, Michio Sada 1, Takashi Okamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009. |
|---|
|
|
Blood pharmacokinetics and safety of oxaliplatin during mFOLFOX6 therapy in the P1-232 hemodialysis patient Kyoko Kimura 1, Rika Fukuda 1, Osamu Egawa 1, Masahiro Sakai 2, Tatsuhiko Nogawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009. |
|---|
|
|
Trial of the sodium benzoate administration for the case that presented hyperammonemia by P1-233 5-FU 三角紳博 1, Great temple Masaharu 2, Takashi Nishino 1, 舛重正人 1, Tomisawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009. |
|---|
|
|
Fact-finding of the skin reaction at the P1-234 metastasis, chemotherapy of recurrent colorectal cancer impossible of excision West Kyoko Tsuji, 野間口寛, Reiko Kirino, Hisanobu Yukawa, Tomohiro Kakimoto, Takeshi Takahashi, Middle Yuka Kihara, Toyosumi Ayako, Kayo Ikemura, Morihiko Terashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2009. |
|---|
|
|
Invention of infusion reaction expression example and the dosing rate setting by P1-235 Cetuximab Kazuyuki Sunada 1, Kishimoto truth 1, Ogyou Yukiko 1, Long ヶ Takuma Hara 1, Yoshimura truth 1, Hirofumi Wakamatsu 1, Yayoi Shinmura 2, Zhongcheng Yuki 2, Fumiko Matsueda 2, 三阪高春 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009. |
|---|
|
|
Fact-finding about the skin reaction in the P1-236 erlotinib remedy patients Makoto Hayashi 1, 2, Miwako Ogawa 1, Hayato Sugimura 1, Kenji Miyazawa 1, Akemasa Yamaya 1, Aspect shrine Koji 1, North Toshiyuki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009. |
|---|
|
|
Contribution of side effect peripheral neuropathy and the vitamin B12 deficiency of the P1-237 anticancer drug Nunotani Masako, Kaoru Kobayashi, Atsushi Kato, Yasuhiko Mimura, Isao Adachi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009. |
|---|
|
|
Making of the manual for the dietary counselling for the patients who induced eating disorders by P1-238 cancer chemotherapy Yumi Nagano 1, Kazuhiro Ishikawa 1, Harumi Takeuchi 2, Masami Sato 3, Masako Miura 3, Seishi Kondo 4, Yoshinori Hasegawa 4, Masayuki Miyazaki 5, Kiyobumi Yamada 5, Yukihiro Noda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009. |
|---|
|
|
Comparison (a significant difference and noninferiority trial) about the effect of injection and the internal agent of antiemetics used at P1-239 chemotherapy Michiyoshi Kumi 1, City residence proton 1, Yasushi Nakagawa chapter 2, Kenji Suzuki 2, Yasuhiro Saeki 1, Masanobu Odaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009. |
|---|
|
|
Side effect monitoring of the chemotherapy for patients with P1-240 S-shape colon cancer postoperative recurrent liver metastasis 高瀬槙子 1, 沼澤聡 1, Masayuki Yoshikawa 2, Yoko Ito 2, Junichiro Murayama 3, Takemi Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2009. |
|---|
|
|
About medical narcotic change and cold water re-hat report in the P1-241 this hospital Rice month Yukinori, Hitoshi Yamada, Ken Suzuki, Samsung intellect, Shuji Yamazaki, Tatsuya Eguchi, Atsushi Sakai, Kazuhiko Nagai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009. |
|---|
|
|
Questionary survey ... to use actual situation - palliative care unit and a regular hospital of the sedative adjuvant in P1-242 cancer pain Ise Mika Baba, Mizuho Takahashi, Kiyomi Sadamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009. |
|---|
|
|
Opioid recognition investigation in the P1-243 this hospital Kenichi Osanami 1, Station Kyoko 2, Emiko Kashima 2, One straw Toyomi 3, Miki Hishi 3, Naoko Takaoka 4, Tadashi Tamura 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009. |
|---|
|
|
It is ... through problem - questionary survey of the psychological care team activity in the P1-244 this hospital Hiroshi Kudo 1, 2, Aki Kuwajima 1, 3, Chiharu Hayashida 1, 3, Yuko Shinohara 1, 3, Yukiyo Funayama 1, Takeo Hashimoto 1, 4, Naoki Hatakeyama 1, 5, Taro Ono 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009. |
|---|
|
|
The presence of change and the psychological care team of the use of medical drug in the P1-245 Fujinomiya Municipal Hospital and pharmacist duties Osamu Kitamura, Yoshinori Kobayashi, Hiroshi Kawaguchi fruit, Kazuo Katsumata, Toyohide Suzuki, Tatsuya Inaba, Takamitsu Kasai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009. |
|---|
|
|
Evaluation ... of the penetrance of pulse-taking - WHO method cancer pain therapy of the cancer pain control in the outpatient of the P1-246 this hospital Takaki Mizutani, Shigeki Hirano, Yuko Deguchi, Aiko Fukui, Yamada Toru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2009. |
|---|
|
|
Examination of the utility of octreotide for gastrointestinal obstruction of the P1-247 cancer terminally ill patients Watanabe method man 1, 3, 安村幹央 2, Takashi Uematsu 2, Shigeru Kiyama 2, Masatoshi Hayashi 2, 中尾真隆 1, Shigeto Abe 1, Keiichi Goto 1, Keiko Yamamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009. |
|---|
|
|
Of the use trend of the opioid preparation in the P1-248 this hospital and the pain management, actually Akira Maruyama 1, Kazuaki Kojima 1, Miwa Takayuki 1, Yuko Isami 2, Emi Kishi 2, Michio Kimoto 3, Keiji Okada 4, Shinobu Araya 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009. |
|---|
|
|
Change of the consumption of the opioid drugs by the psychological care team start in the P1-249 Saga Hospital Masashi Hashimoto, Higashijima good luck way, Tashiro early period, Aya Suzuki, Junko Ide, Yagi Hideaki, Yoshihiro Yasukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009. |
|---|
|
|
Example that somnolence was strongly seen in by combined medicine at P1-250 opioids increase in quantity Masayo Shimomura 1, Takashi Uemura 2, Takahiko Nakao 2, Toshiyuki Kadoi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009. |
|---|
|
|
Comparison between skin reaction - reservoir model and MT type - after the pasting of the P1-251 percutaneous absorption type fentanyl preparation Chikako Numata 1, Reiko Teraoka 2, Kensho Emoto 3, Yagi Keiko 3, Hirai green 4, Shuji Kitagawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009. |
|---|
|
|
Drug control instruction duties - cancer chemotherapy in the P1-252 this hospital obstetrics and gynecology department ward, relation ... to cancer pain relief care Yoko Ogawa 1, Harumi Teramoto 1, Shinichiro Matsuda 1, Yuko Nakagawa 1, Kyoko Kasahara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2009. |
|---|
|
|
About a tendency to use of peripheral neuropathy with the P1-253 cancer chemotherapy and the sedative adjuvant Toshihito Komiyama, Yuka Nakamura, Of Aya Sugai, Deliverer of letters Yoshihito, Junichi Kubo, Yu Goto, Kaya Noriko, Descent from a mountain Koichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009. |
|---|
|
|
Efficacy of the oral naloxone at the P1-254 opioids administration, meta analysis about the safety 小松敏彰 1, Hiroki Okawara 1, Yuka Ishida 2, Mitsuhiro Sugawara 1, Mariko Arai 1, Hajime Matsubara 1, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009. |
|---|
|
|
The medical narcotic use situation in the P1-255 this hospital Yumiko Senoo, Akiko Asada, Tomoko Hayakawa, Nobuyuki Yokota, Yumiko Oshikiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009. |
|---|
|
|
Activity report of the present conditions and the psychological care team charge pharmacist of the P1-256 this hospital psychological care team Kenji Goto 1, 2, Mariko Asai 1, 2, Tanaka reason princess 3, Rumi Yoda 3, Makoto Ishikawa flat 2, 酒井欣嗣 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009. |
|---|
|
|
About the activities of the psychological care team in our P1-257 center Inside many protons 1, Gilt bronze Yoko 1, Tomonori Hirashima 2, Court Security Office Mika 1, Yoshie Tokuoka 3, Teruhisa Ishikawa 1, Nobuhisa Fukushima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009. |
|---|
|
|
The activity of the mild medical project team in the P1-258 Inoue memory hospital and action of the pharmacy Yuki Kobayashi 1, 2, Tsuyoshi Katagiri 2, Hirotoshi Nakamura 1, Nobuhiro Imanaka 1, Tokuko Momose 1, Nihonyanagi Yasuko 1, Mayumi Kato 1, Kyoko Takei 1, 中山眞紀 1, Suda future 1, 立吉勝美 1, Yasuko Yoshimi 1, Junko Sasaki 1, 王伯銘 1, Straight Katsumi Shiroyama 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2009. |
|---|
|
|
Attitude survey about "the explanation" from a medical person at the P1-259 anticancer drug start of therapy Etsuko Arita 1, Satoshi Takeshita 2, Yukio Suzuki 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009. |
|---|
|
|
The activity evaluation in the P1-260 psychological care team and problem of the future pharmacist Sumiko Hiura 1, 2, 3, Rei Kimura sand 1, Middle mountain village Tsu 1, 加藤裕芳 1, Toru Asayama 1, Ikumi Ito 2, Akira Nakamura city 3, Jiro Nagao 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009. |
|---|
|
|
Relation (the second report) of the pharmacist to the P1-261 Toho University medical center Ohashi Hospital psychological care team Rei Kimura sand 1, Middle mountain village Tsu 1, Sumiko Hiura 1, 加藤裕芳 1, Toru Asayama 2, Ikumi Ito 2, Yoichi Nakamura 3, Jiro Nagao 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009. |
|---|
|
|
The present conditions and problems of the end-of-life transfusion treatment judging from the transfusion guidelines for patients with P1-262 end-stage cancer West Yugo, Hiromi Motoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009. |
|---|
|
|
The case that tried control in internal use for pain of the last years of P1-263 rectal cancer Isao Yajima 1, Kumiko Ochiai 1, Natsumi Mukai 2, Takako Yajima 2, Tanaka Chihiro 3, Enomoto space arrow 3, Koichi Kubota 3, Yasuo Kumai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009. |
|---|
|
|
Comparison between opioid quantity of rotation - standard and real dose ... from P1-264 fentanyl patch to a morphine note Kenji Katsuragawa 1, Tatsuya Hisada 1, 牛膓沙織 1, 久保速三 2, Hideaki Ieda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2009. |
|---|
|
|
Examination about the change of the use of opioid agent in the P1-265 palliative care unit Tatsuya Hisada 1, 牛膓沙織 1, Kenji Katsuragawa 1, 久保速三 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009. |
|---|
|
|
Examination - of the rescue dose using action - "rescue record list" of the P1-266 Aichi Hospital Pharmacist Association on koro Gee meeting for the study Mariko Asai 1, 2, Kenji Goto 1, 2, Tanaka reason princess 1, 2, Yasushi Yamamoto University 2, Mountain Seki wisdom 2, Maki Arakawa 2, Maiko Tanaka 2, Kani Kono 2, Yuka Maekawa 2, Yuri Terao 2, Suzuki sheath or 1, 2, Shogo Uchida 2, Iku Kawamura person 2, Yukio Toyama 2, Hiroko Saito 3, Akio Katsumi 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009. |
|---|
|
|
Examination about the recognition of the pharmacist in the P1-267 cancer pain relief Hiroki Mase 1, Takuya Iwamoto 2, Kazuko Koyama 1, Masako Watanabe 1, Sachiko Kubo 1, 伊東貴利 3, Kenji Taniguchi 4, Tomohiro Miyake 5, 堀部千治 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009. |
|---|
|
|
Examination of opioids and gabapentin doses in P1-268 cancer pain 宮部貴識 1, 2, 岡所扶実 1, Misato Tsuji 1, Kanako Kumagai 1, Yoko Ogawa 1, Morizu Hiroki 1, Mika Miyazaki 1, Sagisu Yoshiko 1, Oida chapter 1, Tabuse course 1, Storable duration ヒサ 2, Satoshi Kamiyama autumn 2, 所昭宏 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009. |
|---|
|
|
Change of the opioid prescription after the P1-269 psychological care team organization Yoko Tokuyama 1, Kiyotaka Omori 1, Moat Kei foster child 1, Mika Maruyama 2, Shuichi 3 Kim, Yoshihiro Shimizu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009. |
|---|
|
|
Present conditions investigation of the early pain control in P1-270 cancer practice patients Naoko Tsuji, Masaki Manda, Small bath Takako, Yasuko Takinami, Miyuki Miyake, Kaori Ozaki, Keiko Noguchi, Hitomi Kawaguchi, Takami Fujii, 野際俊希, Fuminori Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2009. |
|---|
|
|
Role of the activities of the P1-271 this hospital psychological care team and the psychological care team pharmacist Mizue Sato 1, Sachiko Koga 2, Kazumi Muta 2, Emiko Kaida 2, Sachi Nakamura 2, Tasuku Kimura Takako 3, Rika Fukuzawa 3, Manabu Koga 4, Eto ten thousand Yoshiko 4, Tatsu Tsukamoto straight 5, Yutaka Imamura 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009. |
|---|
|
|
The future problem that activity contents and the pharmacist of the psychological care team of the hospital attached to the P1-272 Saga University School of Medicine should achieve Sumiyo Iida 1, Mayuko Tanaka 2, 7, Megumi Fukuyama 3, 7, Chizuru Hayashi 4, 7, Yuji Ueki 5, 7, Hidetoshi Sato 6, 7, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009. |
|---|
|
|
About the use situation of a mouth care drug and the anticancer drug in the P1-273 Nagasaki City municipal hospital Quantity lower Hiroko 1, Akemi Morita 1, Blackboard Noriaki 1, Arata Uchida 2, Shiro Tomiyasu 3, South Kazunori 4, 橋口順康 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009. |
|---|
|
|
Present conditions investigation of the treatment with transfusion for patients with end-stage cancer in the P1-274 this hospital Kei Yamaguchi Taro, Naoya Uto, Masaru Nakagawa law of nature, Ichimura line celebration, Kuniko Sawada, Fukada chapter, Masaaki Yamato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009. |
|---|
|
|
Activity evaluation of the P1-275 Fukuoka University Hospital psychological care team Kamura Motoki 1, Hisamitsu Takase 2, 7, 内山将伸 2, 7, Yuriko Nagatomo 3, Keisuke Kakihara 4, Kentaro Ogata 2, Ayami Hotta 5, 7, Kazunori Hirota 6, 7, Kojiro Nikami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009. |
|---|
|
|
Evaluation of the rescue dose judging from the prescription actual situation of the narcotic analgesic in the P1-276 this hospital Valley Daisuke 1, Toru Watanabe flat 1, Takashi Azuma 1, 岩尾岳洋 1, Side shop Yoshibumi 2, Toshiaki Nakamura 1, Mikio Masada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2009. |
|---|
|
|
It is making and the examination of the transfusion treatment flow chart for gastrointestinal tract obstruction of patients with cancer the action of the P1-277 Aichi Hospital Pharmacist Association on koro Gee meeting for the study for terminal phase Sugawara sheath or 1, 2, Aiko Fukui 2, Chika Ieda 2, Mitsuru Suzuki 2, Masayo Tanahashi 2, Satoshi Hibi 2, Takeshi Maeda fine weather 2, Yukimi Matsuura 2, Koji Nakao 2, Teranishi 23s 2, Hiroko Saito 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009. |
|---|
|
|
Clinical analysis - by polypharmacy effect - fentanyl patch and the morphine note combination of opioids for P1-278 cancer pain Toshihisa Hiraiwa, Minako Kumagai, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009. |
|---|
|
|
Gastrointestinal obstruction of patients with P1-279 progress, recurrent cancer, examination about an injection method and the efficacy of acetic acid octreotide Kiyoko Tanimura, Seiji Onda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009. |
|---|
|
|
Activities after the psychological care team system change in the P1-280 this hospital Hitoshi Taniguchi 1, 2, Sono Kaji truth 1, 2, 市場泰全 1, Hideki Yoshida 2, Hiromi Oguchi 2, 岸口武寛 2, 大藤嘉洋 2, 下野玄英 2, Shoji Asakura 2, Keiichi Fujiwara 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009. |
|---|
|
|
Effect of making and the formulation study support task of the opioid dose calculation sheet for the P1-281 PCA pump Koichi Tanabe 1, Tomoaki Ikezaki 1, Satoko Takeuchi 1, Jun Okubo 1, Kaori Yamaya 1, Hidenori Kitazawa 1, Keiko Murasugi 2, Murakami wish 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009. |
|---|
|
|
Examination of an apprentice of go, the psychological care education for the Shinnyu staffs that we obtained than P1-282 cancer professional education Yasuko Takeuchi 1, Kinuyo Matsuda 1, Taeko Suzuki 1, Saori Tominaga 1, Tetsushi Murayama 1, Masae Maruyama 2, Seiko Yamaguchi 2, Kuniyoshi Sato 1, Kazuhiro Sase 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2009. |
|---|
|
|
What do the patients who accepted P1-283 psychological care expect from a pharmacist? Shinji Ito, Junichi Isogai, Reiko Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009. |
|---|
|
|
Construction of the prescription support system for the purpose of the proper use of the opioid analgesic for P1-284 cancer pain Tatsuo Nakagawa, Yoichi Hiraoka, Kazumi Kito, Akito Nagai, Takanobu Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009. |
|---|
|
|
Suspension comparison with each apple juice in P1-285 temozolomide Satoru Tamura, Spring Masato, Koji Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009. |
|---|
|
|
Use and evaluation of the checking prescription check system aiming at the safe use of the oral P1-286 anticancer drug Hitomi Ishigami, Eiji Yoneyama, Satoru Mase, Yuko Kuwayama, Toshiyuki Kubota, Yoji Sugiura, Akio Katsumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009. |
|---|
|
|
Making - of problems and invention - work manual obtained from the use of P1-287 thalidomide case Nozomi Nishida Kushiro, Mayumi Watanabe, Yukio Toyama, Tatsuya Muto, Hiroko Saito, Takaaki Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009. |
|---|
|
|
The present conditions of the P1-288 anticancer drug exposure and future problem (the third report) Manabu Tanimura 1, Kyoko Tadokoro 1, Keiki Mori 1, Hiroaki Nagata 1, Yoko Hamaguchi 1, Tomohiro Miyake 1, Sessink P.J.M.2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2009. |
|---|
|
|
Inspection of the residual error to a lot of P1-289 anticancer drug preparation device 濱宏仁 1, Koichi Fukushima 1, Wasaburo Kataoka 2, Toru Hashida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009. |
|---|
|
|
P1-290 Construction of management and operation of THALED(R) capsule in the general hospital 上野千奈美1, 高谷紀子1, 坂本健一1, 宅江良隼1, 今田雅子1, 関本恭子1, 樫本考司1, 酒井洋子1, 原田保徳1, 片山雄太2, 麻奥英毅3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009. |
|---|
|
|
From the occurrence of doubt inquiry and incident situation in the evaluation -3 year of the P1-291 anticancer drug regimen order system - So Yamamoto one 1, Yusuke Takada 1, Chikako Sawada 1, Yasuyo Fujisawa 1, Yutaka Takahira 1, Norifumi Miyamoto 1, 服部暁昌 1, Hisano Ikeda 2, Crossroads daylight kernel 3, Morita Zhuang Jiro 4, Teruo Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009. |
|---|
|
|
At P1-292 anticancer drug preparation evaluation - of examination -closed system(Clave(R)Oncology System) about preventive measures against pail radiation exposure and the economy Misako Takeda, The Tanaka immensity, So Yamamoto one, Yasuyo Fujisawa, Yusuke Takada, Norifumi Miyamoto, Yutaka Takahira, 服部暁昌, Teruo Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009. |
|---|
|
|
Examination for safe cancer chemotherapy enforcement in the cottage-hospital out of P1-293 Yoichi Nakajima, 葉田昌生, Tadashi Mikami, Yoshiko Murakami, 山方志築, Wataru Shiraishi, Ikuhiro Nose Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009. |
|---|
|
|
Analysis of the doubt inquiry about anticancer drug preparation in the P1-294 this hospital 谷之木佑歌, Hiroyuki Yamaguchi, Yasushi Sekiya, Ito wide commander, Shibata greens Satoko, North field Tomomi, Tomomi Iwakiri, Manabu Okumura, Kazuhiko Arimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2009. |
|---|
|
|
Induction and use of the cancer chemotherapy regimen system that linked P1-295 electronic chart Hisae Shinichiro, 永野俊玲, Yusuke Sato, Toshiharu Asakura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009. |
|---|
|
|
Construction of the registration criteria of the P1-296 cancer registration regimen and the operational system Osamu Abe Eiko, Funatsu Kumi, 工藤尚亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009. |
|---|
|
|
Effect of the knowledge management of the anticancer drug by the P1-297 pharmacist Satoshi Sato, History of Sei Koshiba, Masaki Mizuguchi, Kan Yutaka Otaka, 松井佳彰, Takafumi Ichida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009. |
|---|
|
|
How do make learn a preparation technology to P1-298 anticancer drug preparation inexperienced person; inspection - by - questionary survey? Reiko Koya, Hiroshi Hashiguchi, Kazuma Yano, Masae Kubo, Satoshi Shinoda, Terumi Miyazato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009. |
|---|
|
|
About the use situation of the EGFR inhibitor in the P1-299 this hospital and the effect Masayuki Hoshino 1, Toshie Hoshino 1, Mayumi Yamada 1, Tomoko Umeno 1, Kiso Akira Hara 2, Tetsu Satohara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009. |
|---|
|
|
The actual situation of the initial dose in the treatment with P1-300 anticancer drug Takashi Otsuji, 胡井俊祐, Kiyomi Okazaki, Mitsuko Fujita, Yoshio Katsuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2009. |
|---|
|
|
Use situation investigation of the zoledronic acid for patients with P1-301 breast cancer Yukiko Goto 1, Ai Yoshida 1, Izumi Tanaka 1, Kita Hiroki Oka 1, 清水奈味 1, Yamamuro butterbur child 1, Masanori Mori 1, Katsuhisa Zaitsu 1, Non-Yoshiei will 1, Kondo New Year's Day 1, Shunei Maeda 1, Yasushi Okumura Expo 2, Great Tomofumi Sako 2, Nishimura law joy 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009. |
|---|
|
|
Examination of the medical supplies adoption method for P1-302 drug purchase costs reduction Shoji Koiwa, Yasushi Akutsu, Uesugi chapter period, Ryo Kuroki Taro, Ryoji Kato, Toshiyuki Koga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009. |
|---|
|
|
About the actual situation of the off-label use of the P1-303 antineoplastic Pine ヶ valley Kana 1, Marutani good period 1, Naho Ando 1, Satoshi Ichikawa 1, Satoru Nagata 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009. |
|---|
|
|
Than an example authorized government affairs disaster by risk - occupational exposure of the healthcare worker who handled P1-304 ampoule anticancer drug ... Masako Kondo, Noriko Kawakami, Akira Nagayama, Kazumi Morishita, Toru Mano, Noge Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009. |
|---|
|
|
Examination about the handling of the antineoplastic tumor injection in the P1-305 healthcare setting Kanako Toyama 1, Tomoko Sakakura 1, Yukihiro Hamada 1, Rumiko Kondo 1, Hajime Matsubara 1, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009. |
|---|
|
|
Examination of the utility of eGFR in the P1-306 carboplatin doses setting Sumiyo Ito 1, Iku Kawamura person 1, 前田紗斗美 1, Kazuo Hotta 1, Masayuki Takeuchi 1, Masafumi Onishi 1, Saori Kato 1, Yukio Toyama 1, Hiroko Saito 1, Takaaki Hasegawa 1, Akihiko Wakatsuki 2, Etsuro Yamaguchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2009. |
|---|
|
|
Utility evaluation of the closed system system using the P1-307 anticancer drug preparation training kit Junya Sato, Kazufumi Terui, Nao Odagiri, Yumi Iwasaki, Emi Hosoya, Early hunting truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009. |
|---|
|
|
P1-308 Cetuximab (Erbitux(R)) administration in our hospital and reporting of adverse reactions situation 此松晶子1, 2, 野口周作1, 宮内秀典1, 島田慰彦1, 2, 藤井さとみ2, 3, 吉野雅則4, 渡邊昌則2, 4, 高橋久美子3, 徳永昭4, 片岡博邦1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009. |
|---|
|
|
Reporting and problems ... about the excrement using action ... brochure of the pharmacist for the purpose of the P1-309 anticancer drug exposure reduction Kazuto Sato 1, Toshiyuki Hirai 1, Kenji Asai 1, Yasushi Akiyama 1, Seki Toshikazu 1, Kamiga Masahiro 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009. |
|---|
|
|
Fact-finding about the present conditions of the P1-310 gemcitabine administration Goji Maeda, Hiroshi Sakata, Hiroyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009. |
|---|
|
|
Examination of the utility of closed ring system "cleveite on koro Gee system" and "PhaSeal" in the P1-311 anticancer drug preparation Maki Nakabayashi, Shiho Enami, Yoshiyuki Hayashi, Atsuko Koyama, Mihoko Shimizu, Hiroshi Hatano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009. |
|---|
|
|
Examination about weight loss in the Gemcitabine monotherapy for P1-312 pancreatic cancer, the biliary tract cancer and the withdrawal change Hiroko Tai, Keiko Yamamoto, Kazunori Shimomura, Shinichi Kawaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2009. |
|---|
|
|
Comparison - of examination - filtration device of the removal of the glass piece to mix at P1-313 glass ampule anticancer drug preparation Yuka Kobayashi 1, Hiroki Iwane 1, Ayumu Nozaki 1, 日置三紀 1, Ayako Kondo 1, Kazunari Ishii 2, Toshiko Aramiya 1, Hirokazu Nakanishi 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009. |
|---|
|
|
Action for ensuring safety of the P1-314 cancer pharmacotherapy Masahide Sasaki 1, 伊林範裕 3, Tomoki Nakajima 3, Toshiaki Nakashima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009. |
|---|
|
|
Evaluation of "the cleveite (R) on koro Gee system" in the anticancer drug preparation that we included the priming by the P1-315 pharmacist in Takeshi Nakamura will, Hiromi Fujisawa, Tomoko Fukuda, Ayana Nakamura, Tsuneo Hamaguchi, Hilum Muneo Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009. |
|---|
|
|
About regimen management and problems after the P1-316 chemotherapy Committee establishment Onaga Shinichiro, Rieko Murata, Sayaka Nakamura, Hamamoto good kernel, Takashi Chinen, Pre-night Miho, Tamotsu Hika Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009. |
|---|
|
|
Relation of the pharmacist to cancer chemotherapy regimen examination in the P1-317 this hospital Mt. Ishii husband, Tsuyoshi Suzuki, Satoshi Yamada, Namba existence intellect, Ritsu Hashida, Kyan celebration, Consider among outsiders; a husband, 宇野司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009. |
|---|
|
|
Examination -1 about the permeability of the antitumor agents in medical gloves to put on at P1-318 injection mixture preparation Fold Toyohito, Ryoji Yanagihara, Katsuhiko Nara, Toshihide Abe, Takashi Tomabechi, Taketo Yamamoto, Katsuyoshi Nakajima, Hiroshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2009. |
|---|
|
|
It is a 1 case receiving TS-1 for P1-319 patient on dialysis Shigeru Munemura, West Luo Teruo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009. |
|---|
|
|
Examination of effect of treatment and the adverse event in P1-320 antiEGFR antibody Cetuximab Aki Kuwahara 1, Kawashima greens Yasuko 1, Taeko Saito 1, Naoko Hashiba 1, Yaeko Mishima 1, Keiko Takano 1, Yasuyuki Fukai 2, 芳賀紀裕 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009. |
|---|
|
|
Construction of the cancer chemotherapy support system using the P1-321 marketing database The Atsushi Tomita sum, Tomoo Fujii, Katsuhiko Haneda, Masao Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009. |
|---|
|
|
Examination of the accurate time of administration realization in the P1-322 5FU46 time continuous medication Yasushi Taniguchi tree, Masaru Kawase period, Temple Tai incense, Yoko Kataoka, Masahiko Kitagawa, 成尾千晶, Megumi Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009. |
|---|
|
|
About the anticancer drug pollution in the prevention of exposure objective saline packing administration set at the P1-323 anticancer drug bypass administration Shinya Nakanishi 1, 2, Fujitani Masanori 2, 3, Rie Bando 1, Miyako Kihara 1, 藤戸靖久 1, Yukiyo Monma 1, Hideko Iwasaki 1, Shinichi Sugiura 4, Hirokazu Nakanishi 5, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009. |
|---|
|
|
One patient whom serious drug eruption by P1-324 Sorafenib developed in Makoto Hosomi 1, Aimi Goto 1, Yu Miura 1, Masami Nishihara 1, Kohei Koyama 2, 稲元輝生 2, Masahiro Goto 3, 瀧内比呂也 3, Hiroshi Tamai 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2009. |
|---|
|
|
Cancer board in the P1-325 Kinki center Hospital Kayo Matsuura, Ryuta Urakawa, Sanae Hashimoto, 廣畑秀記, Eri Shibata, Katsunori Sakai, Katsuei Nanba, Yoshiro Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009. |
|---|
|
|
P1-326 organized cancer chemotherapy regimen management and the effect Corner Yumiko Tsuji 1, Koji Moriya 1, Ko Tokuda period 1, Kiyonori Ueda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009. |
|---|
|
|
As compared with evaluation - other medical diseases for the medication medicine instruction to patients with P1-327 cancer - Utako Iwakiri 1, 2, Daisuke Kobayashi 2, Toshio Kubota 2, Rina Hidaka 1, Tottori part Kazuhiro 1, Keiji Suenaga 1, Takao Shimazoe 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009. |
|---|
|
|
Examination about the alcohol detection factor during the exhalation after the P1-328 paclitaxel administration 邉見 paste or 1, 谷口亮央 1, Sato male tree 1, Fujiko Kamata 1, Tomohiro Tada 1, Rie Kawamoto 1, Hatsumi Kikuta 1, Flat land tax 1, Jun Matsunami 1, Ryu Kobayashi 1, Yoshihiro Hashimoto 1, 柴波明男 1, Takao Murohashi 2, Muki Ryoji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009. |
|---|
|
|
Time series analysis of laboratory values in the P1-329 colorectal cancer chemotherapy 外石昇 1, 3, Shigeru Yako 1, Kazuhiko Yoshimatsu 2, Takao Katsube 2, Kenji Ogawa 2, Kozo Takayama 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009. |
|---|
|
|
P1-330 Current status of Thaled(R) (Thalidomide) management and operation of in our hospital 渡辺麻理1, 2, 河井良智1, 長島章1, 荒井宏人1, 奥有紀子1, 松永貴志2, 佐原直日2, 入江誠治2, 三村進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2009. |
|---|
|
|
P1-331 About use experience of Doxil (R) in the our hospital 奥有紀子1, 河井良智1, 長島章1, 荒井宏人1, 渡辺麻理1, 板橋香奈2, 香川秀之2, 三村進1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009. |
|---|
|
|
Comparison of the adverse event expression situation according to the injection method of the P1-332 tea S one Taeko Saito, Aki Kuwahara, Skilled miner Naomi, Keiko Sunakawa, Homiki Ushigome, Kawashima greens Yasuko, Eriko Hiruta, Naoko Hashiba, Yaeko Mishima, Keiko Takano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009. |
|---|
|
|
Patients in P1-333 Aichi on koro Gee society for the study brochure making ... based on the adverse event analysis of Conditioning rejimen for action ... hematopoietic cells transplant Naoki Mukoyama 1, Yoshiaki Ikeda 1, Hiroyuki Niimi 1, Keiji Mizuno 1, 森章哉 2, Kenji Miyazawa 3, Ayumi Nakamura 4, Yuka Tanaka 5, Toru Maeda 6, Satoru Kato next 7, Katsuhiko Haneda 8, Kazuhiro Mori 1, Kiyoshi Fujiyoshi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009. |
|---|
|
|
Making of the anticancer drug information paper for the P1-334 injection Yoshihiko Sugino 1, Akira Hori charges 1, Eriko Takeo 1, 杢原香奈子 1, Kimura Kei and 1, 大圓修身 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009. |
|---|
|
|
P1-335 About impact on cetuximab (Erbitux (R)) clinical examination value at the time of administration 友井理恵子1, 下村好子1, 丁元鎮1, 桝喜恵1, 小枝伸行3, 山本幸子2, 屋木敏也2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009. |
|---|
|
|
P1-336 Usage report of thalidomide in the treatment of multiple myeloma: Presentation of the problems at the time of introduction Thaled 野村浩英, 森真由子, 畑中勝義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2009. |
|---|
|
|
Relation as the pharmacist to the chemotherapy in the P1-337 children region Miho Minami 1, Yoshiko Masaki 1, Kenji Takeda 1, Miwa Kishida 1, 近藤統 2, Masako Muroi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009. |
|---|
|
|
The role of the pharmacist in the P1-338 colorectal cancer molecular target drug proper use team and the action Yusuke Noguchi 1, Yutaka Kawahara 1, Yoko Tokuyama 1, 3, Yoshida Noriko 2, Source Tomoyo beauty 3 to understand, Kiyoshi Uchiyama 4, Yoshihiro Shimizu 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009. |
|---|
|
|
Inflection of the drug control system at the P1-339 thalidomide induction Takamitsu Ochiai, Aiko Fukui, Saori Nishiura, Tomonori Hayashi, Atsushi Hirata, Yutaka Matsuoka, Sada Tachibana sincerity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009. |
|---|
|
|
Examination of the factor which gives it to neutropenia of P1-340 docetaxel Miho Yamazaki 1, Yukiyo Funakoshi 1, Yasuyuki Saeki 2, Usui Kazuko Sana 2, Satoshi Sato person 2, Horizontal Kenji 2, Mamoru Nakamura 1, Katsuaki Takeda 1, Tadaaki Ogawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009. |
|---|
|
|
The analysis of the doubt inquiry example in the P1-341 cancer chemotherapy and construction of the prescription support system Egoe Masayoshi 1, Child 1 too rare Mochinaga, Hideaki Tokushima 1, Koga 1 to bear, Sawako Doi 2, Kazuhiro Hirano 1, 中野行孝 1, Fujito Expo 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009. |
|---|
|
|
Case study about 2 cases that showed hyperglycemia by colorectal cancer chemotherapy containing P1-342 oxaliplatin Kishimoto truth 1, Yoshihiko Shibayama 2, Kosaku Sasaki 3, Yoshimura truth 1, Kazuyuki Sunada 1, Ogyou Yukiko 1, Long ヶ Takuma Hara 1, Hirofumi Iwamatsu 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2009. |
|---|
|
|
Examination about Relative Dose Intensity of the AC therapy in the P1-343 breast cancer postoperative adjuvant chemotherapy Kenji Miyazawa 1, Makoto Hayashi 1, Hayato Sugimura 1, Akemasa Yamaya 1, Way ring Yoshio 2, Bamboo 2, Kawamo, Masato Kiriyama 2, Aspect shrine Koji 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009. |
|---|
|
|
For successful execution of the P1-344 FEC100 therapy role - of - pharmacist 芦埜和幸 1, Takeshi Shibazaki 1, Nakamura incense Sumi 3, Yumiko Suzuki 3, Hijiwara life 2, Taku Asanuma 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009. |
|---|
|
|
Action to patients with cancer explanation documentation by the P1-345 system induction Takae Koike, Yasuo Suzuki, 河内若代, Hiroko Miyake, Mitsuhiro Hatano, Yoshikuni Uchida, Takashi Hayashi clothes Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009. |
|---|
|
|
Study on P1-346 granulocyte colony-stimulating factor-responsive affector 大中博晶, Jin Tsukamoto, Toshiaki Igarashi, Ryoichi Yano, Ukuru Watanabe is flat, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009. |
|---|
|
|
The present conditions of the intravenous alimentation management for the end-of-life cancer case that became poor in oral intake in the P1-347 this hospital Masashi Bando 1, Yuji Adachi 1, 田中育太 2, Hisai Hiroyuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009. |
|---|
|
|
P1-348 Study of platelet-derived growth factor α receptor (PDGFRα) gene expression in hepatocellular carcinoma 北山知里1, 伊藤理菜1, 小林江梨子1, 櫻田大也1, 須永雅彦3, 吉川正治4, 横須賀收4, 野村文夫5, 佐藤信範2, 上田志朗1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2009. |
|---|
|
|
Association with drug handling method and the workplace environmental pollution in the P1-349 anticancer drug preparation room Jin Yoshida 1, Keiko Miyajima 1, Toshiaki Yoshida 1, Shinji Kumagai 1, Shigeki Koda 2, Nishida measure three 3, Fujiwara season Yoshiko 4, Kenzo Moriyama 4, Yuzuru Yamazoe 4, 丁元鎭 5, Chie Mochizuki 5, Measure Kie 5, Makiko Hisada 6, Tomoko Takenaka 6, Kuridani Yoshitaka 6, 西井諭司 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009. |
|---|
|
|
About an anticancer drug diffusion in the hospital pharmacy having a P1-350 anticancer drug preparation room Hiroyuki Nakano 1, Takahiro Sugimoto 1, Chie Mochizuki 1, 丁元鎭 1, 桝喜惠 1, Jin Yoshida 2, Keiko Miyajima 2, Toshiaki Yoshida 2, Shinji Kumagai 2, Shigeki Koda 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009. |
|---|
|
|
Environmental improvement case of the foreign chemotherapy room drug preparation room of this hospital by the P1-351 closed system infusion appliance induction Fujiwara season Yoshiko 1, Jin Yoshida 4, 古川諭 1, Island former Kenji 1, Tree temple Yasuhiro 1, 2, Valley Yoshihiro Mori 1, 2, Akira Kawaguchi example 1, Keiko Miyajima 4, Toshiaki Yoshida 4, Shinji Kumagai 4, Shigeki Koda 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009. |
|---|
|
|
Making of the reporting booklet aiming at effective reporting of P1-352 Gefitinib and erlotinib Naoko Shibata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009. |
|---|
|
|
Treatment evaluation of chronic myelogenous leukemia in the P1-353 Fukuoka University Hospital Kentaro Ogata 1, 2, Yasushi Takamatsu 3, 内山将伸 2, Kazuo Tamura 3, Kojiro Nikami 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009. |
|---|
|
|
Participation of the intracellular signal transduction system in cisplatin resistance of P1-354 pharyngeal cancer cells KCP-4 大磯茂 1, Ryuji Ikeda 2, Kazuo Nakamura 3, Yasuo Takeda 2, 4, Shinichi Akiyama 2, 4, Katsushi Yamada 2, 4, Kaya Hiroko Sono 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2009. |
|---|
|
|
Fact-finding ... of the cancer medical care in action ... health drugstore of the P1-355 Kyoto cancer drug cooperation meeting Shinji Honda, Yasushi Meguro, Keiichi Ono, Yasushi Sunda, Imagawa grammar Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009. |
|---|
|
|
Likelihood to a relation of a medication observance of a contract degree check and the breast cancer recurrent prevention of patients with P1-356 breast cancer Iku Yamamoto reason, 駿田怜香, Makiko Fujiwara, Noriko Iwamoto, Hitomi Sumino, Sachiko Kimura, 舛野 Megumi, 宮宇地瞳, Akane Urata, Mariko Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009. |
|---|
|
|
If P1-357 procedure, environmental management is solid, the anticancer drug exposure is avoided? Ishimaru wide knowledge, Shinji Takayama, Keiko Nikaido, Mitsuru Shiokawa, Makiko Matsui, Kazumi Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009. |
|---|
|
|
One or ... which may meet a spiritual pane at the patient compliance instruction of spiritual pane - why anticancer drug of P1-358 pharmacist and patients with cancer Kenichi in the new line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009. |
|---|
|
|
The problems that were found from the use experience of the P1-359 closed system anticancer drug preparation system "cleveite (R) on koro Gee system" Shiota history on record 1, Junko Kuroda 1, Katsuhiro Kondo 1, Tetsuo Ezaki 1, Mototsugu Kojima 1, Shoko Shibamoto 1, Kayo Koike 1, 木村和哲 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009. |
|---|
|
|
Examination about the effect of 50 mg of oxaliplatin preparation release judging from P1-360 economy, safety Yumi Tsuchiya, Masahiro Tsuda, Tadaharu Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2009. |
|---|
|
|
Search of the anticancerous platinum chelate based on P1-361 exhaustive gene expression analysis-sensitive factor Thicket field Naoki 1, History of Hisashi Takara 2, 峯垣哲也 1, Kitada Noriaki 1, Masayuki Tsujimoto 1, 西口工司 1, Teru Yokoyama reason 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009. |
|---|
|
|
Relation of a role and the pharmacist of P1-362 chemotherapy Committee Ryuta Urakawa, Kayo Matsuura, Sanae Hashimoto, 廣畑秀記, Eri Shibata, Katsunori Sakai, Katsuei Nanba, Yoshiro Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009. |
|---|
|
|
Evaluation about the safety of the anticancer drug preparation in the P1-363 Kurashiki center Hospital Kanako Moriyasu, Kenji Nishimura, Koji Moriya, Ko Tokuda period, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009. |
|---|
|
|
In P1-364 "gastric operations patients exchange meeting" the role of the pharmacist Michiko Nishie, Existence Reiko Sawa, Yasuko Watanabe, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009. |
|---|
|
|
The present conditions and problem of the team approach in medical care in the immunoradiometric therapy with P1-365 ibritumomab tiuxetan (Zevalin) Minoru Hayashi exhibition, Motoaki Abe, 清水裕彰, Tomisawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009. |
|---|
|
|
Action of the pharmacist in safety improvement and the efficiency of the cancer chemotherapy of the P1-366 this hospital 川野昭, Tatsuya Oishi, Hiroyuki Otake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2009. |
|---|
|
|
Reporting of the cancer chemotherapy using the P1-367 medicine notebook and the evaluation Terumasa Sata, Kanako Maeda, Length well Nobutaka, Kimotsuki Miho, 中拂絵里香, The pond increase sweetfish beauty, Shrine gate Takanori, Kazuko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009. |
|---|
|
|
Evaluation of the permission system in the proper use of the P1-368 antimicrobial agent, report system induction Riding ground joy arch 1, Yoshiko Harada 1, Takako Okawa 1, Kazuyo Kondo 1, Kuniyoshi Sato 1, 堀賢 2, Kazuhiro Sase 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009. |
|---|
|
|
About P1-369 carbapenem system and usability of the antiMRSA medicine report system induction Hiroshi Matsumoto 1, 3, Takafumi Nagashima 2, Shigeo Hatta 1, Yuko Sakashita 1, 3, Toyoichi Miyamoto 3, Yo Sakurai fine weather 3, Yoshiko Nakatani 3, Fumiko Inoue 3, Hiroshi Tadokoro 3, Kyoji Yamada 3, Kazuhiko Matsushita 3, Yoshiaki Matsumoto 2, Keiso Masuhara 1, 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009. |
|---|
|
|
The use situation and side effect investigation of the internal use sulfamethoxazole trimethoprim combination aiming at P1-370 proper use Shiho Enami, Yoshiyuki Hayashi, Wakimoto greens existence, Maki Nakabayashi, Hiroshi Hatano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009. |
|---|
|
|
Use fact-finding of Linezolid in the P1-371 Fukuoka Red Cross Hospital Tatsuya Oishi, 川野昭, Hiroyuki Otake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009. |
|---|
|
|
P1-372 Study of factors affecting the expression of the decrease in platelets by linezolid : The need for dose adjustment 丹羽隆1, 2, 鈴木昭夫1, 大森智史1, 吉川武志2, 安田満2, 深尾亜由美2, 松浦克彦1, 後藤千寿1, 2, 村上啓雄2, 伊藤善規1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2009. |
|---|
|
|
Antibacterial macromolecule nano structure body - that bacteriolysis does multiple drug same time resistant bacteria development -2 of the new antibacterial preparation for the P1-373 antibiotics resistant bacteria Asuka Hara, Masako Omura, Kazuto Otsuka, The Hisashi Shimizu up, Shingo Mikami, Castle Shoichi Take Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009. |
|---|
|
|
Newly antiresistant bacteria preparation - that development -3 of the new antibacterial preparation for the P1-374 antibiotics resistant bacteria used antimicrobial agent augmentation of the low, striped bamboo skillfully Yuki Fujiwara 1, 2, Akiko Kaneko 1, Jutaro Nakamura 1, Anabuki Eri 1, Hisashi Shimizu up 1, Eiichi Okada 2, Castle Shoichi Take 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009. |
|---|
|
|
Reciprocity phenomenon - of the antibacterial activity that antibiotics conjugation nanocapsule shows development -1 of the new antibacterial preparation for P1-375 antibiotics Masako Omura, Asuka Hara, The Hisashi Shimizu up, Kazuto Otsuka, Castle Shoichi Take Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009. |
|---|
|
|
The carbapenem-based antibiotic therapy to make the efficacy based on the P1-376 PK-PD theory contributes to pyocyanic selection pressure and spread restraint Yoshikazu Kobayashi 1, Yoshihiro Matsushita 2, Koji Ikuta 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009. |
|---|
|
|
Examination about the administration method and the clinical response of the P1-377 ciprofloxacin injection Shinki Kasai 1, 2, 松尾和廣 2, 判治 fifth 1, Kimura Ito period 1, Tetsuya Hasegawa 1, Takayoshi Kosugi 1, Mitsutoshi Sato 2, Kenji Nishizawa 1, Kan Noriko 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009. |
|---|
|
|
P1-378 Frequencies of the thrombocytopenia by the linezolid and examination about the recovery period 壁谷めぐみ, 湯浅周, 田尻千晴, 皆川葉子, 新木智映子, 加藤多恵, 河合優 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2009. |
|---|
|
|
Examination about the injection method of the Cefepim in consideration of MIC in P1-379 Febrile neutropenia Susumu Kudo 1, 丹代恭太 1, 蒲澤一行 1, Foot Miki Sawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009. |
|---|
|
|
It is an action of the proper use of the antimicrobial agent using Etest in P1-380 PK/PD theory Takahashi sincerity 1, Takuya Ichikawa 1, Hiroko Otsubo 1, Riyoko Asami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009. |
|---|
|
|
P1-381 Pharmaceutical Intervention and its effect on multi-drug resistant prevention of Pseudomonas aeruginosa 新康憲1, 2, 吉岡睦展1, 2, 石村さおり2, 折田環2, 萩原裕子2, 春藤和代2, 児島正道2, 森亜子2, 渡雅克1, 竹中雅彦2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009. |
|---|
|
|
A use of antimicrobial agent trend in the P1-382 this hospital and examination of the pyocyanic chemosensitive change 浅利伸朗 1, Takayuki Miyakoshi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009. |
|---|
|
|
Action to P1-383 antimicrobial agent proper use Kazunori Yamada 1, Tatsu Tomabechi next 4, Woodcut former 1, Mitsuyoshi Ozaki 2, Satoshi Suzuki 2, Your Hisashi Tanaka 3, Tadashi Sekiguchi 2, Atsushi Hojo 2, Yasuharu Aimoto 3, Nobuhito Murakami 3, 岡亨治 2, 武田利兵衛 2, Tooru Hayakawa 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009. |
|---|
|
|
Infection measures - 2007 report and evaluation - to wrestle in P1-384 area 田村健悦 1, Hiraga former 1, Hajime Nakai 2, Kazunari Nakamura 2, Kaoru Kobayashi 3, Ryohei Sakurai 3, 村上待一 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2009. |
|---|
|
|
Correspondence and antimicrobial agent proper use to the MRSA in the P1-385 orthopedics region Hiroshi Yamada group 1, 2, 3, Hiroshi Yamada length 1, Shuko Munakata 1, 宮崎晃臣 1, New Takuya Oka 1, Nobuko Kudo 2, Mutsuko Matsumiya 2, Masahiro Abe 1, New Taisuke Tobe 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009. |
|---|
|
|
The making of the use of P1-386 inside the hospital antimicrobial agent guidebook and examination about the utility Yoshikazu Kobayashi 1, Mai Tanaka 1, Teruko Takano 1, Koji Masubuchi 1, Soichi Shibata 1, Yukio Suzuki 2, 3, Atsuta Koichiro 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009. |
|---|
|
|
About the present conditions of the duration of P1-387 antiMRSA antimicrobial agent use Masahiro Someya, Yuko Ikeda, Kimishima Miyuki, 四方公亮, Toshiaki Murakami, Osamu Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009. |
|---|
|
|
The use situation of the penicillin antimicrobial agent in the P1-388 2 Hospital Chie Okazaki 1, Keiko Morimoto 1, Keiko Yamaguchi 2, Chie Takahashi 2, Tadanori Suzuki 2, West Luo Teruo 2, Kazuyo Shimojima 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009. |
|---|
|
|
The intervention to P1-389 blood cultures-positive patients and medical economic effect by de-escalation of the antimicrobial agent Hiroshi Tanaka period 1, 2, Kazumi Taguchi 2, Mari Hirabayashi 1, 2, Mikako Namiki 1, 2, Kazuhisa Ugajin 2, Kenji Marumo 2, Rumiko Kawano 2, Toshiki Kikuchi 2, Toshitaka Takenouchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009. |
|---|
|
|
Examination of the injection method based on the PK/PD theory of the P1-390 carbapenem system antimicrobial agent meropenem Field stake Naoya 1, Hirofumi Fukushi 2, Kazuya Murata 1, Satoshi Kishino 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2009. |
|---|
|
|
Effect on resistant Pseudomonas aeruginosa isolation rate that P1-391 tazobactam / piperacillin gives Ryutaro Kawamoto 1, Yasuhiro Toda 1, Yuki Miyaki 2, Yamada Toru 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009. |
|---|
|
|
Factor to affect the effect of treatment with the P1-392 antiMRSA medicine Kayo Sugimoto 1, Shoji Hashimoto 2, Yu Fujino person 3, Mitsuko Onda 1, Kazunori Asano 2, Arakawa line straight 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009. |
|---|
|
|
Correspondence to infection consultation in the active relation antimicrobial agent use to infection treatment of the P1-393 pharmacist Nishimoto incense king village, Mari Nagatomo, South tree Arisa, 上山進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009. |
|---|
|
|
Examination of the utility of the pharmacist intervention for the P1-394 antimicrobial agent proper use Toshihiko Ishizaka, Makoto Fukushima, 高橋直継, Masashi Nakagawa, Yukari Yoshihara, Hamada rabbitfish, Cape Ishibashi, Haruyo Okumura, Valley flat A Kei, Miyu Yonehara rice, Mika Kimoto, Miyatake wish, Junji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009. |
|---|
|
|
About the use situation of P1-395 LVFX and association of the quinolone resistant bacteria Yukari Yoshihara, Toshihiko Ishizaka, Makoto Fukushima, 高橋直継, Masashi Nakagawa, Cape Ishibashi, Hamada rabbitfish, Haruyo Okumura, Valley flat A Kei, U.S. Hara non-origin, Mika Kimoto, Miyatake wish, Junji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009. |
|---|
|
|
Infection measures round to be possible even if P1-396 physician is absent Forest dynasty KIBUN Co., Ltd., Izuhara Satoe, Nakata eyes, Fumie Kamata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2009. |
|---|
|
|
Cooperation of P1-397 infection control specialty pharmacist and the ward pharmacist Kimihiro Ito, Shuji Nunokawa, 伊東利紗, Ryohei Sano, History of Satoshi Hori, Soil lower Yoshimasa, Kazuya Takeda, Hiroko Yamada, Yasuo Fujimura, Masaaki Kusumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009. |
|---|
|
|
P1-398 Examination of the effectiveness of the linezolid in the our hospital 阪野和重, 山内悠起子, 三木康弘, 中西俊介, 篝忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009. |
|---|
|
|
About systematization of the blood cultures rate of use before the injectable antimicrobial agent administration according to the system in the P1-399 Shimane Prefectural center Hospital Katsuki Yokote, 滝雪歩, 森山史就, Sumiko Goto, 石野外志勝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009. |
|---|
|
|
Fact-finding of P1-400 antimicrobial agent susceptibility and the use drug 滝波昇悟 1, Auditor Hideo 1, Akemasa Imamura 1, Kawai thickness line 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009. |
|---|
|
|
Effect of the intervention due to the infection control part which gives it to P1-401 antiMRSA medicine consumption 田中亮裕 1, 2, Shinichi Watanabe 1, 2, Kayo Nakano 2, Hitoshi Miyamoto 2, Kazuo Nakanishi 2, 流郷昌裕 2, Ryoji Ito 2, Hisashi Tauchi way 2, 守口淑秀 1, Yoshiro Ikegawa 1, 末丸克矢 1, Hitoshi Hasegawa 2, Kiyoshi Takada type 2, 相引眞幸 2, Masaki Yasukawa 2, Hiroshi Araki positive 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009. |
|---|
|
|
Use situation evaluation of carbapenem system after the use of P1-402 registration system induction and the fourth generation cefem antimicrobial agent Yoshioka Nobumasa 1, Aki Kozono 1, Makoto Ishibashi 1, Ryozo Kobayashi 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2009. |
|---|
|
|
Effect by the review of use antibiotics by the P1-403 orthopedic surgery Saori Hashiguchi 1, Motomura two 1 in total, Sadaji Irie 1, Koji Hashiguchi 2, Miyako Kanazawa 3, Tsuyoshi Machida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009. |
|---|
|
|
Action ... to the antiMRSA medicine proper use for patients with activity - infection with MRSA of the infection control team (ICT) in P1-404 nosocomial infection measures Kenichi Kobayashi 1, Akemi Kawakami 2, Takeaki Nishibori 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009. |
|---|
|
|
Examination ... about the initial administration plan for all evaluation ... treated patients of the utility after the P1-405 antiMRSA medicine TDM system induction Hitoshi Suzuki, Yukiko Hayakawa, Katsuhiro Fuse, Yutaka Kamata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009. |
|---|
|
|
Use of antimicrobial agent experience to the patients whom multidrug-resistant Pseudomonas aeruginosa infection developed in after P1-406 cord-blood transplant all over the chronic GVHD course Hitoshi Yoshida 1, 2, First interview Naoko 2, Sachiko Sakurai 2, Mayumi Takase 2, Setsuko Hosobuchi 2, Teruo Yoshinaga 2, Isono Junichi 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009. |
|---|
|
|
Making of the community-acquired pneumonia drug control instruction pass which adopted the monitoring of P1-407 vital signs Matsuda law of nature beauty 1, Satoshi Kataoka 1, Makoto Tanaka 2, Hidetoshi Tamura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009. |
|---|
|
|
The consumption change of the P1-408 ethanol for disinfection product and the evaluation Noge Ichiro 1, 5, Kazumi Morishita 1, 5, Yuki Kato 1, Yoshiko Aoki 2, 5, Junko Watanabe 2, 5, Katsunori Sano 3, 5, Yasuhide Yoshida 4, 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2009. |
|---|
|
|
Examination of the infection prevention effect by the P1-409 hand lotion Mariko Aota, Masashi Sakano, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009. |
|---|
|
|
Mainly on P1-410 influenza measures questionnaire answer to infection control - from correspondence situation - 232 institutions of the whole country 高橋恭久 1, Yasuhisa Ozawa 2, Tetsuya Fukuda 1, Toshika Sato 3, Tei Yamaguchi husband 4, Taro Ono 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009. |
|---|
|
|
Use of multicenter antimicrobial agent pulse-taking (the first report) in the Tokai district using P1-411 Anatomical Therapeutic Chemical/Defined Daily Dose system Waterfall Hisashi 1, 2, Takumi Umemura 3, Yuichi Muraki 2, 4, 望月敬浩 2, 5, 片山歳也 2, 6, Ken Mori 2, 3, Takao Omagari 7, Nobuyuki Goto 3, 三鴨廣繁 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009. |
|---|
|
|
An antimicrobial agent consumption investigation using ATC/DDD system in the P1-412 Tokai district and relations (the first report) of the pyocyanic carbapenem drugs-sensitive rate Takumi Umemura 1, Waterfall Hisashi 2, 8, 望月敬浩 3, 8, 片山歳也 4, 8, Yuichi Muraki 5, 8, Ken Mori 1, 8, Takao Omagari 6, Nobuyuki Goto 1, 三鴨廣繁 7 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009. |
|---|
|
|
About a hand-washing procedure and the hand washing situation in the P1-413 health insurance pharmacy Yoshio Mori 1, Ueno eyes 2, Naomi Ono 3, 4, Iko, Mayumi Inagaki 5, Kyoko Hayashi 6, Kazuyo Hashimoto 7, Reiko Okumura 7, Masashi Sakano 8 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009. |
|---|
|
|
An action to antimicrobial agent proper use by the intervention of the P1-414 pharmacist and the result Field road Akihiro 1, Yumiko Itani 1, Kunihiko Kagawa 2, Yoshio Kitamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2009. |
|---|
|
|
Evaluation of the hand rough weather depression effect of the barrier type hand cream using making and that of P1-415 hand rough weather evaluation scale Risa Imamura 1, Masayuki Wakita 2, Tomomi Hoshino 2, Wave Noman Rie 2, Koichi Nobata 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009. |
|---|
|
|
Comparison between influenza immunization situation and side reaction - in examination -2007/08 season and 2008/09 season of the P1-416 staff Toshiyuki Kaneko 1, 2, Mayumi Takahashi 1, Flat Hiroyuki 1, 後藤眞弥 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009. |
|---|
|
|
Action of the citizen's comprehensive medical care center pharmacy attached to Yokohama City University in the P1-417 fever outpatient department Hiroko Abe, Eiji Azegami, Ishii great thinker, Shuichi Nawata, Mieko Miyazaki, Shinya Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009. |
|---|
|
|
Study on problem in the TDM enforcement time utilization to have in P1-418 hospital information system Emiko Kageyama 1, Fukumoto piece beauty 1, Takao Orii 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009. |
|---|
|
|
P1-419 acute leukemia, examination of the risk of the fungal infection onset for the patients with marrow aberrant type syndrome 土手賢史 1, 茂本孝裕 1, Ayumu Nozaki 1, Toshiko Aramiya 1, Hirokazu Nakanishi 2, Shoichi Doi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009. |
|---|
|
|
Comparison between Videofluorography and aspiration pneumonitis protective efficacy of the deglutition usability test by the language hearing person using P1-420 iohexol 樗木智聡 1, Satoshi Kamoshita 1, Tsuyoshi Yanagida 2, Kurihashi Hideaki 2, Masashi Shimomura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2009. |
|---|
|
|
Examination results ... in examination - VCM treated patients of the factor which has an influence on the effect of treatment of P1-421 MRSA pneumonia Junko Ogura, Akira Kato example, Rie Kobayashi, Wataru Arai, Yuichi Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009. |
|---|
|
|
Chemical sensitivity and the use of antimicrobial agent situation (the second report) of P1-422 clinic isolation Pseudomonas aeruginosa Koya third son 1, Kosuke Baba 2, 野口雅久 3, Masanori Sasatsu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009. |
|---|
|
|
Examination about the use of the anti-biogram for P1-423 inside the hospital pneumonia The Minoru Watanabe beauty, Masaru Nakajima, Masako Oshima, Akiko Nakayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009. |
|---|
|
|
About antimicrobial agent by the increase of the P1-424 clinical path use patients-sensitive change Keiko Fujita 1, Yoko Yoshinaka 1, Hiroyo Masaki 1, Yoshihiro Sakagami 1, Emiko Tanaka 1, 脇條康哲 1, Tomoyuki Okada 2, Yoshikazu Sakagami 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009. |
|---|
|
|
Surveillance about the antimicrobial agent rate of use and the resistant bacteria isolation rate in the P1-425 Hiroshima throughout the prefecture 11 institution Masaaki Ikemoto, Yasuo Ogasawara, Taichi Okano, Salting Koji, Keiko Kawakami, Shintaro Kurihara, Takafumi Sugawara, 橋本佳浩, This Tawa ear, Toshiharu Matsumoto, 武郷徹, 八島加八, Masahiro Yasuhara, Masako Yasuhara, Kumi Yonezawa, Sawa Akihiro, Itoki Ryozo, Yutaka Tokushima, 三牧祐一, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009. |
|---|
|
|
Action to infection measures improvement using P1-426 bacterial culture test result analysis tool Hidekazu Takamatsu 1, Takeki Nagatomo 2, 須志原陽子 3, Akira Tomita example 4, Kaoru Tateno 1, Kyoko Sato 1, Aratake Tomomi 1, Kaori Sato 1, 盛満博之 1, Akemi Nonaka 1, 盛満友美 1, Mari Kawasaki 1, Tomoko Kawakami 1, Takuya Sugiyama 1, Mai Iwamoto 1, Chiharu Mera 1, Chie Inoue 1, Taniguchi Maro beauty 1, Akiko Takemoto 1, Hama River Toshiaki 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2009. |
|---|
|
|
Antimicrobial agent proper use and evaluation for P1-427 postoperative infection prevention Maruoka eyes, Tetsuo Funamoto, Misae Takase, 飴谷太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009. |
|---|
|
|
Action to ICT activity and infection with MRSA surveillance in the P1-428 this hospital Yukiko Hayakawa, Hitoshi Suzuki, Katsuhiro Fuse, Yutaka Kamata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009. |
|---|
|
|
P1-429 false puncture measures and preventive measures against occupation infection with the vaccination Hideyuki Yanagibashi 1, Tomoyuki Miyauchi 1, Nami Matsui 2, County Takayuki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009. |
|---|
|
|
It is ... for ... basics disinfection confirmation enforcement from a present conditions investigation of P1-430 hand washing and the irrigation disinfection of the enteral feeding appliance Temple Tai incense, Yasushi Taniguchi tree, Masaru Kawase period, Yoko Kataoka, Masahiko Kitagawa, 成尾千晶, Megumi Yamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009. |
|---|
|
|
Examination about the proper use of the antiseptic hand rub using the P1-431 hand washing checker Koji Muto 1, Wataru Takizawa beauty 1, Fujita Michiyo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009. |
|---|
|
|
About aspergillus measures with the P1-432 new ridge construction Takahashi fish to eat beauty 1, Atsushi Kubota 1, Koichi Mizuno 1, Jiro Mikami 1, This point Sumi 2, Emi Kuroda 2, Katsuji Teruya 2, Toshio Shimizu 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2009. |
|---|
|
|
About the detection situation of the MRSA in the P1-433 CCU Toshiyuki Irie 1, 道越淳一 2, 永山眞紀 2, Kazuhisa Masuda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009. |
|---|
|
|
P1-434 new influenza measures ... measures and new in-hospital system ... which we let you go through and obtained Mitsuru Machida 1, Maebara Kojiro 2, Hisashi Okada product 3, Katsue Hayashi 4, Teiko Ueda 4, Takuya Ebine 1, Naohisa Koseki 1, Orimoto 1, Katsura, Nihiko Sekine 1, Satomi Yoshida 1, Matsuyo Watanabe 4, Takumi Kubota 5, Shiro Sakamoto 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009. |
|---|
|
|
A change of the injection antimicrobial agent consumption by the P1-435 DPC induction and effect on in-hospital isolate Masayuki Maeda 1, Miura Liao child 1, Chika Kawahara 2, Tadao Inoue 1, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009. |
|---|
|
|
Perform the questionary survey about infection measures in the health insurance pharmacy in action ... Higashiyodogawa-ku of infection measures in P1-436 regional alliances; and ... Kyoji Terasawa 1, Aiko Yamazaki 1, Ai Sakamoto 1, Uchiyama eyes 1, Tomoko Yamashita 1, Kitasato moral principles 2, Mayumi Yoshimura 3, Takashi Kochi 4, Ippei Morimoto 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009. |
|---|
|
|
New influenza measures in the P1-437 fever ambulatory municipal hospital which there is not Takako Yuko, Yumiko Hara, Hosomi Kengo, Hiroki Sugita, Norio Masumoto, 大槻裕朗, Yoshihisa Takao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009. |
|---|
|
|
Attitude survey for the authorized pharmacist system revision specialized in infection control by the P1-438 Nagasaki Hospital Pharmacist Association Tadayuki Harada 1, 2, Hiroo Nakagawa 1, 3, Saori Hashiguchi 1, 4, Yukiko Nagata 1, 5, Shinnichi Sado 1, 6, Koichi Kawasaki 1, 7, Takahide Araki 1, 8, Takashi Kitahara 3, Hitoshi Sasaki 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2009. |
|---|
|
|
The present conditions of infection measures in the health insurance pharmacy obtained from P1-439 questionnaire results Katsutoshi Takada 1, 2, Straight Katsumi Shiroyama 1, 3, Takao Aoyama 1, 4, 大澄朋香 1, Hiroshi Uno exhibition 1, Hisashi Iijima 1, Yoshikazu Ishino 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009. |
|---|
|
|
Action for the P1-440 vaccination promotion Sangayama Hiroki 1, Emiko Kawano 1, Atsushi Ishida world 1, Ema Matsumoto 1, Naomi Nakamura 1, Hiroko Yasunaga 1, Etsuko Okuyama 1, Norio Takahashi 1, Shinsuke Mishima 2, Toshimasa Nishiyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009. |
|---|
|
|
One discussion about new influenza measures in the P1-441 Hoshigaoka welfare annuity hospital Yoshiko Michishita 1, Takako Morita 1, Makoto Kimura plan 1, Mariko Tatsuno 1, Katsumi Oishi 2, Takato Nakamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009. |
|---|
|
|
Correspondence to new influenza in the hospital pharmacy attached to the P1-442 Kobe University School of Medicine Hideaki Daimatsu, Takashi Ueda, Kazuhiko Yamashita, Nobuko Omoto, Mikio Kakumoto, Makimoto Hiroo, Tsuyoshi Hirano, Hirai green Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009. |
|---|
|
|
Correspondence to new influenza (A/H1N1) of P1-443 seriously disabled child, the person institution and future problem Mika Arima, 大石美惠, Yamaguchi Miyuki, Takashi Mito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009. |
|---|
|
|
The impact that P1-444 new influenza A(H1N1) gave in a hospital Rika Tomita, Michiko Kishimoto, Kumiko Ohara, Kanako Ukita, Hitomi Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2009. |
|---|
|
|
About the making of the P1-445 "new influenza measures manual of the pharmacy" Yoshiyuki Tawada 1, Yukiko Kita 1, Hirotsugu Kita 1, 2, 伊波潔 2, Yuji Niisato 2, Koichi Ikehara 2, 与古田美智代 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009. |
|---|
|
|
Measurement and analysis of measles, rubella, the mumps of the P1-446 new appointment healthcare worker and the serum antibody titer for the saricella virus Jun Hosoya 1, 2, Teiko Toyoguchi 1, 2, Tadashi Shiraishi 1, 2, Atsuko Omiya 2, Hiroyuki Umino 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009. |
|---|
|
|
P1-447 Examination of prescription and characterization of severe wound treatment for a new formulation using Glyloid 6C (R) 廣瀬香織1, 笹津備尚2, 松本隆行3, 林太祐2, 4, 関根祐介5, 牛久保裕子6, 河野弥生2, 7, 原田寿7, 荻田義明2, 8, 堀川俊二9, 町田良治2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009. |
|---|
|
|
Participation of the pharmacist for the team approach in medical care in pressure sore due to P1-448 undernutrition Yusuke Nishinomiya 1, 名倉弘哲 2, 3, Yachiyo Sakamoto 3, Okuno sincerity branch 3, Yoko Sakagami 3, Takashi Senoo arrow 3, Kaori Miyake 3, Tree south Mika 3, It is still 1 Matsunaga, Sendo Toshiaki 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009. |
|---|
|
|
Intervention (the second report) to use of drug inappropriate potentially which assumed Beers Criteria for P1-449 Japan grounds Tomoyasu Watanabe 1, Megumi Yamazaki 1, Koichi Takatori 1, Tetsu Ando sincerity 1, Hirohisa Imai 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009. |
|---|
|
|
Action of the pharmacist in the P1-450 dementia treatment ward Hiromichi Suzuki 1, Rika Suehiro 1, Tomoo Nakata 1, Shuzo Abe 2, Hironobu Kurita 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2009. |
|---|
|
|
Prescription investigation of elderly patients with dementia of the P1-451 this hospital Chikako Shimokawa, Kyoko Mori, Kazuko Yamada, April first day of a month Tomiji child, Seiichi Ishikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009. |
|---|
|
|
Safety assessment (the first report) of the magnesium preparation in P1-452 elderly people Yumi Akai 1, Tomoko Aoyama 1, Yukari Mihara 1, Shikishima Yayoi 1, Seven Jo connection 1, Flower shelf Akiko 1, Yoshiko Endo 2, History of country Yuichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009. |
|---|
|
|
Point to keep in mind in the safety assessment (the second report) of the magnesium preparation in P1-453 elderly people simple suspension method enforcement 賀勢泰子 1, Tomoko Aoyama 1, Yukari Mihara 1, Yumi Akai 1, Shikishima Yayoi 1, Seven Jo connection 1, Flower shelf Akiko 1, Yoshiko Endo 2, History of country Yuichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009. |
|---|
|
|
Examination of the use drug for the standardization of the P1-454 mouth care Aya Wakamatsu incense 1, 2, North field Tomohide 1, Naomi Sogabe 1, Eriko Takano 2, Megumi Hashimoto 2, Hitomi Suzuki 2, Toshie Nagakura 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009. |
|---|
|
|
Analysis of the drug related factor to give to fall, the fall accident patients in the Mr. P1-455 care insurance institution 永瀬怜司 1, Mitsuru Iwasaki 2, Fujimura Hiroe 3, 植沢芳広 4, Okuyama immediate pupil 1, Mori Kiminori 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009. |
|---|
|
|
Use situation investigation of second generation antipsychotics (SGA) in P1-456 psychiatry inpatients Long volost Chikako, Junichiro Kato, Kazuhisa Akaishi, Masaki Kitamura, Takashi Kawakubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2009. |
|---|
|
|
Prescription fact-finding of the P1-457 antipsychotics It is still the beginning Tsuda, Jun Yoshizawa, Ai Takanashi, Kazutaka Nagashima, Shigeo Asai, Takashi Toyota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009. |
|---|
|
|
Retrograded investigation examination about the prescription situation of the P1-458 aripiprazole Tomoki Tanabe 1, Tsukiji jasmin child 1, 仲佐啓詳 1, Hiroshi Nakamura justice 1, Amount of Ariyoshi example 1, 伊豫雅臣 2, Koichi Kitada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009. |
|---|
|
|
Fact-finding of antipsychotics and the mood stabilizer combination therapy in the P1-459 schizophrenia patient and analysis of problems Yuta Nakao 1, Yuika Takahashi 2, Kenichi Sagawa 2, Jun Ishigooka 3, Your Yu Akagi 1, Takao Aoyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009. |
|---|
|
|
Quit trial - triazolam and flunitrazepam of the P1-460 benzodiazepine drugs weight loss during adoption; and - Yuko Abe 1, Asako Endo 1, Koba Sani beauty 1, Kenzo Miyazaki 1, Koichi Oda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009. |
|---|
|
|
One patient who felt the need in consideration of interaction due to the P1-461 drug metabolism Yumiko Yada, 新美詠彦, Reiko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009. |
|---|
|
|
Relations of hyponatremia formation and the Ht level decrease in the P1-462 psychiatry region The Yasushi Mukai truth, Hideki Shiraiwa, Mitsuru Watanabe village, Long Mitsunori season Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2009. |
|---|
|
|
Analysis about the weight gain of atypical antipsychotic agents in the P1-463 University of Tokushima Hospital Yasushi Kirino 1, Kazuhiko Teraoka 1, Hisatsugi U.S. Toshihide 1, Kazuyoshi Kawazoe 1, Tetsuro Omori 2, Kazuo Mizuguchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009. |
|---|
|
|
Action of the pharmacist for the purpose of the prevention of the readmission in the P1-464 psychiatry Haruko Shimada 1, Kenji Doi 1, 山口長浩 2, Kaji tail a lot of years 1, Okada early period 1, Yuki Tokunaga 1, Yoko Fujii 1, Masako Ogawa 1, Hitoshi Harada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009. |
|---|
|
|
Relation of the pharmacist to medication management, the education for patients in the P1-465 psychiatry hospitalization ridge Watanabe Tarou 1, 藏田康秀 1, Toshiyuki Imanaga 1, Miyoshi straight celebration 2, Shinji Isomura 3, 兼行浩史 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009. |
|---|
|
|
Study on sodium valproate doses for P1-466 bipolar patients and therapeutic range Nagoshi hsiang tsai child 1, Yuki Tobita 1, 2, Takeshi Hirayama 1, 2, Chihiro Kawano 1, 2, Masaichi Kuroyama 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009. |
|---|
|
|
About the effect that P1-467 smoking gives in the TDM of the psychotropic drug Satoru Koizumi child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009. |
|---|
|
|
Trial of the blood glucose monitoring in case of the P1-468 atypical antipsychotic agents administration Well bird Keiichi 1, Shu Hayashi Ichiro 2, Kazuhide Hayashi 2, Takashi Hayashi child 1, Tadashi Inomata 1, Kano South Seas child 1, Yumiko Ito 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2009. |
|---|
|
|
Report about the review of the antipsychotics using the CP reduced value in the P1-469 this hospital mind medical treatment ward Current Keita, Nagadome dance, Night Keiko, Hiroyuki Yoshinaga, Masazumi Imakiire, 中島泰廣, Hideya Samejima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009. |
|---|
|
|
About a serum magnesium level of patients with magnesium oxide preparation taking P1-470 Otaru City brain, circulatory organ, heart investigation in the medical center psychiatry Katsusane Tsurutani 1, 2, Ai Yokoyama 1, Mari Kasahara 1, Makiko Honma 1, Dotani 1-saving, Hiroshi Shirai 1, Akiko Takeya 1, High circle Yuji 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009. |
|---|
|
|
Out of the hospital prescription situation investigation of the antipsychotics in the P1-471 schizophrenia outpatient Taisuke Fukushima 1, Toshie Ishii 1, Masako Kasahara 1, Koichi Watanabe 1, Ohira good luck 1, 恒木 Masami 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009. |
|---|
|
|
Likelihood as antidepressants of P1-472 hydrophobicity dipeptide Leu-Ile Yoko Hibi 1, Atsumi Nitta 1, Takeshi Ikeda 2, Koji Morishita 2, Ebi Daisuke 1, Al cam torr loss 3, Toshitaka Nabeshima 3, Kiyobumi Yamada 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009. |
|---|
|
|
Construction of drug control instruction duties for the adherence improvement of the patients in P1-473 psychiatric hospitals Ball place Ai 1, Akira Sakai 2, Motoko Sato 2, Yukiko 2 between the pond, Kiyohide Matsuzaki 2, 田伏英晶 3, Yukihiro Noda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009. |
|---|
|
|
The present conditions and problem of the P1-474 schizophrenia patient education (medicine classroom) Azusa Matsumoto, Yuichi Umeda, 進健司, Katsuji Hayashi, Shinsuke Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2009. |
|---|
|
|
Measurement of the stress-related material out of the saliva of patients with depression in the P1-475 psychiatry outpatient department Nobuaki Egashira 1, Naoki Uchida 2, Ayumi Ishibashi 3, Plover Shozo 2, Kenichi Mishima 3, Katsunori Iwasaki 3, Ryoji Nishimura 2, Ryozo Oishi 1, Michihiro Fujiwara 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009. |
|---|
|
|
1 case that showed quality of life improvement by P1-476 team approach in medical care Miki Sato, 曽我師賢, Isurugi Ikuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009. |
|---|
|
|
Attitude survey of the pharmacy student for the schizophrenia patient with the P1-477 new curriculum induction Saito hundreds of branches beauty 1, Machiko Watanabe 1, Watanabe many Maki 1, Shigekazu Watanabe 1, 土屋雅勇 1, Keiko Yamaoka 1, Shinichi Niwa 2, Keizo Inoue 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009. |
|---|
|
|
About the questionary survey "background and consciousness of the seminar participant" about the pharmacist seminar specialized in psychiatry in the P1-478 Sapporo Hospital Pharmacist Association Isurugi Ikuko 1, 2, Takako Toi 2, 3, Miki Sato 1, 2, 斉藤嘉津彦 2, 4, Hongo education 2, 5, Kiyotaka Takeda 2, 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009. |
|---|
|
|
Study - ever change about the media news (newspaper article) associated with the P1-479 sleeping drug for 20 years and discussion - Yoshinobu Sasaki 1, 堺慎太朗 2, Takeshi Hirayama 1, Field ヶ 谷浩邦 2, Masaichi Kuroyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009. |
|---|
|
|
Examination about division characteristics of the P1-480 suppository Asako Terashima, Kayoko Maezawa, Junko Kitsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2009. |
|---|
|
|
Questionary survey - Red Cross about the spread of P1-481 simple suspension methods, virtue County Council, Saiseikai, public welfare ream, count results ... of the medical treatment type Nishizono Kenro 1, 2, Koto Fujiwara 3, Junichi Iida 4, Teruaki Okura 5, 賀勢泰子 2, 6, Tetsu Ando sincerity 2, Is Kurata; see it; 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009. |
|---|
|
|
It is ... for reevaluation - continuation-like inhalational instruction of the patient compliance instruction in the P1-482 inhalation steroid medicine 寺戸靖 1, Naoya Tanaka 2, Sumiko Kondo 1, Hidekazu Tanaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009. |
|---|
|
|
About the Tocilizumab induction investigation for the RA patients in the P1-483 this hospital Yumiko Itani 1, Masao Nishida 1, Yoshio Kitamura 1, Shiro Oshima 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009. |
|---|
|
|
It is used fondaparinux in the VTE prophylaxis and the low molecular weight heparin properly after P1-484 cosmetic surgery procedures Hamada rabbitfish, Toshihiko Ishizaka, Makoto Fukushima, 高橋直継, Masashi Nakagawa, Cape Ishibashi, Yukari Yoshihara, Haruyo Okumura, Valley flat A Kei, U.S. Hara non-origin, Mika Kimoto, Miyatake wish, Junji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009. |
|---|
|
|
About the association between use situation and change of the prophylactic antimicrobial agent cefazolin of the nonsteroidal pain-killer after the P1-485 operation on the heart Seiji Machida, Toshiaki Tomita, Masaru Fukushima friend, Kazuhisa Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009. |
|---|
|
|
Relation of the pharmacist for the biological preparation induction pass hospitalization of patients with P1-486 articular rheumatism Tomoyo Nakajima 1, Asahara Minoru straight 1, Toshihiko Ushio 1, Kojiro Takahashi 1, Kazuhisa Nakano 2, Riyosai Tanaka 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2009. |
|---|
|
|
The use of opioids in the mild medical care of the P1-487 nerves intractable disease and the effect Natsuko Ishida 1, 佐野晃宏 1, Kazumasa Murakami 1, Chiho Ishida 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009. |
|---|
|
|
Efficacy of clopidogrel for P1-488 patients with acute coronary syndrome and safe examination Ooi greens Yoshiko, Yukari Hayashi, Tsuyoshi Fujita is flat, Takahiro Murakami, Hiura Kazuya, Shuji Azuma, 高山範康, Takato Imai, Hiroshi Tamura, 目黒亨治, New home Kiminori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009. |
|---|
|
|
Effect on effect of treatment of the P1-489 peginterferon weight loss and examination about weight loss criteria Fumiko Nagakura 1, Shigeo Hatta 2, Chisato Kawahata 2, Eiko Komiya 2, 浅見妥江 2, Yuko Sakashita 2, Keiso Masuhara 2, Ikuo Oike 1, Tomoji Osawa 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009. |
|---|
|
|
A side effect evaluation at the P1-490 peginterferon ribavirin combination therapy and revision of the check list Katsuhiko Owada 2, Toru Numano 1, Yasuko Kumagai 1, Toshiaki Akatsu 1, Kato Kei Mizuki 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009. |
|---|
|
|
Comparison between characteristic - ticlopidine and clopidogrel of the onset of liver damage with the P1-491 thienopyridine system antiplatelet drug Naoki Shimomura 1, Mitsutoshi Sato 1, Daisuke Kishi 2, Koji Hamada 2, Keiko Fukuda 2, 雪吹周生 3, Kiyohiko Seino 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009. |
|---|
|
|
Measures of the use situation and the side effect reduction of P1-492 temozolomide Kazuko Kawai 1, Satoru Kato next 1, Seiichi Ito 1, Takamitsu Akita 1, Noriyuki Maeda 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2009. |
|---|
|
|
P1-493 For the purpose of proper drug treatment of clinical Medicament business the way (23): Analysis of patient and a lot of drugs brought the remaining drugs number 神崎久美子1, 磯部芳江1, 鈴木聖1, 久保智美1, 樋口和子1, 小坂信二1, 福岡憲泰1, 飯原なおみ2, 二宮昌樹2, 芳地一1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009. |
|---|
|
|
Consciousness - of the patients for way (24)- medication and the treatment of P1-494 clinical pharmacy duties for the purpose of the appropriate medical treatment Yoshie Isobe 1, Kumiko Kanzaki 1, Sei Suzuki 1, Sakae Matsuoka virtue 3, Masatoshi Kagawa 3, Shinji Kosaka 1, 福岡憲泰 1, Is Iibaru; see it; 2, Masaki Ninomiya 2, 芳地一 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009. |
|---|
|
|
P1-495 Therapeutic effect and the viral kinetics of PEG-IFNα-2b and Ribavirin combination therapy for type 1 and high viral load chronic hepatitis C : Use the Rebound Index 笹瀬典子1, 中尾啓子1, 山本香織1, 志方真央1, 木村訓世1, 大谷綾1, 金啓二1, 浅田裕美子2, 白川祥実2, 黒田絵理2, 北河修治2, 門前縁3, 吉野伸3, 金守良4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009. |
|---|
|
|
A utility and safety of the double filtration plasma exchange (DFPP) combination IFN therapy for the P1-496 chronic hepatitis C intractable case Kaori Yamamoto 1, Keiko Nakao 1, Shikata Mao 1, Satoshi Kimura world 1, Aya Otani 1, Bamboo grass shallows Noriko 1, Keiji 1 Kim, Yumiko Asada 2, Sho Shirakawa true 2, Eri Kuroda 2, Shuji Kitagawa 2, Door front relationship 3, Shin Yoshino 3, 金守良 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009. |
|---|
|
|
Efficacy of the rosuvastatin in P1-497 elderly people and safe evaluation Kazutaka Hiraga, Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009. |
|---|
|
|
Child dose of the renal excretion type drug based on P1-498 physiological fluid volume distribution and the renal function development Hiroyuki Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2009. |
|---|
|
|
Clinical significance of the foreign antimicrobial agent intravenous-injection treatment in the P1-499 community-acquired pneumonia Risa Takagoshi 1, Takao Shimizu 2, Shinichi Nakamura 1, Willow comfort intellect justice 2, Yoshihiko Kida 1, Ken Sano 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009. |
|---|
|
|
It is ... through relation ... graduate school ward training to pharmacotherapy in the P1-500 ischemic heart disease Mari Ishikawa picture 1, Sayaka Takahashi 1, Sachiko Tanaka 1, 沼澤聡 1, 北原加奈之 2, Koji Karasawa 2, Junichiro Murayama 2, Takemi Yoshida 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009. |
|---|
|
|
About the lipids improvement in the P1-501 insulin resistance improvement agent Kana Kato, Takako Nakajima, Yuichiro Wada, Sakaki source Yoichi, Eri Wakita, Shigeru Yamada tree Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009. |
|---|
|
|
Examination of the effect of the bevacizumab intravitreal administration on P1-502 growth diabetic retinopathy Okuyama immediate pupil 1, 2, 永瀬怜司 2, Nozawa (Ishii) Reiko 3, Koichi Takeuchi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009. |
|---|
|
|
P1-503 anti-peptic ulcus agents sofalcone improves the inflammatory interaction of fat cells and the macrophage and restrains the differentiation of fat progenitor cells Kenji Onda, Hideaki Tanaka, Nakamura star, Tomoya Tazaki, Toshihiko Hirano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009. |
|---|
|
|
Effect on examination - arteriosclerosis risk factor - of the medical treatment evaluation check seat of the drug control instruction duties standardization for P1-504 acute myocardial infarction inpatients Kyoko Nomura, 岡城彩, Kiyotaka Inoue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2009. |
|---|
|
|
Examination and efficacy of the methotrexate (MTX) dose at renal dysfunction in the P1-505 articular rheumatism (RA) patients Aya Yoshida 1, Yukiko Ishii 2, 小林靖奈 1, Takeo Isozaki 3, Ryo Takahashi 3, Noriyuki Yajima 3, Yusuke Miwa 3, Tsuyoshi Kasama 3, Junichiro Murayama 4, 山元俊憲 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009. |
|---|
|
|
Investigation of the factor influencing anticoagulant action of heparin in the P1-506 percutaneous transluminal coronary angioplasty Ito greens wave 1, Ayumu Nozaki 1, 茂木孝裕 1, Tomoko Fujita 1, Toshiko Aramiya 1, Hirokazu Nakanishi 2, Enjoji Yoshihisa 3, Shigeru Nakamura 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009. |
|---|
|
|
Advantage of drug control instruction duties in National Cardiovascular Center where P1-507 medicine and surgery makes concomitance Yuta Kato 1, 小嶋文良 1, 2, Tomoya Sato 1, Teiko Toyoguchi 1, Tadashi Shiraishi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009. |
|---|
|
|
Examination of the arteritis depression effect with the antiTNF - alpha therapy using the P1-508 kawasaki disease arteritis model Hiroshi Mamata 1, Seki, Ohara Toshiaki 2, Satoshi Muto 3, Mizuho Takahashi 1, Satoshi Takahashi 2, Kiyomi Sadamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009. |
|---|
|
|
Making of the P1-509 kawasaki disease fur Matthew tical care worksheet 詫間章俊 1, Hitomi Wakabayashi 2, Fuke Shunnya 2, Junichiro Murayama 2, Yasuko Nakano 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009. |
|---|
|
|
Trend of the use of chronic hepatitis type B therapeutic drug patients in the P1-510 this hospital Landowner Takafumi, Up valley Kana, Naoya Suzuki, Tomoaki Hatakeyama, Maiko Segawa, 嶽石茉里, Shohei Kawahara, Makoto Takahashi, Jin Hatanaka University, Hiroshi Iwamoto, Masaomi Tanaka, Tadahiro Aota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2009. |
|---|
|
|
Study of the peripheral T cells-related factor about utility of the cyclosporine therapy in P1-511 patients with myasthenia gravis Sachiko Tanaka 1, Nao Yamada 1, Kanako Nakajima 1, Masayuki Masuda 2, Nobuhiro Ido 2, Takashi Otsuka man 2, Masashi Nishida 2, Hironari Utsumi 2, Toshihiko Hirano 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009. |
|---|
|
|
P1-512 Study of health-related QOL of PEG-IFNα-2a and PEG-IFNα-2b in patients with chronic hepatitis C 杉本智恵子1, 平野克治2, 玄田拓哉2, 市田隆文2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009. |
|---|
|
|
Examination about the number of the concussion method of the P1-513 suspension type fixed-quantity aerosol-type inhalational steroid medicine and the necessary concussion Masashi Sakano 1, Izumi Shimada 2, Takasaki lawn world 3, 柏宗伸 4, Ryo Matsushita 5 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009. |
|---|
|
|
Utility of the trainer, exercise device in the P1-514 inhalational instruction Mitsuyo Takemura 1, Fusa Honna beauty 1, Kyoko Kaga 1, Akira Kodama person 1, Shinsuke Mori 1, Appearance open Toyoko 1, Fumio Tsuji 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009. |
|---|
|
|
One case that used a cyclosporine ophthalmic solution together for eyes lesion in toxic epidermal necrolysis that progressed from P1-515 Stevens-Johnson syndrome Yagi Takahiko 1, Etsuko Honda 2, Hideki Mori 2, Masaru Inoue 3, Mutsuko Kato 4, Kazuaki Shinomiya 1, Sendo Toshiaki 5, Manager former man 2, Yoshihisa Kitamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009. |
|---|
|
|
Likelihood of weight loss, the cancellation of the steroid medicine internal use in infliximab treated patients of the P1-516 this hospital Akemi Nonaka, Kaoru Tateno, Aratake Tomomi, Kaori Sato, Hidekazu Takamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2009. |
|---|
|
|
Examination of the pain relief by the P1-517 clonidine 盛満友美 1, Kyoko Sato 1, Hidekazu Takamatsu 1, Takeshi Uno 2, Shingo Tateyama 2, Ritsuko Ono 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009. |
|---|
|
|
Hypotensive effect of ethyl icosapentate (EPA) for the patients who complicated P1-518 arteriosclerosis obliterans and hyperlipidemia Eri Sugiyama 1, Sato Bansei 2, Yukiko Takahashi 1, Daisuke Teraoka 1, Takafumi Nagatomo 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009. |
|---|
|
|
Evaluation - of making and the utility of patient compliance instruction - medication manual for the P1-519 HIV outpatient Mariko Arai 1, Marie Nakamura 2, Hiroyuki Tanaka 1, Ayako Wada 1, 斉京明子 1, Hajime Matsubara 1, Kazuo Yago 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009. |
|---|
|
|
The present conditions of the pharmacist intervention to foreign HAART in the P1-520 St. Marianna University School of Medicine Hospital Kanako Nakajima 1, Kano sheath or 1, 濱野公俊 1, Mieko Yokoyama 1, Yorihisa Miura man 2, Keiso Masuhara 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009. |
|---|
|
|
About the present conditions and the problems of questions and answers about the pharmacotherapy to P1-521 pregnant woman, nursing mother Aya Hachisuka 1, Soichi Shibata 2, Teruko Takano 2, Kuwahara Funato charges 2, Koji Masubuchi 2, Atsuta Koichiro 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009. |
|---|
|
|
Case control study about the use of antimicrobial agent during P1-522 pregnancy Kudo sheath or 1, Bamboo blind Takashi 1, Eriko Kobayashi 1, Daiya Sakurada 1, Noboru Sato example 2, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2009. |
|---|
|
|
Making of the brochure about nursing and the use for the P1-523 nursing mother of drug 丸田樹明, Katsuyo Akiko, Yuko Tanaka, Yasuhiro Tomita, Chiyoko Arima, Ikuo Nagata, Mieko Tsuruta, Michio Sada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009. |
|---|
|
|
Attitude survey for medical supplies, the supplement of the pregnant woman who participated in the P1-524 mothers' class Yoshiyuki Miyasaka, Maho Miyake, Saori Takano, 山口茉都夏, Cheap Takeo, Relation bowl Hideo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009. |
|---|
|
|
"Consciousness for the medicine" of P1-525 pregnant woman, the nursing mother and the related factor Takagi Kayoko 1, Iwaki Akifumi 2, Mitsuko Onda 1, Arakawa line straight 1, Naoki Nishikawa 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009. |
|---|
|
|
From questionary survey in the P1-526 BFH Hospital (to the action program of the pharmacist) Iwaki Akifumi 1, Takagi Kayoko 2, Mitsuko Onda 2, Arakawa line straight 2, Naoki Nishikawa 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009. |
|---|
|
|
Attitude survey for the self-medication of P1-527 pregnant woman, the nursing mother Tomoko Fujita 1, Kaoru Nakajo 1, Hiromi Kinoshita 1, Nakamoto celebration of longevity husband 2, It is still I 2 Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009. |
|---|
|
|
Prediction of the milk transitivity using the properties of matter parameter of the P1-528 drug Koedo Taiki, 伊藤晃成, Hiroshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2009. |
|---|
|
|
Use experience of the low-dose aspirin in the P1-529 anti-phospholipid antibody syndrome Emi Honda 1, 今田愛也 2, Tail Asuka Sako 1, Mayuko Soma 1, Yoichi Sasaki 1, Hiroshi Yoshida 3, Noboru Sato example 4, Inotsume Nobuo 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009. |
|---|
|
|
Investigation - in attitude survey - mother class about the medicine of the P1-530 pregnant woman Kazuko Uematsu 1, Eiko Kobayashi 1, Masanobu Odaka 1, Hiroko Imoto 2, Kana Hashimoto branch 2, Mitsuhiro Sugimoto 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009. |
|---|
|
|
Relation of the pharmacist in the maternity ward of the P1-531 this hospital Saki Watanabe child 1, Tomura sum rare 1, West Tomoko 1, Let go through; Akiko 1, Teahouse Yukiko 2, Akemi Inoue 2, Hiromi Motoyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009. |
|---|
|
|
P1-532 Creating side effects expression situation and the patient for side effects description brochure of pregnant women who were administered Utemerin 増田はるか1, 小坂好男1, 漣由水1, 牧野仁美2, 正岡直樹3, 坂井昌人4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009. |
|---|
|
|
Examination of usage and the blood magnesium level of P1-533 magnesium sulfate preparation Yoshie Nomura 1, Rock fence Shigeki 2, Takahiro Kumagai 1, Yukiko Shibata 1, Yumi Suzuki 1, Takuya Goto 1, Makoto Nakajima 1, Kimio Wakabayashi 1, 加藤浩充 1, Shuichi Matsumoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009. |
|---|
|
|
Fact-finding of the P, Ca level of the patient on dialysis by the P1-534 multicenter conjugation Shintaro Takayama 1, Kazuharu Fukuno 2, 10, Hideki 3 in the appearance, 10, Ryu Kobayashi 4, 10, Tatsuya Ito 5, 10, Masaru Fujii 6, 10, Kimito Oshita 7, 10, Takayuki Miyakoshi 2, 10, Hideki Sato 8, 10, Kiyotaka Takeda 3, 10, Michiya Kobayashi 9, 10, Koji Saito 9, 10 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2009. |
|---|
|
|
The renal function investigation of the patients in the P1-535 chronic disease internal medicine outpatient department and promotion of the appropriate administration 中村孝佑, Hiroshi Yamazaki man, Masanori Oda, Fumiaki Miyamae, Kawano table Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009. |
|---|
|
|
Relation of fact-finding and the pharmacist of the chronic renal failure in the P1-536 acute phase ward Hiroshi Hori child, Yuko Kuroki, Kumagaya wish, 大汐欣輝, Junko Fukunaga, Kyoko Yamaguchi, Posterior Hiroyuki Sako Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009. |
|---|
|
|
Effect to give to the serum potassium concentration of the drug in patients with renal failure for P1-537 conservation period Takenoshita Minoru Eda 1, Noriko Takeuchi 1, Ayano Kato 1, Eriko Kobayashi 1, Daiya Sakurada 1, Noboru Sato example 2, Shiro Ueda 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009. |
|---|
|
|
About the effect of treatment with the optimal dose by the P1-538 renal function degeneracy Takuma Oiwa, Hiroshi Sakata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009. |
|---|
|
|
The present conditions and problem of the composition of the amino acid preparation in the parenteral nutrition performed in P1-539 blood maintenance patient on dialysis Yasushi Asai term, 東敬一朗, Hiroko Okawa, Sparrow good luck way, Kenichi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009. |
|---|
|
|
Pharmaceutical management in medical treatment patients using the P1-540 CKD check sheet Junko Fukunaga, 大汐欣輝, Hiroshi Hori child, Posterior Hiroyuki Sako Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2009. |
|---|
|
|
Examination about the anemia in renal disease treatment manual in the P1-541 patient on dialysis 松井七奈 1, Masaru Watanabe 1, Yu Kubo 1, Miyuki Imada 1, Yumi Abe 2, Shunichi Fujita 2, 儀間充 2, 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009. |
|---|
|
|
About effect on renal function of ARB in the P1-542 CKD patients Hiroshi Hozumi, Masayuki Hirose, Yoichi Sakakibara, Yuichi Takemoto, Ayumu Ichimura, Hiromi Sakai, Shigeru Yamada tree Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009. |
|---|
|
|
For support of the formulation study depending on CKD measures renal function by the P1-543 pharmacist Ema Matsumoto, Emiko Kawano, Sangayama Hiroki, Hiroko Yasunaga, Naomi Nakamura, Etsuko Okuyama, Niizaki Takao, Norio Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009. |
|---|
|
|
Examination of the efficacy of the China Cal Seto hydrochloride for the secondary hyperparathyroidism under the P1-544 maintenance dialysis 宮宗宏, Ayako Oka, Hiroshi Kita University, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009. |
|---|
|
|
The effect that P1-545 calcium receptor agonist gives to the serum oxidative stress of patients with secondary hyperparathyroidism Hiroshi Watanabe 1, Akira Tokunaga oneself 1, Katsumi Mera 1, Motoko Tanaka 2, Masashi Fukagawa 3, Odagiri A tree 1, Toru Maruyama 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009. |
|---|
|
|
About the correspondence to the new style of the adverse event report with the P1-546 revised GCP enforcement Masami Kawahara 1, 2, Kenichi Miyamoto 1, 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2009. |
|---|
|
|
The setting of the special germfree laboratory in conformity with the P1-547 investigational new drug GMP and the use Machiko Oka, Toyokuni cherry blossom Hideaki, Jun Yonezawa, 寺田智祐, Toshiya Katsura, Kenichi Inui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009. |
|---|
|
|
Examination about the cost effectiveness of P1-548 clinical report coordinator duties Mizue Shida 1, 2, Yumiko Saito 1, 2, Mika Maeda 1, 2, Naoko Kamimiya 1, 2, 高橋賢成 1, 2, Yukio Ogawa 1, 2, 佐藤士朗 2, Yasuhiko Ikeda 2, Yuji Kumagai 2, Masaichi Kuroyama 2 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009. |
|---|
|
|
The review of pharmacy trial duties as the P1-549 trial core Hospital and the result and future role Ikuyo Ueda, Naoki Kondo, Funasaki Hideki, Genei Shinya, Mai Itagaki, Tomoko Ogawa, Yoshizo Watanabe, Ichiji Endo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009. |
|---|
|
|
About trial secretariat duties with the making of the summary of the record of the meeting of the P1-550 IRB Hajime Yamazaki, Sakiko Ichijo, Yoko Kawamura, Naomi Yamamoto, Megumi Harada, Hideyuki Hayashi, Kazunori Asano, Sako field Saburo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009. |
|---|
|
|
An action to the trial enlightenment to the patients using P1-551 trial brochure and the evaluation Naomi Kawabata 1, Bell Yuko 1 old, Saeko Naito 1, Hiroki Tamaki 1, 2, Yoshitomo Nozu 1, Nobuhiro Nishimura 2, 直良浩司 1, 2, Hideyuki Kawauchi 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009. |
|---|
|
|
About the making of environment for P1-552 clinical studies enforcement of trial management room in -179 beds of acute phases Hospital and clinical Research Department wrestle; - Depths Jo Makiko 1, Fumi Inada 2, Ishikawa Nanase 2, Mika Kozai 2, Yosuke Oka 2, Mayumi Okazaki 2, Tomoya Asada 2, 眞鍋伸次 2, 森由弘 3, Thickness well Bunichi 3 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2009. |
|---|
|
|
Epicritic difference in new bar code by the P1-553 bar code leader Inui ratio Isano, Makiko Nakano, Nishisato Yuri, Rika Kiyokawa, Kazuyuki Ikeda, Yukiko Morita, North Keiji, Masayuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009. |
|---|
|
|
P1-554 A study on the distribution drugs confirmation of pharmacist : In the orthopedic ward 岡田志保, 下川福子, 山内祐人, 森本由美, 野口久美子, 川嵜英二, 安本祥子, 堀川泰清, 韓秀妃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009. |
|---|
|
|
Action to "physician - pharmacist collaboration type medical information training" in the P1-555 School of Medicine clinic training Fumiko Suzuki 1, Iida A Taro 1, Yotaro Matsumoto 1, Tomoko Uenishi 1, Yuriko Murai 1, 2, Shigeru Asada period 3, Satoshi Arai line 4, Miki Shimada 1, 眞野成康 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009. |
|---|
|
|
Recognition investigation of the democracy about the role of the P1-556 pharmacist Suzuko Kubo 1, Miwako Kamei 2, Reiko Motojima 3, Yoichi Hasegawa 4, Ichiji Endo 5, 七海朗 6 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009. |
|---|
|
|
About P1-557 Tris(2-ethylhexyl)Trimellitate and the degradation product Harunobu Iwase 1, Fumio Soeda 2, 大磯茂 3, Flower garden Megumi 2, Eagle head Asami 2, Ryuji Ikeda 4, Kaya Hiroko Sono 3, Kazuo Takahama 2, Kazuo Nakamura 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009. |
|---|
|
|
Intraoral collapse (OD) film with P1-558 heat seal characteristics 廣永麻貴, Takeshi Miyata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2009. |
|---|
|
|
Examination of the contributing factor to achievement of LDL-Cholesterol target value for hypercholesterolemia of the P1-559 statin remedy patients 藤戸靖久, Miyako Kihara, Yukiyo Monma, Yutaka Ichikawa oneself, Shinya Nakanishi, Hideko Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009. |
|---|
|
|
It is the discussion based on data in 2008 in this hospital the examination about the factor about the improvement of the P1-560 patient compliance instruction efficiency Masako Ieda, Morihiro Nomura, Yasuyuki Tsukioka, Ken Yamazoe, Yutaka Kuwano line, Kenzo Moriyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009. |
|---|
|
|
Role of the ward permanent residence pharmacist in the quality improvement of the P1-561 medical care Yasuaki Ide, Takishima sheath, Mieko Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009. |
|---|
|
|
It is ... through overseas support activity - Red Cross Bogor hospital pharmacy duties support by the P1-562 pharmacist in Indonesia Sakawa hardy 1, Eiko Kobayashi 1, 槙島敏治 2, Masanobu Odaka 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009. |
|---|
|
|
Evaluation of the utility in the package of the P1-563 bisphosphonate once a week remedy preparation Mizoguchi A 1, Takashi Tomizawa 2, 倭文啓恵 1, Motoi Makoto Wada 3, Kiyomi Sadamoto 1 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009. |
|---|
|
|
Information exchange with the dialysis room staff to push forward through P1-564 exchange diary 酒井孝征 1, Yusuke Watanabe 1, Chiaki Yasui 1, Aki Kuwahara 1, Takashi Joko person 1, Taka Hayashi child 1, Okuda Kei three 1, Depths Asami 2, Fujihashi quiet 2, Yoko Morioka 2, Eiko Tsutsumi 2, Silk river Ayano 3, Kunimi Nagasaka 3, Masashi Izawa 3, 西崇男 4, Watarida Shoji 4 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2009. |
|---|
